0001493152-18-018010.txt : 20181227 0001493152-18-018010.hdr.sgml : 20181227 20181227172533 ACCESSION NUMBER: 0001493152-18-018010 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181227 DATE AS OF CHANGE: 20181227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Digipath, Inc. CENTRAL INDEX KEY: 0001502966 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 273601979 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54239 FILM NUMBER: 181255294 BUSINESS ADDRESS: STREET 1: 2360 CORPORATE CIR STREET 2: SUITE 400 CITY: HENDERSON STATE: NV ZIP: 89074 BUSINESS PHONE: 702-527-2060 MAIL ADDRESS: STREET 1: 2360 CORPORATE CIR STREET 2: SUITE 400 CITY: HENDERSON STATE: NV ZIP: 89074 FORMER COMPANY: FORMER CONFORMED NAME: DigiPath,Inc. DATE OF NAME CHANGE: 20101006 10-K 1 form10-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended September 30, 2018

 

OR

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission file number: 000-54239

 

 

DIGIPATH, INC.

(Exact name of registrant as specified in its charter)

 

NEVADA   27-3601979
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

6450 Cameron Street, Suite 113

Las Vegas, Nevada 89118

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (702) 527-2060

 

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes [  ]             No [X]

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.

Yes [  ]            No [X]

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]             No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes [X]            No [  ]

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Accelerated filer [  ]
Non-accelerated filer [  ] Smaller reporting company [  ]
Emerging growth company [X]    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ]           No [X]

 

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant based upon the closing price of $0.21 per share as of March 31, 2018 was approximately $8,120,756.

 

As of December 25, 2018, there were 43,257,277 shares of registrant’s common stock outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE: None

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
PART I    
Item 1. Business   1
Item 1A. Risk Factors   5
Item 1B. Unresolved Staff Comments   9
Item 2. Properties   9
Item 3. Legal Proceedings   9
Item 4. Mine Safety Disclosures   9
PART II    
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   10
Item 6. Selected Financial Data   12
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations   13
Item 7A. Quantitative and Qualitative Disclosures About Market Risk   18
Item 8. Financial Statements and Supplementary Data   19
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   20
Item 9A. Controls and Procedures   20
Item 9B. Other Information   20
PART III    
Item 10. Directors, Executive Officers and Corporate Governance   21
Item 11. Executive Compensation   22
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   25
Item 13. Certain Relationships and Related Transactions, and Director Independence   26
Item 14. Principal Accounting Fees and Services   26
PART IV    
Item 15. Exhibits and Financial Statement Schedules   27
SIGNATURES   29

 

 

 

 

PART I

 

Forward Looking Statements

 

This Form 10-K contains “forward-looking” statements including statements regarding our expectations of our future operations. For this purpose, any statements contained in this Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control.

 

These risks and uncertainties include demand for our products and services, governmental regulation of the cannabis industry, our ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of our liquidity and financial strength to support our growth, general economic and market conditions; our ability to sustain, manage, or forecast growth, our ability to successfully make and integrate acquisitions, new product development and introduction, existing government regulations and changes in, or the failure to comply with, government regulations, adverse publicity, difficulty in forecasting operating results, change in business strategy or development plans, business disruptions, and the ability to attract and retain qualified personnel. Although the forward-looking statements in this report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. In light of these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, we undertake no obligation to announce publicly revisions we make to these forward-looking statements to reflect the effect of events or circumstances that may arise after the date of this report. All written and oral forward-looking statements made subsequent to the date of this report and attributable to us or persons acting on our behalf are expressly qualified in their entirety by this section.

 

ITEM 1. DESCRIPTION OF BUSINESS

 

Overview

 

Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (“Digipath,” the “Company,” “we,” “our” or “us”) supports the cannabis industry’s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units as of September 30, 2018 are described below.

 

  Digipath Labs, Inc. Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.
     
  The National Marijuana News Corp. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving—and profoundly controversial—medicinal and recreational marijuana industry.

 

Business

 

Digipath Labs, Inc. - Cannabis Testing

 

Our cannabis testing business is operated through our wholly owned subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. We opened our first testing lab in Las Vegas, Nevada in May of 2015 to serve the new State approved and licensed medical marijuana industry. We have plans to open labs in other legal states, assuming resources permit.

 

We seek to be the nation’s highest standard, full-service testing lab for cannabis and ancillary cannabis infused products. We are a third party independent testing laboratory facility for cannabis, cannabis infused products and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products.

 

Our mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our client’s products through research, development and standardization.

 

1

 

 

As a premier cannabis testing laboratory with ISO-17025:2017 accreditation, we take a careful, strategic approach to all of our cannabis testing. A diverse array of tests combined with our lab equipment and analytical instrumentation enable us to accurately test cannabis for potency, the presence of pesticides, microbial contamination, metals and heavy metals, which include, but are not limited to, substances like arsenic, cadmium, lead, or mercury. Not only is testing for potency and Cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) content important, we recognize that more profound testing is needed particularly as a true national standard is developed. Digipath Labs is committed to follow Food and Drug Administration (“FDA”), Drug Enforcement Agency (“DEA”), Environmental Protection Agency (“EPA”), US Department of Agriculture (“USDA”) guidelines, proprietary standard operating procedures (“SOP”), and Good Lab Practices (“GLP”) that are in line with current Federal and State governing bodies. We utilize a variety of tests to safely and effectively share enhanced understanding of the cannabis plant with caregivers, dispensaries and patients. We are committed to the advancement of science by offering a method of standardization for cannabis that is intricate and accurate. This approach and our investment in state-of-the-art testing equipment is of the utmost importance.

 

Digipath Labs screens medicinal and recreational cannabis for potentially harmful contaminants, including:

 

— Residual Solvents (for extracts)

— Pesticides

— Mold and Yeast

— Heavy metals, including mercury, arsenic, lead, cadmium, chromium and nickel

— Biological toxins, such as aflatoxin and ocratoxins

— Microbial contaminants including E. coli, salmonella, Aspergillus and gram negative bacteria

 

Digipath Labs also tests cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific chemoprofiles for the treatment of specific ailments.

 

We utilize one of our two Ultra-High Performance Liquid Chromatographs (“UPLC”), which accurately separates and measures the cannabinoid content of any sample of flower, edible, concentrate or other cannabis product. Our Inductively Coupled Plasma Mass Spectrometer (“ICP-MS”) is utilized for heavy metals testing, and provides accurate readings for harmful metals ensuring that the Parts Per Billion (“PPB”) are substantially below the regulated and accepted trace amounts. Our laboratory testing equipment is calibrated using third party reference standards to ensure precision measurements throughout the testing process and has been certified by ISO-17025:2017 standards.

 

With accurate science becoming a major part of the cannabis industry, the major question is one of standards; we hold ourselves accountable and provide efficient and accurate research and results to our clients. Our test results are meant to help dispensaries, caregivers and patients know the concentration and quality of their cannabis without having to question the credibility of the data.

 

Market Overview

 

The United States’ legal cannabis market is projected to reach $11 billion in consumer spending in 2018 and more than $23 billion by 2022, according to key insights featured in our newest report: The State of Legal Marijuana Markets, 6th Edition (SOLMM6), co-produced by Arcview Market Research in partnership with BDS Analytics. This growth has the potential to generate more than 467,000 full-time equivalent jobs in 2022. In addition, the Nevada Department of Taxation recently disclosed that it collected more than $5.8 million in tax revenue on the sale of nearly $38 million worth of cannabinoid-related products during the month of October 2017, and more than $69 million in tax revenue on north of $529 million of sales during the first fiscal year since the legalized sale of recreational cannabis went into effect on July 1, 2017. As the cannabis industry continues to expand, we expect to see a parallel increase in state regulations related to the testing and disclosure of cannabis and cannabis related products. We believe that there will be a strong demand for qualified laboratories to perform such testing, both to assist producers of cannabis and cannabis products to meet expected state mandated requirements, and to provide assurance to consumers and state regulators regarding the safety and composition of such products.

 

With increased legalization nationwide, the lab-testing sector is expected to experience substantial growth. GreenWave Advisors, an independent research and financial analyst firm, projects annual revenue of $553 million for lab testing alone if the U.S. legalizes cannabis on a federal level. When adding in related services, such as data analytics and consulting, the revenue potential could surpass $866 million annually. The data troves collected through the testing process are already creating value and could become an increasingly valuable asset and generate substantial revenue for the most accomplished laboratories. This data could also be used to determine specific genetic attributes of targeted cannabinoids and assist with maximizing medicinal benefits and individualized medicine in the future.

 

2

 

 

Competition

 

The cannabis industry in the United States is highly fragmented, rapidly expanding and evolving. The industry is characterized by new and potentially disruptive or conflicting legislation promulgated on a state-by-state basis. Our competitors include local enterprises, some of which may have financial, technical, sales, marketing and other resources greater than ours. These companies also compete with us in recruiting and retaining qualified personnel and consultants.

 

Our competitive position depends on our ability to attract and retain qualified scientists and other personnel, develop effective proprietary products and solutions, the personal relationships of our executive officers and directors, and our ability to secure adequate capital resources. We compete to attract and retain customers of our services. We compete in this area on the basis of price, regulatory compliance, vendor relationships, usefulness, availability, excellent customer service and ease of use of our services.

 

Government Regulation

 

Marijuana is categorized as a Schedule-I controlled substance by the Drug Enforcement Agency and the United States Department of Justice and is illegal to grow, possess and consume under Federal law. A Schedule-I controlled substance is defined as a substance that has no currently accepted medical use in the United States, a lack of safety for use under medical supervision and a high potential for abuse. The Department of Justice defines Schedule 1 controlled substances as “the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.” However, since 1995, thirty-three states and the District of Columbia have passed state laws that permit doctors to recommend prescribing cannabis for medical-use and ten states and the District of Columbia have enacted laws that legalize the adult-use of cannabis for any reason. This has created an unpredictable business-environment for dispensaries and collectives that legally operate under state-laws but in violation of Federal law. On August 29, 2013, United States Deputy Attorney General James Cole issued the Cole Memo to United States Attorneys guiding them to prioritize enforcement of Federal law away from the cannabis industry operating as permitted under state law, so long as:

 

  cannabis is not being distributed to minors and dispensaries are not located around schools and public buildings;
  the proceeds from sales are not going to gangs, cartels or criminal enterprises;
  cannabis grown in states where it is legal is not being diverted to other states;
  cannabis-related businesses are not being used as a cover for sales of other illegal drugs or illegal activity;
  there is not any violence or use of fire-arms in the cultivation and sale of marijuana;
  there is strict enforcement of drugged-driving laws and adequate prevention of adverse health consequences; and
  cannabis is not grown, used, or possessed on Federal properties.

 

The Cole Memo was meant only as a guide, not a rule of law, for United States Attorneys and did not alter in any way the Department of Justice’s Federal authority to enforce Federal law, including Federal laws relating to cannabis, regardless of state law. Moreover, the Cole Memorandum also provided that it could not be used as a defense to any criminal prosecution.

 

On January 4, 2018, United States Attorney General Jefferson Sessions issued a Memorandum to United States Attorneys rescinding the Cole Memorandum, stating that prosecutors should follow well-established principles in effect prior to the issuance of the Cole Memorandum that govern all federal prosecutions in deciding which activities to prosecute under existing federal laws. Federal legislation has been proposed over the years to reschedule or de-schedule cannabis, as well as to transform the Cole Memorandum into a rule of law.

 

The National Marijuana News Corp. – Cannabis News

 

In May 2014, we established an online radio program called The National Marijuana News (“TNMNews”). TNMNews educates the public regarding the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving and controversial medicinal and recreational marijuana industry from diverse and dissenting perspectives. We have expanded our web presence as “THE” destination for unbiased news and information on everything marijuana. As we expand TNMNews, we hope to increase advertising revenue, collect user and consumer data and continue to provide a platform for our own products and services.

 

TNMNews is an Internet radio news and talk show featuring unbiased reporting of the burgeoning marijuana industry. Although leaning more towards a medicinal use platform, the show seeks to foster thought-provoking discussion of both the medicinal and recreational marijuana markets.

 

We launched TNMNews’ Internet radio program on Live 365 and several terrestrial radio stations around the country in 2014. Our Facebook page has also garnered over 172,000 page likes and TNMNews has become a leader in cannabis news, interviews and education. We now also broadcast on Facebook live and Spotify.

 

3

 

 

Competition

 

TNMNews faces competition from traditional news media as well as new publications and web sites devoted to cannabis use. However, most marijuana-themed Internet podcasts are pro-cannabis and appeal to the recreational user. In contrast, we are pioneering a new path down the middle by presenting both sides of marijuana issues in a professional and unbiased format. Major media players are hopping on the marijuana bandwagon. Local publications like the Denver Post and the San Francisco Chronicle have dedicated space to cannabis coverage. The Huffington Post and many of the other major daily newspapers cover cannabis news. MSNBC, CNN, and truTV are developing series around cannabis. We believe that increasing public interest in this topic ensures we will have an audience and be able to attract paid advertisers.

 

Government Regulation

 

The following is a brief summary of certain statutes, regulations, policies and proposals affecting our media business. For example, radio broadcasting is subject to the jurisdiction of the FCC under the Communications Act. This does not comprehensively cover all current and proposed statutes, regulations and policies affecting our media and business. Reference should be made to the Communications Act and other relevant statutes, regulations, policies and proceedings for further information concerning the nature and extent of regulation of our media business. Finally, several of the following matters are now, or may become, the subject of court litigation, and we cannot predict the outcome of any such litigation or its impact on our media business.

 

Federal law regulates the broadcast of obscene, indecent or profane material. Legislation enacted by Congress provides the FCC with authority to impose fines of up to $325,000 per utterance with a cap of $3.0 million for any violation arising from a single act. In June 2012, the U.S. Supreme Court ruled on the appeals of several FCC indecency enforcement actions. While setting aside the particular FCC actions under review on narrow due process grounds, the Supreme Court declined to rule on the constitutionality of the FCC’s indecency policies, and the FCC has since solicited public comment on those policies. We may receive in the future, letters of inquiry and other notifications from the FCC concerning complaints that programming contains indecent or profane language. We cannot predict the outcome of our outstanding letters of inquiry and notifications from the FCC or the nature or extent of future FCC indecency enforcement actions.

 

Customers

 

We provide cannabis lab testing services in Las Vegas to Nevada licensed Medical Marijuana Enterprises (“MMEs”), and have expanded to recreational use facilities with the recently passed legislation that allows for the recreational use of marijuana in Nevada. We sell our services to these enterprises on a fixed fee per test or panel of tests, and offer a discounted price for customers based on volume. On June 17, 2014, Clark County approved a total of 117 special use permits to cultivation and 87 production applicants. There may be some cross-over applicants in this total whereby an applicant was awarded both a cultivation and production permit, and some of these applicants will undoubtedly not be able to commence operations and will lose their permits, but this is generally our pool of customers, along with additional permit holders in the Cities of Las Vegas and North Las Vegas. As of December 25, 2018, MMEs approved by the State of Nevada include 61 dispensaries, with an additional 60 more dispensary licenses pending, 115 cultivators, 81 production facilities, 24 distributors and 11 labs. We have worked with over 85 cultivators and producers in and around Clark and Nye County. As new harvests come to market, we anticipate further customer growth, especially with last year’s legalization of recreational cannabis in the State of Nevada. We also anticipate a steady stream of new Nevada MMEs to become operational and licensed throughout 2019, which should result in additional opportunities for Digipath Labs.

 

Research and Development

 

We believe that our future success will be impacted by our ability to continue to enhance and broaden our services to meet the evolving needs of a relatively newly regulated cannabis services industry. Our research and development efforts are focused on developing new, complementary solutions to streamline our processes and provide optimal services to both our customers and for regulators.

 

When developing our technical solutions to provide cannabis testing solutions, industry regulatory requirements also dictate that substantial documentation be created to demonstrate data integrity. Our standard operating procedures include streamlined methodologies for generating and maintaining testing services that can be tailored to the variations in other State jurisdictions, as necessary.

 

We expect to continue to invest in our businesses and to invest further as we expand our lab business for cannabis testing to other jurisdictions.

 

4

 

 

Marketing, Sales and Support

 

We use a range of communication platforms to reach our target customers. The goal of the marketing strategy is to position us as the leading testing company in the botanical, nutraceutical, and cannabis industries in the country. Our marketing efforts include digital/online, industry conferences and affiliations, media outreach, our own TNMNews, direct response and public relations. We believe that these efforts have the ability to deliver our brand message in a powerful way to maximize audience reach.

 

Seasonality

 

Our businesses are not subject to seasonality.

 

Insurance

 

We do not currently maintain property, business interruption and casualty insurance. We intend to obtain such insurance in accordance with customary industry practices when we have sufficient financial resources.

 

Employees

 

As of September 30, 2018, we had eighteen employees. None of our employees are members of a trade union. We believe that we maintain good relationships with our employees, and have not experienced any strikes or shutdowns and have not been involved in any labor disputes.

 

Corporate Information

 

Our principal executive offices are located at 6450 Cameron Street, Suite 113, Las Vegas, Nevada 89118, Telephone No.: (702) 527-2060. Our website is located at http://www.digipath.com. The content on our website is available for information purposes only. It should not be relied upon for investment purposes, nor is it incorporated by reference into this Report.

 

ITEM 1A. Risk Factors

 

The following important factors, and the important factors described elsewhere in this report or in our other filings with the SEC, could affect (and in some cases have affected) our results and could cause our results to be materially different from estimates or expectations. Other risks and uncertainties may also affect our results or operations adversely. The following and these other risks could materially and adversely affect our business, operations, results or financial condition.

 

An investment in the Company is highly speculative in nature and involves an extremely high degree of risk.

 

We have a limited operating history and if we are not successful in continuing to grow our business, then we may have to scale back or even cease our ongoing business operations. We have a limited operating history. Our operations are subject to all the risks inherent in the establishment of a developing enterprise and the uncertainties arising from the absence of a significant operating history. If our business plan is not successful, and we are not able to operate profitably, investors may lose some or all of their investment in our company.

 

Our auditor has expressed substantial doubt about our ability to continue as a going concern. We may be unable to obtain additional capital required to implement our business plan. As a result of recurring net losses and insufficient cash reserves, our independent certified public accountant has added a paragraph to its report on our financial statements for the year ended September 30, 2018 questioning our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to raise additional capital and to achieve sustainable revenues and profitable operations. Since inception, we have raised funds primarily through the sale of equity securities. We will need and are currently seeking additional funds to operate our business. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, it may contain undue restrictions on our operations or cause substantial dilution for our stockholders. If we are unable to obtain additional funds, our ability to carry out and implement our planned business objectives and strategies will be significantly delayed, limited or may not occur. We cannot guarantee that we will become profitable. Even if we achieve profitability, given the competitive and evolving nature of the industry in which we operate, we may not be able to sustain or increase profitability and our failure to do so would adversely affect our business, including our ability to raise additional funds.

 

5

 

 

Our failure to manage growth effectively could impair our business. Our business strategy envisions a period of rapid growth that may put a strain on our administrative, operational resources and funding requirements. Our ability to effectively manage growth will require us to continue to expand the capabilities of our operational and management systems and to attract, train, manage and retain qualified personnel. There can be no assurance that we will be able to do so, particularly if losses continue and we are unable to obtain sufficient financing. If we are unable to successfully manage growth, our business, prospects, financial condition, and results of operations could be adversely affected.

 

Our plans are dependent upon key individuals and the ability to attract qualified personnel. In order to execute our business plan, we will be dependent on upon our executive officers and directors, as well as other key personnel. The loss of any of the foregoing individuals could have a material adverse effect upon our business prospects. Moreover our success continues to depend to a significant extent on our ability to identify, attract, hire, train and retain qualified professional, creative, technical and managerial personnel. Competition for such personnel is intense, and there can be no assurance that we will be successful in identifying, attracting, hiring, training, and retaining such personnel in the future. If we are unable to hire, assimilate and retain such qualified personnel in the future, our business, operating results, and financial condition could be materially adversely affected. We may also depend on third party contractors and other partners, to assist with the execution of our business plan. There can be no assurance that we will be successful in either attracting and retaining qualified personnel, or creating arrangements with such third parties. The failure to succeed in these endeavors would have a material adverse effect on our ability to consummate our business plans.

 

Risks Related To Our Cannabis Related Businesses

 

Our business is dependent on state laws pertaining to the cannabis industry. As of December 25, 2018, thirty-three states and the District of Columbia allow its citizens to use medical cannabis. Additionally, ten states and the District of Columbia have legalized cannabis for adult recreational use, and additional recreational measures are expected to be pursued by other states in the future. Continued development of the cannabis industry is dependent upon continued legislative authorization of cannabis at the state level. Any number of factors could slow or halt progress in this area. Further, progress in the cannabis industry, while encouraging, is not assured. While there may be ample public support for legislative action, numerous factors impact the legislative process. Any one of these factors could slow or halt use of cannabis, which would negatively impact our business.

 

Cannabis remains illegal under federal law and a change in federal enforcement practices could significantly and negatively affect our business. Despite the development of a cannabis industry legal under state laws, state laws legalizing medicinal and adult cannabis use are in conflict with the Federal Controlled Substances Act, which classifies cannabis as a Schedule-I controlled substance and makes cannabis use and possession illegal on a national level. The United States Supreme Court has ruled that it is the Federal government that has the right to regulate and criminalize cannabis, even for medical purposes, and thus Federal law criminalizing the use of cannabis preempts state laws that legalize its use. While the Obama Administration’s Department of Justice adopted a policy (known as the Cole Memorandum) that effectively stated that it was not an efficient use of resources to direct Federal law enforcement agencies to prosecute those lawfully abiding by state-designated laws allowing the use and distribution of medical cannabis, on January 4, 2018, the United States Attorney General rescinded the Cole Memorandum. The Federal government’s enforcement of Federal laws could cause significant financial damage to us and our shareholders.

 

The loss or temporary suspension of one or more of our licenses could significantly reduce our revenues. Our ability to operate our cannabis testing lab is dependent upon maintaining licenses issued by state and local regulators in Nevada. Our cannabis testing and business licenses were briefly suspended by Nevada regulators on January 19, 2018 and were reinstated on January 31, 2018. This significantly affected our financial results for the second and third fiscal quarters of 2018. In order to retain our licenses, we are required to comply with ongoing compliance and reporting requirements and ongoing regulation and oversight by governmental authorities. Any failure to comply with any such regulatory requirements or any failure to maintain any required licenses would have a material adverse effect on our business, financial condition, results of operation and, in the extreme case, require us to discontinue operations.

 

As the possession and use of cannabis is illegal under the Federal Controlled Substances Act, we may be deemed to be aiding and abetting illegal activities through the services that we provide. As a result, we may be subject to enforcement actions by law enforcement authorities, which would materially and adversely affect our business. Under Federal law, and more specifically the Federal Controlled Substances Act, the possession, use, cultivation, and transfer of cannabis is illegal. Our business provides services to customers that are engaged in the business of possession, use, cultivation, and/or transfer of cannabis. As a result, law enforcement authorities, in their attempt to regulate the illegal use of cannabis, may seek to bring an action or actions against us, including, but not limited, to a claim of aiding and abetting another’s criminal activities. The Federal aiding and abetting statute provides that anyone who “commits an offense against the United States or aids, abets, counsels, commands, induces or procures its commission, is punishable as a principal.” 18 U.S.C. §2(a). As a result of such an action, we may be forced to cease operations and our investors could lose their entire investment. Such an action would have a material negative effect on our business and operations.

 

6

 

 

Laws and regulations affecting the cannabis and marijuana industries are constantly changing, which could detrimentally affect our business, and we cannot predict the impact that future regulations may have on us. Local, state and federal cannabis laws and regulations are constantly changing and they are subject to evolving interpretations, which could require us to incur substantial costs associated with compliance or to alter one or more of our service offerings. In addition, violations of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect on our revenues, profitability, and financial condition. We cannot predict the nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have on our business. Any change in law or interpretation could have a material adverse effect on our business, financial condition, and results of operations.

 

Federal enforcement practices could change with respect to services providers to participants in the cannabis industry, which could adversely impact us. If the federal government were to change its practices, or were to expand its resources attacking providers in the cannabis industry, such action could have a materially adverse effect on our operations, our customers, or the sales of our products. It is possible that additional Federal or state legislation could be enacted in the future that would prohibit our customers from selling cannabis, and if such legislation were enacted, such customers may discontinue the use of our services. We cannot predict the nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have on our business.

 

Expansion by well-established laboratory testing companies into the cannabis industry could prevent us from realizing anticipated growth in customers and revenues. Traditional laboratory testing companies may expand their businesses into cannabis testing. If they decided to expand into cannabis testing, this could hurt the growth of our business and cause our revenues to be lower than we expect.

 

Due to our involvement in the cannabis industry, we may have a difficult time obtaining the various insurances that are desired to operate our business, which may expose us to additional risk and financial liabilities. Insurance that is otherwise readily available, such as workers’ compensation, general liability, and directors and officers insurance, is more difficult for us to find, and more expensive, because we are service providers to companies in the cannabis industry. There are no guarantees that we will be able to find such insurances in the future, or that the cost will be affordable to us. If we are forced to go without such insurances, it may prevent us from entering into certain business sectors, may inhibit our growth, and may expose us to additional risk and financial liabilities.

 

Participants in the cannabis industry have difficulty accessing the service of banks, which makes it difficult for us to operate. Despite rules issued by the United States Department of the Treasury mitigating the risk to banks that do business with cannabis companies permitted under state law, as well as guidance from the United States Department of Justice, banks remain wary to accept funds from businesses in the cannabis industry. In fact, we were previously notified by our bank that our deposit accounts would be closed, and we are currently looking for a replacement banking institution. Since the use of cannabis remains illegal under Federal law, there remains a compelling argument that banks may be in violation of Federal law when accepting for deposit, funds derived from the sale or distribution of cannabis. Consequently, businesses involved in the cannabis industry, including us, continue to have trouble establishing and maintain banking relationships. An inability to open and maintain bank accounts may make it difficult for us and our customers to do business. In addition, our inability to maintain a bank account has resulted in our holding large sums of cash. Although we store our cash in a secure safe, we are exposed to a greater risk of theft.

 

Risks Relating To Media Business

 

We face intense competition in our media businesses. We operate in a highly competitive industry, and we may not be able to maintain or increase our current audience ratings and advertising and sales revenues, if any. Our media and advertising businesses compete for audiences and advertising revenues with other media businesses, as well as with other media, such as newspapers, magazines, television, direct mail, portable digital audio players, mobile devices, satellite radio, Internet-based services and live entertainment, within their respective markets. Audience ratings and market shares are subject to change, which could have the effect of reducing our revenues in that market. Our competitors may develop technology, services or advertising media that are equal or superior to those we provide or that achieve greater market acceptance and brand recognition than we achieve. It also is possible that new competitors may emerge and rapidly acquire significant market share in any of our business segments. An increased level of competition for advertising dollars may lead to lower advertising rates as we attempt to retain customers or may cause us to lose customers to our competitors who offer lower rates that we are unable or unwilling to match.

 

Our business is dependent on our management team and other key individuals. Our media business is dependent upon the performance of our management team and other key individuals, and in particular, Todd Denkin, our Chief Executive Officer, who also acts as the host of many of our programs. We can give no assurance that all or any of our management team and other key individuals will remain with us. Competition for these individuals is intense and many of our key employees are at-will employees who are under no legal obligation to remain with us, and may decide to leave for a variety of personal or other reasons beyond our control. If members of our management or key individuals decide to leave us in the future, or if we are not successful in attracting, motivating and retaining other key employees, our business could be adversely affected.

 

7

 

 

Extensive current government regulation, and future regulation, may limit our media operations or adversely affect our business and financial results. Congress and several federal agencies, including the FCC, extensively regulate the domestic radio industry. For example, the FCC could impose large fines on us if, in response to pending complaints, it finds that we broadcast indecent programming. We cannot predict whether legislation affecting our media business will be adopted. Such legislation could have a material impact on our operations and financial results. Finally, various regulatory matters relating to our media and business are now, or may become, the subject of court litigation, and we cannot predict the outcome of any such litigation or its impact on our business.

 

If our security measures are breached, we may face liability and public perception of our services could be diminished, which would negatively impact our ability to attract listeners, business partners and advertisers. Although we have implemented physical and electronic security measures to protect against the loss, misuse and alteration of our websites, digital assets and proprietary business information as well as listener, consumer, business partner and advertiser personally identifiable information, no security measures are perfect and impenetrable and we may be unable to anticipate or prevent unauthorized access. A security breach could occur due to the actions of outside parties, employee error, malfeasance or a combination of these or other actions. If an actual or perceived breach of our security occurs, we could lose competitively sensitive business information or suffer disruptions to our business operations. In addition, the public perception of the effectiveness of our security measures or services could be harmed, we could lose listeners, consumers, business partners and advertisers and we could suffer financial exposure in connection with remediation efforts, investigations and legal proceedings and changes in our security and system protection measures.

 

Additional restrictions on advertising of cannabis and other products may further restrict the categories of clients that can advertise using our products. For example, out-of-court settlements between the major U.S. tobacco companies and all 50 states, the District of Columbia, the Commonwealth of Puerto Rico and other U.S. territories include a ban on the outdoor advertising of tobacco products. Other products and services may be targeted in the U.S. in the future, including cannabis products. Any significant reduction in cannabis-related advertising or advertising of other products due to content-related restrictions could cause a reduction in our direct revenues from such advertisements.

 

Risks Related To Our Common Stock

 

Our operating results may fluctuate causing volatility in our stock price. Our operating results may fluctuate as a result of a number of factors, many of which are outside of our control. The following factors may affect our operating results causing volatility in our stock price:

 

  Our ability to execute our business plan, compete effectively and attract customers;
  Our ability to respond effectively to a rapidly evolving regulatory and competitive landscape;
  The amount and timing of operating costs and capital expenditures related to the maintenance and expansion of our business, operations and infrastructure;
  Our ability to obtain working capital financing;
  Our ability to attract, motivate and retain top-quality employees;
  Investors’ general perception of us; and
  General economic conditions and those economic conditions specific to cannabis industry.

 

Trading in our common stock has been limited, there is no significant trading market for our common stock, and purchasers of our common stock may be unable to sell their shares. Our common stock is currently eligible for quotation on the OTCQB and OTCBB, however trading to date has been limited. If activity in the market for shares of our common stock does not increase, purchasers of our shares may find it difficult to sell their shares. We currently do not meet the initial listing criteria for any registered securities exchange, including the Nasdaq Stock Market. The OTCQB and OTCBB are often characterized by low trading volume and significant price fluctuations. These and other factors may further impair our stockholders’ ability to sell their shares when they want to and/or could depress our stock price. As a result, stockholders may find it difficult to dispose of, or obtain accurate quotations of the price of our securities because smaller quantities of shares could be bought and sold, transactions could be delayed and security analyst and news coverage of our Company may be limited. These factors could result in lower prices and larger spreads in the bid and ask prices for our shares of common stock.

 

8

 

 

Applicable sec rules governing the trading of “penny stocks” may limit the trading and liquidity of our common stock which may affect the trading price our common stock. Our common stock is a “penny stock” as defined under Rule 3a51-1 of the Exchange Act, and is accordingly subject to SEC rules and regulations that impose limitations upon the manner in which our common stock can be publicly traded. Penny stocks generally are equity securities with a per share price of less than $5.00 (other than securities registered on some national securities exchanges or quoted on NASDAQ). The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and, if the broker-dealer is the sole market maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market, and monthly account statements showing the market value of each penny stock held in the customer’s account. In addition, broker-dealers who sell these securities to persons other than established customers and “accredited investors” must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. Consequently, these requirements may have the effect of reducing the level of trading activity, if any, of our common stock and reducing the liquidity of an investment in our common stock.

 

We have outstanding shares of preferred stock with rights and preferences superior to those of our common stock. The issued and outstanding shares of Series A Cumulative Convertible Preferred Stock grant the holders of such preferred stock liquidation rights that are superior to those held by the holders of our common stock.

 

We have not paid dividends in the past and do not expect to pay dividends in the future. Any return on investment may be limited to the value of our common stock. We have never paid cash dividends on our common stock and do not anticipate doing so in the foreseeable future. The payment of dividends on our common stock depends on earnings, financial condition and other business and economic factors affecting us at such time as our board of directors may consider relevant.

 

ITEM 1B. Unresolved Staff Comments

 

None.

 

ITEM 2. Properties

 

Our principal executive offices are located at 6450 Cameron Street, Suite 113, Las Vegas, Nevada 89118, Telephone No.: (702) 527-2060. Our leased premises are 6,000 square feet and are utilized for corporate business offices and a cannabis testing lab. Our premises are subject to a lease agreement expiring June 14, 2021. Our anticipated future lease commitments on a calendar year basis, including common area maintenance, are as follows:

 

2018  $48,872 
2019   198,904 
2020   151,283 
2021   50,102 
Total  $449,161 

 

We believe that our current facilities are adequate for our current needs. We intend to secure new facilities or expand existing facilities as necessary to support future growth. We believe that suitable additional space will be available on commercially reasonable terms as needed to accommodate our operations.

 

ITEM 3. Legal Proceedings

 

There are no material pending legal proceedings to which we are a party or to which any of our property is subject, nor are there any such proceedings known to be contemplated by governmental authorities. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

9

 

 

PART II

 

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

Shares of our common stock trade on the over-the-counter market and are quoted on the OTCBB and OTCQB under the symbol “DIGP”. As of December 25, 2018, the closing price of our common stock on the OTCQB was $0.1297.

 

The following table sets forth, for the fiscal quarters indicated, the high and low bid information for our common stock, as reported on the OTCQB. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

   High   Low 
Fiscal Year Ended September 30, 2018          
First Quarter  $0.39   $0.15 
Second Quarter  $0.59   $0.16 
Third Quarter  $0.25   $0.17 
Fourth Quarter  $0.20   $0.14 
           
Fiscal Year Ended September 30, 2017          
First Quarter  $0.29   $0.13 
Second Quarter  $0.36   $0.17 
Third Quarter  $0.27   $0.17 
Fourth Quarter  $0.24   $0.15 

 

As of December 25, 2018, there were approximately 119 shareholders of record of our common stock. Such number does not include any shareholders holding shares in nominee or “street name”. As of December 25, 2018, there were 43,257,277 shares of common stock outstanding on record.

 

Dividends

 

We have not declared or paid any dividends on our common stock since our inception and do not anticipate paying dividends for the foreseeable future. The payment of dividends is subject to the discretion of our board of directors and depends, among other things, upon our earnings, our capital requirements, our financial condition, and other relevant factors. We intend to reinvest any earnings in the development and expansion of our business. Any cash dividends in the future to common shareholders will be payable when, as and if declared by our board of directors, based upon the board’s assessment of our financial condition and performance, earnings, need for funds, capital requirements, prior claims of preferred stock to the extent issued and outstanding, and other factors, including income tax consequences, restrictions and applicable laws. There can be no assurance, therefore, that any dividends on our common stock will ever be paid.

 

10

 

 

Equity Compensation Plan Information

 

Plan category  Number of securities to be issued upon exercise of outstanding options, warrants and rights   Weighted-average exercise price of outstanding options, warrants and rights   Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) 
    (a)    (b)    (c) 
Equity compensation plans approved by security holders (1)   8,537,500   $0.2115    2,962,500 
Equity compensation plans not approved by security holders (2)   659,800    0.1901    N/A 
Total   10,449,800   $0.2099    2,208,470 

 

(1) Represents awards under our 2012 Stock Incentive Plan which was initially adopted with shareholder approval, and amended on June 21, 2016 without shareholder approval (as amended, the “2012 Incentive Plan”). Below is a brief description of the material terms of the 2012 Incentive Plan and the awards that may be granted thereunder.

 

(2) Consists of warrants issued to consultants of the Company in consideration of services with exercise prices of $0.1901 per share. For additional details see Note 9 to the accompanying financial statements.

 

2012 Incentive Plan

 

Effective Date and Expiration. The 2012 Incentive Plan, as amended, became effective on March 5, 2012, and will terminate on March 5, 2022, unless it is terminated earlier by our board of directors. No award may be made under the Incentive Plan after its expiration date, but awards made prior thereto may extend beyond that date.

 

Share Authorization. The maximum aggregate number of Shares which may be issued pursuant to awards granted under the 2012 Incentive Plan is Eleven Million Five Hundred Thousand (11,500,000) shares. Prior to its amendment in June 2016, Three Million shares had been authorized for issuance under the 2012 Plan.

 

General; Types of Awards. The 2012 Incentive Plan provides for the grant of options to purchase shares of common stock, restricted stock, stock appreciation rights (“SARs”) and restricted stock units (rights to receive, in cash or stock, the market value of one share of our commons stock). Incentive stock options (“ISOs”) may be granted only to employees. Nonstatutory stock options and other stock-based awards may be granted to officers, employees, non-employee directors and consultants.

 

Administration. The 2012 Incentive Plan will be administered by our board of directors or a committee of our board of directors (the “Administrator”) as provided in the 2012 Incentive Plan. The Administrator will have the authority to select the eligible participants to whom awards will be granted, to determine the types of awards and the number of shares covered and to set the terms, conditions and provisions of such awards, to cancel or suspend awards under certain conditions, and to accelerate the exercisability of awards. The Administrator will be authorized to interpret the 2012 Incentive Plan, to establish, amend, and rescind any rules and regulations relating to the 2012 Incentive Plan, to determine the terms of agreements entered into with recipients under the 2012 Incentive Plan, and to make all other determinations that may be necessary or advisable for the administration of the 2012 Incentive Plan.

 

Eligibility. Options and other awards may be granted under the 2012 Incentive Plan to directors, officers, employees and consultants of our company and any of our subsidiaries, provided that the services of such consultants are not in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for our securities. At the date of this prospectus, all of our officers, directors and employees would have been eligible to receive awards under the 2012 Incentive Plan.

 

Stock Options. The exercise price per share of our common stock purchasable upon exercise of any stock option or SAR will be determined by the Administrator, but cannot in any event be less than 100% of the fair market value of our common stock on the date the award is granted. The Administrator will determine the term of each stock option or SAR (subject to a maximum term of 10 years) and each option or SAR will be exercisable pursuant to a vesting schedule determined by the Administrator. The grants and the terms of ISOs will be restricted to the extent required for qualification as ISOs by the U.S. Internal Revenue Code of 1986, as amended. Subject to approval of the Administrator, options or SARs may be exercised by payment of the exercise price in cash, shares of common stock or pursuant to a “cashless exercise” through a broker-dealer under an arrangement approved by the Administrator. The Administrator may require the grantee to pay to us any applicable withholding taxes that we are required to withhold with respect to the grant or exercise of any option. The withholding tax may be paid in cash or, subject to applicable law, the Administrator may permit the grantee to satisfy these obligations by the withholding or delivery of shares of our common stock. We may withhold from any shares of our common stock that may be issued pursuant to an option or from any cash amounts otherwise due from us to the recipient of the option an amount equal to such taxes.

 

11

 

 

Restricted Stock. Restricted shares may be sold or awarded for consideration determined by the Administrator, including cash, full-recourse promissory notes, as well as past and future services. Any award of restricted shares will be subject to a vesting schedule determined by the Administrator. Any restricted shares that are not vested will be subject to rights of repurchase, rights of first refusal or other restrictions as determined by the Administrator. In general, holders of restricted shares will have the same voting, dividend and other rights as our other stockholders.

 

Adjustments upon Changes in Capitalization. In the event of any change affecting shares of our common stock by reason of any stock dividend or split, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distribution to stockholders other than cash dividends, the Administrator will make substitutions or adjustments in the aggregate number of shares that may be distributed under the 2012 Incentive Plan, and in the number and types of shares subject to, and the exercise prices under, outstanding awards granted under the 2012 Incentive Plan, in accordance with Section 10 and other provisions of the 2012 Incentive Plan.

 

Assignment. Unless otherwise permitted by the 2012 Incentive Plan and approved by the Administrator as permitted by the 2012 Incentive Plan, no award will be assignable or otherwise transferable by the grantee other than by will or the laws of descent and distribution and, during the grantee’s lifetime, an award may be exercised only by the grantee.

 

Amendment. Our board of directors may amend the 2012 Incentive Plan in any and all respects without stockholder approval, except as such stockholder approval may be required under applicable law or pursuant to the listing requirements of any national market system or securities exchange on which our equity securities may be listed or quoted.

 

Recent Sales of Unregistered Securities

 

The following issuances of our securities during the three month period ended September 30, 2018 were exempt from the registration requirements of the Securities Act of 1933 pursuant to Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder. The purchasers were accredited investors, familiar with our operations, and there was no general solicitation.

 

On September 25, 2018, we issued 39,344 shares of common stock to Todd Denkin for his services rendered as our President and Chief Executive Officer.

 

On September 25, 2018, we issued 98,361 shares of common stock to Todd Peterson for his services rendered as our Chief Financial Officer.

 

On September 25, 2018, we issued a total of 150,000 shares of common stock to three consultants that were engaged to assist the Company with acquisition activities.

 

On September 12, 2018, we issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors.

 

On July 11, 2018, we sold 66.67 units, consisting of 666,667 shares of common stock and three-year warrants to purchase 333,334 shares of common stock at an exercise price $0.30 per share, in exchange for total proceeds of $100,000.

 

ITEM 6. Selected Financial Data

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

12

 

 

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This discussion summarizes the significant factors affecting the operating results, financial condition, liquidity and cash flows of the Company and its subsidiaries for the fiscal years ended September 30, 2018 and 2017. The discussion and analysis that follows should be read together with the section entitled “Forward Looking Statements” and our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this annual report on Form 10-K.

 

Except for historical information, the matters discussed in this section are forward looking statements that involve risks and uncertainties and are based upon judgments concerning various factors that are beyond the Company’s control. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report.

 

Overview

 

Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (“Digipath,” the “Company,” “we,” “our” or “us”) supports the cannabis industry’s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units as of September 30, 2017 are described below.

 

  Digipath Labs, Inc. Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.
     
  The National Marijuana News Corp. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving—and profoundly controversial—medicinal and recreational marijuana industry.

 

Critical Accounting Policies

 

The establishment and consistent application of accounting policies is a vital component of accurately and fairly presenting our financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”), as well as ensuring compliance with applicable laws and regulations governing financial reporting. While there are rarely alternative methods or rules from which to select in establishing accounting and financial reporting policies, proper application often involves significant judgment regarding a given set of facts and circumstances and a complex series of decisions.

 

Basis of Accounting

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission. Intercompany accounts and transactions have been eliminated. All references to GAAP are in accordance with The FASB Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company determined it has two reportable segments.

 

13

 

 

Fair Value of Financial Instruments

 

The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

 

  - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.  
  - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.  
  - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.  

 

The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short term nature of the instruments.

 

Fixed Assets

 

Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:

 

Software   3 years 
Office equipment   5 years 
Furniture and fixtures   5 years 
Lab equipment   7 years 
Leasehold improvements   Term of lease 

 

Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.

 

Impairment of Long-Lived Assets

 

Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.

 

Our intellectual property is comprised of indefinite-lived brand names acquired and have been assigned an indefinite life as we currently anticipate that these brand names will contribute cash flows to the Company perpetually. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 605, Revenue Recognition. ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery of product has met the criteria established in the arrangement or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. This occurs when the products or services are completed in accordance with the contracts we have with clients. In connection with our products and services arrangements, when we are paid in advance, these amounts are classified as deferred revenue and amortized over the term of the agreement. With respect to our cannabis lab testing revenues, we sell our services on a determinable fixed fee per test, or panel of tests basis, and offer a discounted price for customers that agree to enter into exclusive, long term contracts or certain volume commitments. We typically require payment within thirty days of the delivery of results. Revenues are recognized upon the substantial completion of the tests when collectability is reasonably assured, which is usually upon delivery of results to the customer.

 

14

 

 

Advertising Costs

 

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $108,295 and $138,026 for the years ended September 30, 2018 and 2017, respectively.

 

Basic and Diluted Loss Per Share

 

The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended September 30, 2018 and 2017, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.

 

Stock-Based Compensation

 

The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 505-50 (ASC 505-50). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.

 

Income Taxes

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.

 

Uncertain Tax Positions

 

In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.

 

15

 

 

Results of Operations

 

Our cannabis testing lab operations have steadily increased as the Nevada cannabis market has begun to mature. The following table shows operating results for the years ended September 30, 2018 and 2017.

 

   Years Ended September 30,   Increase / 
   2018   2017   (Decrease) 
Revenues  $2,839,916   $1,898,172   $941,744 
Cost of sales   2,069,837    904,166    1,165,671 
Gross profit   770,079    994,006    (223,927)
                
Operating expenses:               
General and administrative   1,451,642    1,257,745    193,897 
Professional fees   1,094,486    1,001,289    93,197 
Bad debts expense   (17,280)   32,180    (49,460)
Total operating expenses:   2,528,848    2,291,214    237,634 
                
Operating loss   (1,758,769)   (1,297,208)   461,561 
                
Total other income (expense)   105,112    232,068    (126,956)
                
Net loss  $(1,653,657)  $(1,065,140)  $588,517 

 

Revenues

 

Revenues were generated by our cannabis testing lab and to a de minimis extent, from advertising on TNMNews media. Aggregate revenues for the year ended September 30, 2018 were $2,839,916, compared to revenues of $1,898,172 during the year ended September 30, 2017, an increase of $941,744, or 50%. The increase in revenue was due to the continued growth of our testing lab operations in Nevada as our customer base, consisting of production and cultivation facilities, increased their operations, particularly following the implementation of the Nevada law permitting the recreational use of marijuana, which went into effect on July 1, 2017. However, our revenues during the fiscal year were negatively impacted by the brief, temporary suspension of our testing and business licenses by Nevada regulators in January 2018.

 

Cost of Sales

 

Cost of sales for the year ended September 30, 2018 were $2,069,837, compared to $904,166 during the year ended September 30, 2017, an increase of $1,165,671, or 129%. Cost of sales consists primarily of labor, depreciation, maintenance on lab equipment, and supplies consumed in our testing operations. The increased cost of sales in the current year was primarily due to the cost of temporarily outsourcing our pesticide testing to a third party while we repaired and upgraded instrumentation to comply with regulators’ requirements, and increased labor and supply costs required both to comply with regulators’ requirements (including in connection with implementing ISO/IEC 17025 testing and calibration standards), and in anticipation of increased demand. At the end of June, our pesticide methods were certified by the State of Nevada and we were able to resume our own pesticide testing, which significantly reduced our cost of sales for the fourth quarter. Our gross margins of approximately 27%, decreased during the year ended September 30, 2018, compared to gross margins of approximately 52% during the year ended September 30, 2017, as we devoted significant resources to the improvement of operations in response to the temporary suspension of our Nevada licenses. We expect cost of sales to decrease and gross margins to increase as we continue to grow, and for gross margins to be in the neighborhood of 50%.

 

General and Administrative Expenses

 

General and administrative expenses for the year ended September 30, 2018 were $1,451,642, compared to $1,257,745 during the year ended September 30, 2017, an increase of $193,897, or 15%. The expenses consisted primarily of marketing, rent, salaries and wages, and travel expenses. General and administrative expenses increased primarily due to increased salaries and travel costs during the current year.

 

16

 

 

Professional Fees

 

Professional fees for the year ended September 30, 2018 were $1,094,486, compared to $1,001,289 during the year ended September 30, 2017, an increase of $93,197, or 9%. Professional fees increased primarily due to increased stock-based compensation paid to consultants during the current period, partially offset by a decrease in legal fees. Stock based compensation was $892,390 during the year ended September 30, 2018, compared to $636,116 during the year ended September 30, 2017, an increase of $256,274, or 40%.

 

Bad Debt Expense (recoveries)

 

Bad debt expense (recoveries) for the year ended September 30, 2018 was $(17,280), compared to $32,180 during the year ended September 30, 2017, a decrease of $49,460, or 154%. Bad debt recoveries during the current period consisted of a change in the allowance for doubtful accounts of $14,900, compared to an allowance of $32,180 as of September 30, 2017. We have not yet realized any bad debts on our trade receivables.

 

Operating Loss

 

Operating loss for the year ended September 30, 2018 was $1,758,769, compared to $1,297,208 during the year ended September 30, 2017, an increase of $461,561, or 36%. Operating loss increased primarily due to complying with regulators’ requirements, which resulted in temporarily outsourcing our pesticide testing to a third party while we repaired and upgraded instrumentation, and increased labor and supply costs, offset in part by our increased revenues during the year ended September 30, 2018, compared to the year ended September 30, 2017.

 

Other Income (Expense)

 

Other income for the year ended September 30, 2018 was $105,112, compared to other income, on a net basis, of $232,068 during the year ended September 30, 2017, a decrease of $126,956. Other income during the year ended September 30, 2018, consisted of rental income of $76,800 from subleased office space and $28,312 of restitution payments received from a former employee. Other income during the year ended September 30, 2017, consisted of rental income of $20,568 from subleased office and storage space, $250,000 received pursuant to the settlement under a license agreement with GB Sciences, Inc., and $11,500 of restitution payments received from a former employee.

 

Net Loss

 

Net loss for the year ended September 30, 2018 was $1,653,657, compared to $1,065,140 during the year ended September 30, 2017, an increase of $588,517, or 55%. The increased net loss was primarily due to increased costs for complying with regulators’ requirements as described above and in connection with increased revenues, offset in part by our increased revenues.

 

Liquidity and Capital Resources

 

As of September 30, 2018, the Company had current assets of $442,095, comprising of cash of $176,027, accounts receivable of $167,734, prepaid expenses of $72,690, and deposits of $25,647. The Company’s current liabilities as of September 30, 2018 were $384,627, consisting of $325,864 of accounts payable, $58,238 of accrued expenses and $525 of deferred revenues.

 

The following table summarizes our total current assets, liabilities and working capital at September 30, 2018 and 2017.

 

   September 30, 
   2018   2017 
Current Assets  $442,098   $544,187 
           
Current Liabilities  $384,627   $163,998 
           
Working Capital  $57,471   $380,189 

 

17

 

 

The following table summarizes our cash flows during the years ended September 30, 2018 and 2017, respectively.

 

   Years Ended 
   September 30, 
   2018   2017 
Net cash used in operating activities  $(163,405)  $(376,877)
Net cash used in investing activities   (207,353)   (140,836)
Net cash provided by financing activities   368,608    560,500 
           
Net change in cash  $(2,150)  $42,787 

 

The decrease in funds used in operating activities for the year ended September 30, 2018, compared to the year ended September 30, 2017, was primarily due to sales growth.

 

The increase in funds used in investing activities for the year ended September 30, 2018, compared to the year ended September 30, 2017, was due primarily to increased equipment purchases in the year ended September 30, 2018, as we upgraded certain instrumentation to comply with Nevada regulations.

 

The decrease in funds provided by financing activities for the year ended September 30, 2018, compared to the year ended September 30, 2017, was due to decreased sales of our securities through private placement offerings in the year ended September 30, 2018.

 

Satisfaction of our Cash Obligations for the Next 12 Months

 

As of September 30, 2018, our balance of cash on hand was $176,027. We do not currently have sufficient funds to fund our operations at their current levels for the next twelve months. As we continue to develop our lab testing business and attempt to expand operational activities, we expect to continue to experience net negative cash flows from operations in amounts not now determinable, and will be required to obtain additional financing to fund operations. Our ability to continue as a going concern is dependent upon our ability to raise additional capital and to achieve sustainable revenues and profitable operations. Since inception, we have raised funds primarily through the sale of equity securities. We will need and are currently seeking additional funds to operate our business. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, it may contain undue restrictions on our operations or cause substantial dilution for our stockholders. If we are unable to obtain additional funds, our ability to carry out and implement our planned business objectives and strategies will be significantly delayed, limited or may not occur. We cannot guarantee that we will become profitable. Even if we achieve profitability, given the competitive and evolving nature of the industry in which we operate, we may not be able to sustain or increase profitability and our failure to do so would adversely affect our business, including our ability to raise additional funds.

 

Off-Balance Sheet Arrangements

 

We have no outstanding off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading activities involving non-exchange traded contracts.

 

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

18

 

 

ITEM 8. Financial Statements and Supplementary Data

 

DIGIPATH, INC. & SUBSIDIARIES

 

FINANCIAL STATEMENTS

 

FOR THE YEARS ENDED SEPTEMBER 30, 2018 AND 2017

 

TABLE OF CONTENTS

 

  Page
Report of Independent Registered Public Accounting Firm, M&K CPAS, PLLC F-1
   
Consolidated Balance Sheets as of September 30, 2018 and 2017 F-2
   
Consolidated Statements of Operations for the years ended September 30, 2018 and 2017 F-3
   
Consolidated Statement of Stockholders’ Equity for the years ended September 30, 2018 and 2017 F-4
   
Consolidated Statements of Cash Flows for the years ended September 30, 2018 and 2017 F-5
   
Notes to Consolidated Financial Statements F-6

 

19

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Digipath, Inc.,

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Digipath, Inc. (“the Company”) as of September 30, 2018 and 2017, and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the years in the two-year period ended September 30, 2018, and the related notes and schedules (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2018 and 2017, and the results of its operations and its cash flows for each of the years in the two-year period ended September 30, 2018, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has recurring losses from operations and insufficient working capital, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters also are described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

/s/ M&K CPAS, PLLC

We have served as the Company’s auditor since 2017.

Houston, TX

December 27, 2018

 

F-1

 

 

DIGIPATH, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   September 30,   September 30, 
   2018   2017 
Assets          
           
Current assets:          
Cash  $176,027   $178,177 
Accounts receivable   167,734    266,613 
Prepaid expenses   72,690    73,750 
Deposits   25,647    25,647 
Total current assets   442,098    544,187 
           
Fixed assets, net   957,108    1,027,049 
           
Total Assets  $1,399,206   $1,571,236 
           
Liabilities and Stockholders’ Equity          
           
Current liabilities:          
Accounts payable  $325,864   $121,994 
Accrued expenses   58,238    42,004 
Deferred revenues   525    - 
Total current liabilities   384,627    163,998 
           
Total Liabilities   384,627    163,998 
           
Stockholders’ Equity:          
Series A convertible preferred stock, $0.001 par value, 10,000,000 shares authorized; 1,425,942 and 1,897,942 shares issued and outstanding at September 30, 2018 and 2017, respectively   1,426    1,898 
Common stock, $0.001 par value, 90,000,000 shares authorized; 42,245,364 and 35,027,118 shares issued and outstanding at September 30, 2018 and 2017, respectively   42,245    35,027 
Additional paid-in capital   14,121,236    12,866,984 
Accumulated (deficit)   (13,150,328)   (11,496,671)
           
Total Stockholders’ Equity   1,014,579    1,407,238 
           
Total Liabilities and Stockholders’ Equity  $1,399,206   $1,571,236 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-2

 

 

DIGIPATH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the Years Ended 
   September 30, 
   2018   2017 
         
Revenues  $2,839,916   $1,898,172 
Cost of sales   2,069,837    904,166 
Gross profit   770,079    994,006 
           
Operating expenses:          
General and administrative   1,451,642    1,257,745 
Professional fees   1,094,486    1,001,289 
Bad debts expense (recoveries)   (17,280)   32,180 
Total operating expenses   2,528,848    2,291,214 
           
Operating loss   (1,758,769)   (1,297,208)
           
Other income:          
Other income   105,112    282,068 
Loss on impairment of securities available-for-sale   -    (50,000)
Total other income   105,112    232,068 
           
Net loss  $(1,653,657)  $(1,065,140)
           
Weighted average number of common shares outstanding - basic and fully diluted   39,079,547    29,321,193 
           
Net loss per share - basic and fully diluted  $(0.04)  $(0.04)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

DIGIPATH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

 

                       Accumulated         
   Series A Convertible           Additional   Other       Total 
   Preferred Stock   Common Stock   Paid-in   Comprehensive   Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Loss   (Deficit)   Equity 
                                 
Balance, September 30, 2016   3,520,442   $3,520    22,491,041   $22,491   $11,681,282   $(40,800)  $(10,431,531)  $1,234,962 
                                         
Units of common stock and warrants sold for cash   -    -    3,498,577    3,499    557,001    -    -    560,500 
                                         
Common stock issued for services   -    -    925,000    925    245,455    -    -    246,380 
                                         
Common stock options issued for services   -    -    -    -    389,736    -    -    389,736 
                                         
Conversion of preferred stock to common stock   (1,622,500)   (1,622)   8,112,500    8,112    (6,490)   -    -    - 
                                         
Realized loss on available-for-sale securities   -    -    -    -    -    40,800    -    40,800 
                                         
Net loss for the year ended September 30, 2017   -    -    -    -    -    -    (1,065,140)   (1,065,140)
                                         
Balance, September 30, 2017   1,897,942   $1,898    35,027,118   $35,027   $12,866,984   $-   $(11,496,671)  $1,407,238 
                                         
Units of common stock and warrants sold for cash   -    -    2,158,934    2,159    366,449    -    -    368,608 
                                         
Common stock issued for services   -    -    2,326,855    2,327    450,210    -    -    452,537 
                                         
Common stock options issued for services   -    -    -    -    439,853    -    -    439,853 
                                         
Conversion of preferred stock to common stock   (472,000)   (472)   2,360,000    2,360    (1,888)   -    -    - 
                                         
Cashless exercise of options and warrants   -    -    372,457    372    (372)   -    -    - 
                                         
Net loss for the year ended September 30, 2018   -    -    -    -    -    -    (1,653,657)   (1,653,657)
                                         
Balance, September 30, 2018   1,425,942   $1,426    42,245,364   $42,245   $14,121,236   $-   $(13,150,328)  $1,014,579 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

DIGIPATH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the Years Ended 
   September 30, 
   2018   2017 
Cash flows from operating activities          
Net loss  $(1,653,657)  $(1,065,140)
Adjustments to reconcile net loss to net cash used in operating activities:          
Change in allowance for doubtful accounts   (17,280)   32,180 
Depreciation and amortization expense   277,294    253,535 
Stock issued for services   452,537    246,380 
Options and warrants granted for services   439,853    389,736 
Realized loss on available-for-sale securities   -    50,000 
Decrease (increase) in assets:          
Accounts receivable   116,159    (200,352)
Prepaid expenses   1,060    (49,504)
Deposits   -    14,203 
Increase (decrease) in liabilities:          
Accounts payable   203,870    (35,672)
Accrued expenses   16,234    (12,243)
Deferred revenues   525    - 
Net cash used in operating activities   (163,405)   (376,877)
           
Cash flows from investing activities          
Purchase of fixed assets   (207,353)   (140,836)
Net cash used in investing activities   (207,353)   (140,836)
           
Cash flows from financing activities          
Proceeds from sale of common stock   368,608    560,500 
Net cash provided by financing activities   368,608    560,500 
           
Net increase (decrease) in cash   (2,150)   42,787 
Cash - beginning   178,177    135,390 
Cash - ending  $176,027   $178,177 
           
Supplemental disclosures:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 
           
Non-cash investing and financing activities:          
Value of preferred stock converted to common stock  $472,000   $1,622,500 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

DIGIPATH, INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 – Nature of Business and Significant Accounting Policies

 

Nature of Business

 

Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (“Digipath,” the “Company,” “we,” “our” or “us”) supports the cannabis industry’s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units are described below.

 

  Digipath Labs, Inc. Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.
     
  The National Marijuana News Corp. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving—and profoundly controversial—medicinal and recreational marijuana industry.

 

Basis of Accounting

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The FASB Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:

 

    State of    
Name of Entity(1)   Incorporation   Relationship
Digipath, Inc.(2)   Nevada   Parent
Digipath Labs, Inc.   Nevada   Subsidiary
TNM News, Inc.   Nevada   Subsidiary
GroSciences, Inc.(3)   Colorado   Subsidiary

 

(1) All entities are in the form of a corporation.

(2) Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.

(3) Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.

 

The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company and subsidiaries will be collectively referred to herein as the “Company”, “Digipath” or “DIGP”. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its customers are within the United States.

 

These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.

 

Reclassifications

 

Prior period interest income in the amount of $10,000 has been reclassified to net against the related $10,000 of bad debt expense to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

F-6

 

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.

 

Fair Value of Financial Instruments

 

The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

 

  - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.  
  - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.  
  - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.  

 

The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short term nature of the instruments.

 

Accounts Receivable

 

Accounts receivable are carried at their estimated collectible amounts. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. The Company had an allowance for doubtful accounts of $14,900 and $32,180 as of September 30, 2018 and 2017, respectively.

 

Fixed Assets

 

Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:

 

Software 3 years
Office equipment 5 years
Furniture and fixtures 5 years
Lab equipment 7 years
Leasehold improvements Term of lease

 

Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.

 

Impairment of Long-Lived Assets

 

Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.

 

Our intellectual property is comprised of indefinite-lived brand names acquired and have been assigned an indefinite life as we currently anticipate that these brand names will contribute cash flows to the Company perpetually. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.

 

Revenue Recognition

 

Effective October 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.

 

F-7

 

 

There was no impact on the Company’s financial statements from ASC 606 for the years ended September 30, 2018 or 2017 since it was not adopted until October 1, 2018.

 

Revenue is primarily generated through our subsidiary, Digipath Labs, Inc., which recognizes revenue from the analytical testing of cannabis products for licensed producers and cultivators within the state of Nevada on a determinable fixed fee per test, or panel of tests basis. Revenue from the performance of those services is recognized upon completion of the tests, at which time test results are delivered to the customer, provided collectability of the fee is reasonably assured. We typically require payment within thirty days of the delivery of results. Management estimates an allowance for doubtful accounts based on the aging of its receivables.

 

The Company also recognizes revenue through our subsidiary, TNM News Corp., which primarily recognizes revenue from advertisements through partnered merchants. Payment for ad revenues are received prior to the distribution of the ad campaign, and the revenues are recognized ratably over the campaign. The Company defers any revenue for which the term of the campaign has not yet been realized. To date, these revenues have not been materially significant. Deferred revenues on advertisement campaigns was $525 at September 30, 2018.

 

Advertising Costs

 

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $108,295 and $138,026 for the years ended September 30, 2018 and 2017, respectively.

 

Basic and Diluted Loss Per Share

 

The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended September 30, 2018 and 2017, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.

 

Stock-Based Compensation

 

The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 505-50 (ASC 505-50). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.

 

Income Taxes

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.

 

Uncertain Tax Positions

 

In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.

 

F-8

 

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

Recent Accounting Pronouncements

 

In June 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the “Tax Act”) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The calculation of accumulated foreign earnings requires an analysis of each foreign entity’s financial results going back to 1986. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The guidance permits entities to reclassify tax effects stranded in Accumulated Other Comprehensive Income as a result of tax reform to retained earnings. This new guidance is effective for annual and interim periods in fiscal years beginning after December 15, 2018. Early adoption is permitted in annual and interim periods and can be applied retrospectively or in the period of adoption. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.

 

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted the new standard to be effective with our first interim reporting period for the three months ended December 31, 2017. We use the modified retrospective method of adoption. We have completed an initial evaluation of the potential impact from adopting the new standard, including a detailed review of performance obligations for all material revenue streams. Based on this initial evaluation, adoption does not have a material impact on our financial position, results of operations, or cash flows. Related disclosures have been expanded in line with the requirements of the standard.

 

There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

 

Note 2 – Going Concern

 

As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses from operations resulting in an accumulated deficit of ($13,150,328), and as of September 30, 2018, the Company’s cash on hand may not be sufficient to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management is actively pursuing new customers to increase revenues. In addition, the Company is currently seeking additional sources of capital to fund short term operations. Management believes these factors will contribute toward achieving profitability. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. These financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

F-9

 

 

Note 3 – Related Party Transactions

 

Stock Issued to Officers for Services

 

On September 25, 2018, we issued 39,344 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On September 25, 2018, we issued 98,361 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On June 25, 2018, we issued 118,421 shares of common stock to our then Chief Executive Officer, Joseph Bianco, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $22,500 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On June 25, 2018, we issued 31,579 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On June 25, 2018, we issued 78,947 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On March 26, 2018, we issued 207,852 shares of common stock to our then Chief Executive Officer, Joseph Bianco, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $45,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On March 26, 2018, we issued 55,427 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $12,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On March 26, 2018, we issued 138,568 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $30,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On December 22, 2017, we issued 300,000 shares of common stock to our Chief Financial Officer, Todd Peterson, as a bonus for services rendered. The aggregate fair value of the common stock was $78,828 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

Stock Issued to Directors for Services

 

On September 12, 2018, we issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company’s common stock on the date of grant, and is to be expensed over the requisite service period through September 30, 2019. A total of $1,458 was expensed during the year ended September 30, 2018, and as of September 30, 2018, a total of $29,562 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.

 

On December 22, 2017, we issued 100,000 shares of common stock to Dr. Alfredo Axtmayer for his service on our Board of Directors. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

F-10

 

 

Options Issued to Officers and Directors for Services

 

On September 12, 2018, we granted options to purchase 200,000 shares of common stock as compensation for services to our Chief Science Officer pursuant to her appointment to the Company’s Board of Directors. The options vest over a one-year period and are exercisable for a ten-year period at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. The options are being expensed over the vesting period, resulting in $1,170 of stock-based compensation expense during the year ended September 30, 2018. As of September 30, 2018, options to purchase 200,000 shares of common stock remained unvested and a total of $23,735 of unamortized expense is expected to be expensed during the fiscal year ended September 30, 2019.

 

On December 22, 2017, we granted fully vested options to purchase 500,000 shares of common stock as compensation for services to our Chief Executive Officer, Todd Denkin. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.2094, was $104,698, which was expensed on the grant date, resulting in $104,698 of stock-based compensation expense during the year ended September 30, 2018.

 

Note 4 – Fair Value of Financial Instruments

 

Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value.

 

The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows:

 

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

 

Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).

 

Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.

 

F-11

 

 

The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets as of September 30, 2018 and 2017, respectively:

 

   Fair Value Measurements at September 30, 2018 
   Level 1   Level 2   Level 3 
Assets               
Cash  $176,027   $-   $- 
Total assets   176,027    -    - 
Liabilities               
None   -    -    - 
Total liabilities   -    -    - 
   $176,027   $-   $- 

 

   Fair Value Measurements at September 30, 2017 
   Level 1   Level 2   Level 3 
Assets               
Cash  $178,177   $-   $- 
Total assets   178,177    -    - 
Liabilities               
None   -    -    - 
Total liabilities   -    -    - 
   $178,177   $-   $- 

 

The fair value of our intellectual properties are deemed to approximate book value, and are considered Level 3 inputs as defined by ASC Topic 820-10-35.

 

There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the years ended September 30, 2018 or 2017.

 

We recognized other than temporary impairment losses of $50,000 on our available-for-sale securities during the year ended September 30, 2017.

 

Note 5 – Accounts Receivable

 

Accounts receivable was $167,734 and $266,613 at September 30, 2018 and 2017, respectively, net of allowance for uncollectible accounts of $14,900 and $32,180 at September 30, 2018 and 2017, respectively.

 

Note 6 – Fixed Assets

 

Fixed assets consist of the following at September 30, 2018 and 2017:

 

   For the Years Ended 
   September 30, 
   2018   2017 
Software  $123,492   $121,617 
Office equipment   54,877    36,080 
Furniture and fixtures   28,486    14,285 
Lab equipment   1,110,930    938,450 
Leasehold improvements   489,147    489,147 
    1,806,932    1,599,579 
Less: accumulated depreciation   (849,824)   (572,530)
Total  $957,108   $1,027,049 

 

On October 1, 2016, we disposed of fixed assets with a net book value of $3,122 pursuant to the deconsolidation of Digipath Corp. The fixed assets consisted of furniture and fixtures with a historical cost basis of $48,779 and software with a historical cost basis of $10,019, and accumulated depreciation of $48,779 and $6,897, respectively. No gain or loss was recognized on the disposals.

 

Depreciation and amortization expense totaled $277,294 and $253,535 for the years ended September 30, 2018 and 2017, respectively.

 

F-12

 

 

Note 7 – Stockholders’ Equity

 

Convertible Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share, of which 6,000,000 have been designated as Series A Convertible Preferred Stock (“Series A Preferred”), with the remaining 4,000,000 shares available for designation from time to time by the Board as set forth below. As of September 30, 2018, there were 1,425,942 shares of Series A Preferred issued and outstanding. The Board of Directors is authorized to determine any number of series into which the undesignated shares of preferred stock may be divided and to determine the rights, preferences, privileges and restrictions granted to any series of the preferred stock. Each share of Series A Preferred is currently convertible into five shares of common stock.

 

The conversion price is adjustable in the event of stock splits and other adjustments in the Company’s capitalization, and in the event of certain negative actions undertaken by the Company. At the current conversion price, the 1,425,942 shares of Series A Preferred outstanding at September 30, 2018 are convertible into 7,129,710 shares of the common stock of the Company. No holder is permitted to convert its shares of Series A Preferred if such conversion would cause the holder to beneficially own more than 4.99% of the issued and outstanding common stock of the Company immediately after such conversion, unless waived by such holder by providing at least sixty-five days’ notice.

 

Additional terms of the Series A Preferred include the following:

 

  The shares of Series A Preferred are entitled to dividends when, as and if declared by the Board as to the shares of the common stock of the Company into which such Series A Preferred may then be converted, subject to the 4.99% beneficial ownership limitation described above.
     
  Upon the liquidation or dissolution of the Company, or any merger or sale of all or substantially all of the assets, the shares of Series A Preferred are entitled to receive, prior to any distribution to the holders of common stock, 100% of the purchase price per share of Series A Preferred plus all accrued but unpaid dividends.
     
  The Series A Preferred plus all declared but unpaid dividends thereon automatically will be converted into common stock, at the then applicable conversion rate, upon the affirmative vote of the holders of a majority of the outstanding shares of Series A Preferred.
     
  Each share of Series A Preferred will carry a number of votes equal to the number of shares of common stock into which such Series A Preferred may then be converted, subject to the 4.99% beneficial ownership limitation described above. The Series A Preferred generally will vote together with the common stock and not as a separate class, except as provided below.
     
  Consent of the holders of the outstanding Series A Preferred is required in order for the Company to: (i) amend or change the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series A Preferred; (ii) authorize, create or issue shares of any class of stock having rights, preferences, privileges or powers superior to the Series A Preferred; (iii) reclassify any outstanding shares into shares having rights, preferences, privileges or powers superior to the Series A Preferred; or (iv) amend the Company’s Articles of Incorporation or Bylaws in a manner that adversely affects the rights of the Series A Preferred.
     
  Pursuant to the Securities Purchase Agreements, holders of Series A Preferred are entitled to unlimited “piggyback” registration rights on registrations by the Company, subject to pro rata cutback at any underwriter’s discretion.

 

Preferred Stock Conversions for the Year Ended September 30, 2018

 

For the year ended September 30, 2018, a total of 472,000 shares of Series A Preferred were converted into 2,360,000 shares of common stock at a value of $0.20 per share of common stock, or a total of $472,000. The stock was converted in accordance with the conversion terms; therefore no gain or loss has been recognized.

 

Preferred Stock Conversions for the Year Ended September 30, 2017

 

For the year ended September 30, 2017, a total of 1,622,500 shares of Series A Preferred were converted into 8,112,500 shares of common stock at a value of $0.20 per share of common stock, or a total of $1,622,500. The stock was converted in accordance with the conversion terms; therefore no gain or loss has been recognized.

 

Common Stock

 

Common stock consists of $0.001 par value, 90,000,000 shares authorized, of which 42,245,364 shares were issued and outstanding as of September 30, 2018.

 

F-13

 

 

Common Stock Sales for the Year Ended September 30, 2018

 

On July 11, 2018, the Company sold 66.67 units, consisting of 666,667 shares of its common stock and warrants to purchase 333,334 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $100,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On April 13, 2018, the Company sold 14 units, consisting of an aggregate of 140,000 shares of its common stock and warrants to purchase 70,000 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $25,200. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On April 12, 2018, the Company sold 28 units, consisting of an aggregate of 280,000 shares of its common stock and warrants to purchase 140,000 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $50,400. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On April 10, 2018, the Company sold 27.78 units, consisting of an aggregate of 277,778 shares of its common stock and warrants to purchase 138,889 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On December 20, 2017, the Company sold 10 units, consisting of an aggregate of 100,000 shares of its common stock and warrants to purchase 50,000 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $18,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On December 14, 2017, the Company sold 13.89 units, consisting of an aggregate of 138,889 shares of its common stock and warrants to purchase 69,445 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $25,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On December 14, 2017, the Company sold 55.56 units, consisting of an aggregate of 555,600 shares of its common stock and warrants to purchase 277,800 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $100,008. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

Common Stock Sales for the Year Ended September 30, 2017

 

On August 25, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On August 25, 2017, the Company sold 7 units, consisting of 70,000 shares of its common stock and warrants to purchase 35,000 shares of common stock, exercisable at $0.30 per share over a sixty month period, in exchange for total proceeds of $10,500. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On August 4, 2017, the Company sold 100 units, consisting of 1,000,000 shares of its common stock and warrants to purchase 500,000 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $150,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On July 28, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On June 21, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On February 21, 2017, the Company sold 1,428,575 units, consisting of 1,428,575 shares of its common stock and warrants to purchase 714,285 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $250,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis. The warrants were assigned to two individuals by the purchaser at the time of the sale.

 

Exercise of Options for the Year Ended September 30, 2018

 

On January 3, 2018, two option holders exercised options to purchase a total of 500,000 shares of common stock at $0.181 per share on a cashless basis, resulting in the issuance of 317,172 shares of common stock.

 

F-14

 

 

On January 2, 2018, an option holder exercised options to purchase 37,500 shares of common stock at $0.22 per share on a cashless basis, resulting in the issuance of 21,000 shares of common stock.

 

Exercise of Warrants for the Year Ended September 30, 2018

 

On January 3, 2018, a warrant holder exercised warrants to purchase 71,428 shares of common stock at $0.26 per share on a cashless basis, resulting in the issuance of 34,285 shares of common stock.

 

Additional Common Stock Issuances for the Year Ended September 30, 2018

 

On September 25, 2018, the Company issued 39,344 shares of common stock to its President and CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 25, 2018, the Company issued 98,361 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $22,875 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 12, 2018, the Company issued 193,424 shares of common stock to another consultant for business development services. The fair value of the common stock was $30,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 12, 2018, the Company issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company’s common stock on the date of grant, and is to be expensed over the requisite service period through September 30, 2019. A total of $1,458 was expensed during the year ended September 30, 2018, and as of September 30, 2018, a total of $29,562 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.

 

On June 25, 2018, the Company issued 118,421 shares of common stock to its then CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $22,500 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 31,579 shares of common stock to its then President and COO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 78,947 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 131,579 shares of common stock to a consultant for business development services. The fair value of the common stock was $25,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 100,000 shares of common stock to another consultant for business development services. The fair value of the common stock was $19,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 207,852 shares of common stock to its then CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $45,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 55,427 shares of common stock to its then President and COO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $12,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

F-15

 

 

On March 26, 2018, the Company issued 138,568 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $30,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 69,284 shares of common stock to a consultant for business development services. The fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On December 22, 2017, the Company issued 300,000 shares of common stock to its CFO as a bonus for services rendered. The aggregate fair value of the common stock was $78,828 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On December 22, 2017, the Company issued 100,000 shares of common stock to Dr. Alfredo Axtmayer for his service on our Board of Directors. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On November 29, 2017, a total of 314,069 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $82,600 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

Additional Common Stock Issuances for the Year Ended September 30, 2017

 

On May 2, 2017, the Company issued 100,000 shares of common stock to Dr. John Abroon in connection with his appointment to our newly created Advisory Board. The aggregate fair value of the common stock was $20,900 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On May 2, 2017, the Company issued 140,000 shares of common stock to a consultant in consideration of services rendered from April 1, 2017 through May 31, 2017. The aggregate fair value of the common stock was $29,260 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On March 1, 2017, the Company issued 25,000 shares of common stock to its CFO as a bonus for services rendered. The aggregate fair value of the common stock was $6,623 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On March 1, 2017, the Company issued 50,000 shares of common stock to its Chief Scientist as a bonus for services rendered. The aggregate fair value of the common stock was $13,245 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On February 23, 2017, the Company issued 100,000 shares of common stock to a consultant for services to be rendered over a six month period. The aggregate fair value of the common stock was $29,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2017.

 

On February 22, 2017, the Company issued 100,000 shares of common stock to Dr. Alfredo Axtmayer in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $34,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On February 22, 2017, the Company issued 40,000 shares of common stock to a consultant for services rendered. The aggregate fair value of the common stock was $13,600 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On February 7, 2017, a total of 370,000 shares of common stock were issued to six consultants that were engaged to assist the Company with acquisition activities over a six month period. The aggregate fair value of the common stock was $82,251 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2017.

 

F-16

 

 

Note 8 – Common Stock Options

 

Stock Incentive Plan

 

On June 21, 2016, we amended and restated our 2012 Stock Incentive Plan (the “2012 Plan”), which was originally adopted on March 5, 2012 and previously amended on May 20, 2014. As amended, the 2012 Plan provides for the issuance of up to 11,500,000 shares of common stock pursuant to the grant of options or other awards, including stock grants, to employees, officers or directors of, and consultants to, the Company and its subsidiaries. Options granted under the 2012 Plan may either be intended to qualify as incentive stock options under the Internal Revenue Code of 1986, or may be non-qualified options, and are exercisable over periods not exceeding ten years from date of grant. Options to purchase a total of 8,537,500 shares of common stock were outstanding as of September 30, 2018

 

Common Stock Option Issuances for the Year Ended September 30, 2018

 

On September 12, 2018, we granted options to purchase 200,000 shares of common stock as compensation for services to our Chief Science Officer pursuant to her appointment to the Company’s Board of Directors. The options vest over a one-year period, are exercisable over a ten-year period at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. The options are being expensed over the vesting period, resulting in $1,170 of stock-based compensation expense during the year ended September 30, 2018. As of September 30, 2018, options to purchase 200,000 shares of common stock remained unvested and a total of $23,735 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.

 

On December 22, 2017, we granted fully vested options to purchase 500,000 shares of common stock as compensation for services to our then President and COO. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.2094, was $104,698. The options were expensed over the vesting period, resulting in $104,698 of stock-based compensation expense during the year ended September 30, 2018.

 

On November 29, 2017, we granted fully vested options to purchase 100,000 shares of common stock as compensation for services to our Chief Scientist. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.21, was $21,004. The options were expensed over the vesting period, resulting in $21,004 of stock-based compensation expense during the year ended September 30, 2018.

 

On November 29, 2017, we granted fully vested options to purchase an aggregate of 205,000 shares of common stock as compensation for services to a total of ten of our employees. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.21, was $43,057. The options were expensed over the vesting period, resulting in $43,057 of stock-based compensation expense during the year ended September 30, 2018.

 

Common Stock Options Exercised for the Year Ended September 30, 2018

 

On January 3, 2018, two option holders exercised options to purchase a total of 500,000 shares of common stock at $0.181 per share on a cashless basis, resulting in the issuance of 317,172 shares of common stock.

 

On January 2, 2018, an option holder exercised options to purchase 37,500 shares of common stock at $0.22 per share on a cashless basis, resulting in the issuance of 21,000 shares of common stock.

 

Common Stock Options Cancelled or Expired for the Year Ended September 30, 2018

 

During the year ended September 30, 2018, options to purchase an aggregate of 110,000 shares of common stock, exercisable over a ten-year period, at a weighted average exercise price of $0.25 per share expired.

 

During the year ended September 30, 2018, options to purchase an aggregate of 1,110,000 shares of common stock, exercisable over a three-year period, at a weighted average exercise price of $0.44 per share expired.

 

Common Stock Options Cancelled or Expired for the Year Ended September 30, 2017

 

On January 1, 2017, a total of 1,530 common stock options exercisable over a three-year period from the original grant date of January 1, 2014 with an exercise price of $3.30 per share expired.

 

F-17

 

 

The following is a summary of information about the stock options outstanding at September 30, 2018.

 

Shares Underlying Options Outstanding   Shares Underlying
Options Exercisable
 
                          
         Weighted                
    Shares    Average    Weighted    Shares    Weighted 
Range of   Underlying    Remaining    Average    Underlying    Average 
Exercise   Options    Contractual    Exercise    Options    Exercise 
Prices   Outstanding    Life    Price    Exercisable    Price 
                          
$0.16 – $0.40   8,537,500    4.27 years   $0.20    8,337,500   $0.21 

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

   September 30,   September 30, 
   2018   2017 
         
Average risk-free interest rates   1.36%   N/A%
Average expected life (in years)   5.25    N/A 
Volatility   112%   N/A%

 

The Black-Scholes option pricing model was developed for use in estimating the fair value of short-term traded options that have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including expected stock price volatility. Because the Company’s common stock options have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion the existing models do not necessarily provide a reliable single measure of the fair value of its common stock options. During the years ended September 30, 2018 and September 30, 2017, there were no options granted with an exercise price below the fair value of the underlying stock at the grant date.

 

The weighted average fair value of options granted with exercise prices at the current fair value of the underlying stock during the year ended September 30, 2018 was approximately $0.25 per option.

 

The following is a summary of activity of outstanding common stock options:

 

       Weighted 
       Average 
   Number   Exercise 
   of Shares   Price 
         
Balance, September 30, 2016   9,291,530   $0.23 
Options expired   (1,530)   (3.30)
           
Balance, September 30, 2017   9,290,000    0.23 
Options issued   1,005,000    0.25 
Options exercised   (537,500)   (0.18)
Options expired   (1,220,000)   (0.42)
           
Balance, September 30, 2018   8,537,500   $0.20 
           
Exercisable, September 30, 2018   8,337,500   $0.21 

 

Amortization of Stock Options

 

A total of $439,853 and $389,736 of stock-based compensation expense was recognized from the amortization of options over their vesting period during the years ended September 30, 2018 and 2017, respectively.

 

As of September 30, 2018, these options in the aggregate had no intrinsic value as the per share market price of $0.15 of the Company’s common stock as of such date was less than the weighted-average exercise price of these options of $0.20.

 

F-18
 

 

Note 9 – Common Stock Warrants

 

We issued warrants in connection with private placements of our securities as set forth in Note 8 above.

 

On January 3, 2018 a warrant holder exercised warrants to purchase 71,428 shares of common stock at $0.26 per share on a cashless basis, resulting in the issuance of 34,285 shares of common stock.

 

On December 31, 2017, warrants to purchase 200,000 shares of common stock at $0.30 per share expired, and on December 30, 2017, warrants to purchase another 300,000 shares of common stock at $0.45 per share also expired.

 

The following is a summary of information about our warrants to purchase common stock outstanding at September 30, 2018 (including those issued to both investors and service providers).

 

   Shares Underlying 
Shares Underlying Warrants Outstanding    Warrants Exercisable 
                          
         Weighted                
    Shares    Average    Weighted    Shares    Weighted 
Range of   Underlying    Remaining    Average    Underlying    Average 
Exercise   Warrants    Contractual    Exercise    Warrants    Exercise 
Prices   Outstanding    Life    Price    Exercisable    Price 
                          
$0.1901 – $0.40   6,450,462    1.65 years   $0.28    6,450,462   $0.28 

 

The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

   September 30,   September 30, 
   2018   2017 
         
Average risk-free interest rates   1.56%   1.11%
Average expected life (in years)   3.00    3.50 
Volatility   110%   145%

 

The weighted average fair value of warrants granted with exercise prices at the current fair value of the underlying stock during the years ended September 30, 2018 and 2017 was approximately $0.29 and $0.26 per warrant, respectively.

 

The following is a summary of activity of outstanding common stock warrants:

 

       Weighted 
       Average 
   Number   Exercise 
   of Shares   Price 
         
Balance, September 30, 2016   4,193,136   $0.29 
Warrants granted   1,749,286    0.26 
           
Balance, September 30, 2017   5,942,422    0.28 
Warrants granted   1,079,468    0.29 
Warrants exercised   (71,428)   (0.26)
Warrants expired   (500,000)   (0.36)
           
Balance, September 30, 2018   6,450,462   $0.28 
           
Exercisable, September 30, 2018   6,450,462   $0.28 

 

F-19
 

 

Note 10 – Commitments and Contingencies

 

Lease Commitment

 

The Company leases space for its lab operations in Las Vegas, Nevada. Amounts of minimum future annual commitments on a calendar year basis, including common area maintenance fees, under non-cancelable operating leases are as follows:

 

2018  $48,872 
2019   198,904 
2020   151,283 
2021   50,102 
Total  $449,161 

 

Rent expense was $191,751 and $210,907 for the years ended September 30, 2018 and 2017, respectively.

 

Note 11 – Other Income

 

Other income for the years ended September 30, 2018 and 2017 consisted of the following:

 

   September 30, 
   2018   2017 
Settlement income on license agreement  $-   $250,000 
Rental income on subleases   76,800    20,568 
Restitution income   28,312    11,500 
   $105,112   $282,068 

 

Note 12 - Income Tax

 

The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences.

 

For the years ended September 30, 2018 and 2017, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At September 30, 2018, the Company had approximately $7,982,500 of federal net operating losses. The net operating loss carry forwards, if not utilized, will begin to expire in 2031.

 

The effective income tax rate for the years ended September 30, 2018 and 2017 consisted of the following:

 

   September 30, 
   2018   2017 
Federal statutory income tax rate   21%   35%
State income taxes        -%   -%
Change in valuation allowance   (21)%   (35)%
Net effective income tax rate   -    - 

 

The components of the Company’s deferred tax asset are as follows:

 

   September 30, 
   2018   2017 
Deferred tax assets:          
Net operating loss carry forwards  $1,676,325   $2,531,725 
           
Net deferred tax assets before valuation allowance  $1,676,325   $2,531,725 
Less: Valuation allowance   (1,676,325)   (2,531,725)
Net deferred tax assets  $-   $- 

 

F-20
 

 

Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at September 30, 2018 and 2017, respectively.

 

In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.

 

Note 13 – Subsequent Events

 

Debt Financing

 

On November 8, 2018, the Company sold 8% Senior Secured Convertible Notes in the aggregate principal amount of $500,000 to two institutional investors. The Notes mature on December 31, 2020, bear interest at a rate of 8% per annum, and are convertible into shares of the Company’s common stock at a fixed conversion price of $0.14 per share. The Company’s obligation under the Notes are secured by a lien on the assets of the Company and its wholly-owned subsidiary Digipath Labs, Inc., pursuant to a Security Agreement between the Company, Digipath Labs, Inc. and the collateral agent for the investors.

 

Common Stock Issued for Services

 

On December 25, 2018, the Company issued 46,261 shares of common stock to its President and CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On December 25, 2018, the Company issued 115,652 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On December 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $19,455 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On November 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $19,260 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On October 30, 2018, the Company issued 400,000 shares of common stock to another consultant for business development services to be performed from November 1, 2018 through April 30, 2019. The fair value of the common stock was $54,120 based on the closing price of the Company’s common stock on the date of grant, and is being expensed over the requisite service period.

 

On October 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $23,250 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

Common Stock Option Issuances

 

On December 25, 2018, we granted options to purchase an aggregate of 235,000 shares of common stock as compensation for services to a total of ten of our employees, vesting twelve months from the grant date. The options are exercisable over a ten-year period at an exercise price of $0.13 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1017, was $35,078. The options are to be expensed over the vesting period.

 

Common Stock Warrants Expired

 

On December 21, 2018, warrants to purchase 166,667 shares of common stock at $0.30 per share expired.

 

On November 23, 2018, warrants to purchase another 100,000 shares of common stock at $0.40 per share also expired.

 

F-21
 

 

ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None

 

ITEM 9A. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Principal Executive Officer and our Principal Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2018 (the “Evaluation Date”). The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of September 30, 2018, our Principal Executive Officer and Principal Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management has conducted, with the participation of our Principal Executive Officer and our Principal Accounting Officer, an assessment, including testing of the effectiveness, of our internal control over financial reporting as of Evaluation Date. Management’s assessment of internal control over financial reporting was conducted using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013 Framework).

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. In connection with management’s assessment of our internal control over financial reporting as required under Section 404 of the Sarbanes-Oxley Act of 2002, we have not identified any material weaknesses in our internal control over financial reporting as of the Evaluation Date. We have thus concluded that our internal control over financial reporting was effective as of the Evaluation Date.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to an exemption for smaller reporting companies under Section 989G of the Dodd-Frank Wall Street Reform and Consumer Protection Act.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) or in other factors that occurred during the fourth fiscal quarter of 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. Other Information

 

None.

 

20
 

 

PART III

 

ITEM 10. Directors, Executive Officers and Corporate Governance

 

Set forth below are the present directors and executive officers of the Company. There are no arrangements or understandings between any of the directors, officers and other persons pursuant to which such person was selected as a director or an officer.

 

Name  Age  Position
Todd Denkin  55  Chairman of the Board, CEO
Todd A. Peterson  49  CFO, Secretary
Cindy Orser  62  Director
Bruce Raben  65  Director

 

Biographies

 

Set forth below are brief accounts of the business experience of each director and executive officer of the Company.

 

Todd Denkin has over ten years of experience in the “legal” marijuana industry. Mr. Denkin joined us as the President of The National Marijuana News Corp. in August 2014 and has served as our President and Chief Executive Officer since July 3, 2018 and from October 2014 until June, 2016. From June 2016 until July 3, 2018, Mr. Denkin served as our President and Chief Operating Officer. Prior to joining Digipath, Mr. Denkin served as co-founder and president of both 10 Mile and Growopp, LLC where he created controlled environmental indoor hydroponic grow chambers from 2011 to 2013. From 2009 until 2011, Mr. Denkin was a founder and director of GrowLife, Inc. Prior to joining GrowLife, Inc., Mr. Denkin was the head of the direct sales and marketing teams from 2002 through 2008 with Digital FX International, and helped build a sales organization of over 60,000 representatives. He is a 30-year veteran of the TV and film industry, working at top companies like Dick Clark Productions, Barris/Guber/Peters, the Nickelodeon Network, Disney/MGM Studios and Time Warner. Mr. Denkin has been a key contributor to shows for ABC, NBC, CBS, ESPN and MTV. He also directed and produced “The Australian Experience,” a film featured on The Today Show and screened at the opening ceremonies of the 2000 Olympics. We believe that Mr. Denkin’s industry experience qualifies him to serve as our director.

 

Todd Peterson, CPA, has been the chief financial officer of Digipath since June 19, 2015. Mr. Peterson had previously been the president of KSNE2 Enterprises, LLC, an accounting and consulting firm located in Las Vegas, Nevada specializing in publicly traded microcap companies, since August 2008. From February 2007 to August 2008, he was the senior accounting manager of Accuity Financial, an accounting firm located in Las Vegas, Nevada specializing in publicly traded microcap companies, Mr. Peterson was the audit manager of DeJoya Griffith and Company a PCAOB registered audit firm located in Las Vegas, Nevada providing audit and accounting services primarily to publicly traded microcap companies from November 2004 to February 2007, he was also the audit manager of Ocel, Heimer & Associates, Ltd., a regional audit firm located in Minneapolis, Minnesota from 1999 to 2004. Upon graduating from the University of St. Thomas with a Bachelor of Arts degree in accounting in 1997, Mr. Peterson worked as an accountant during 1998 for R.W. Ramsay & Associates, Ltd.

 

Dr. Cindy Orser was appointed to our Board of Directors on September 12, 2018. Dr. Orser has served as our Chief Science Officer since June 1, 2014. Since 2007, she has also been the President of Big Sky Biosystems, Inc., a consulting company through which Dr. Orser provides service to us and other clients. Dr. Orser holds a Ph.D. in Genetics, Plant Pathology from the University of California, Berkeley, and a B.S. in Botany and Philosophy from Montana State University-Bozeman. We believe that Dr. Orser’s experience and expertise in the cannabis testing industry qualify her to serve as our director.

 

Bruce Raben was appointed to our Board of Directors on September 12, 2018. Mr. Raben is the Managing Member of Hudson Capital Advisors BD, LLC, a registered broker dealer that he founded in 2004. Mr. Raben has been an investment banker, merchant banker and private investor for approximately 30 years. Starting in 1979 at Drexel Burnham Lambert, he worked on many leveraged buyouts and recapitalizations including Mattel Toys, SFN Co.’s, Magma Copper, Warnaco, Mellon Bank and John Fairfax. Mr. Raben then went on to co-found the Corporate Finance Department at Jeffries & Co. in 1990. Mr. Raben opened a west coast office for CIBC’s high yield finance and merchant banking activities in 1996. Mr. Raben received his A.B. from Vassar College in 1975 and his MBA from Columbia University in 1979. We believe that Mr. Raben’s investment banking and financial experience qualify him to serve as our director.

 

Family Relationships

 

None.

 

21
 

 

Board Committees and Audit Committee Financial Expert

 

We do not currently have a standing audit, nominating or compensation committee of the board of directors, or any committee performing similar functions. Our board of directors performs the functions of audit, nominating and compensation committees. As of the date of this prospectus, no member of our board of directors qualifies as an “audit committee financial expert” as defined in Item 407(d)(5) of Regulation S-K promulgated under the Securities Act.

 

Director Nominations

 

As of September 30, 2018, we did not affect any material changes to the procedures by which our shareholders may recommend nominees to our board of directors. We have not established formal procedures by which security holders may recommend nominees to the Company’s board of directors.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires the Company’s directors, executive officers and persons who own more than 10% of a registered class of the Company’s securities to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Directors, executive officers and greater than 10% stockholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) reports they file. To our knowledge, based solely on the review of the copies of these forms furnished to us and representations that no other reports were required, the Company believes that all forms required to be filed under Section 16 of the Exchange Act for the year ended September 30, 2018 were filed timely, except that each of Todd Denkin, Todd Peterson and Joseph Bianco filed a Form 4 one day late in March 2018; Todd Denkin and Todd Peterson filed late Form 4s in July and December 2018, and Dr. Cindy Orser and Bruce Raben filed a late Form 4 in September 2018.

 

Code of Ethics

 

We have adopted a code of ethics that applies to our principal executive officers, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of our code of ethics may be obtained free of charge by contacting us at the address or telephone number listed on the cover page hereof.

 

ITEM 11. Executive Compensation

 

Summary Compensation Table

 

The following summary compensation table sets forth the aggregate compensation we paid or accrued during the fiscal years ended September 30, 2018 and September 30, 2017 to persons serving as our Chief Executive Officer and Chief Financial Officer who are our only executive officers, during 2018.

 

Name and  Fiscal       Stock   Option     
Financial Position  Year   Salary   Awards   Awards(9)   Total 
                     
Todd Denkin,   2018   $205,042   $24,000(2)  $197,776(3)  $426,818 
President and Chief Executive Officer   2017   $201,000   $-   $124,104(3)  $325,104 
                          
Todd A. Peterson,   2018   $99,001   $138,828(4)  $-   $237,829 
Chief Financial Officer   2017   $96,000   $6,623(5)  $-   $102,623 
                          
Joseph J. Bianco,(1)   2018   $111,219   $67,500(6)  $176,846(8)  $355,565 
Former Chief Executive Officer   2017   $110,135   $17,500(7)  $235,800(8)  $363,435 

 

22
 

 

(1)Mr. Bianco was our Chief Executive Officer until his passing on July 1, 2018. The Company chose to continue to pay Mr. Bianco’s salary to his surviving wife through September 30, 2018.
  
(2)Consists of quarterly awards of stock in lieu of cash from March 26, 2018 through September 25, 2018, totaling 126,350 shares in the aggregate. The Company recognized $24,000 of stock-based compensation expense during the year ended September 30, 2018.
  
(3)Consists of options to purchase 500,000 shares of common stock exercisable at $0.27 per share over 10 years issued as a bonus on December 22, 2017 that vested immediately, and options to purchase 2,500,000 shares of common stock exercisable at $0.20 per share over 10 years that vest immediately as to one-half of the shares, one year from the grant date as to one-quarter of the shares, and two years following the grant date as to the remaining one-quarter of the shares issued as a signing bonus on June 21, 2016. The Company recognized $197,776 and $124,104 of stock-based compensation expense during the years ended September 30, 2018 and 2017, respectively.
  
(4)Consists of 300,000 shares of common stock issued as a bonus on December 22, 2017, and quarterly awards of stock in lieu of cash from March 26, 2018 through September 25, 2018, totaling 315,876 shares in the aggregate. The Company recognized $138,828 of stock-based compensation expense during the year ended September 30, 2018.
  
(5)Consists of 300,000 shares of common stock issued as a bonus on September 30, 2016. The Company recognized $6,623 of stock-based compensation expense during the year ended September 30, 2017.
  
(6)Consists of quarterly awards of stock in lieu of cash from March 26, 2018 through June 25, 2018, totaling 326,273 shares in the aggregate. The Company recognized $67,500 of stock-based compensation expense during the year ended September 30, 2018.
  
(7)Consists of 500,000 shares of common stock issued for service as a Director on January 1, 2016. The Company recognized $17,500 of stock-based compensation expense during the year ended September 30, 2017.
  
(8)Consists of options to purchase 4,750,000 shares of common stock exercisable at $0.20 per share over 10 years issued as a signing bonus on June 21, 2016. The option vests immediately as to one-half of the shares, one year from the grant date as to one-quarter of the shares, and two years following the grant date as to the remaining one-quarter of the shares. The Company recognized $176,846 and $235,800 of stock-based compensation expense during the years ended September 30, 2018 and 2017, respectively. As of September 30, 2018, the options were fully vested and will be exercisable by Mr. Bianco’s heir until January 1, 2020.
  
(9)See Note 8 of our audited financial statements included herein for additional information on assumptions made in the valuation of option awards.

 

Employment Agreements

 

We entered into an Amended and Restated Employment Agreement with Todd Denkin, dated June 21, 2016, which was amended on December 22, 2017 (as amended, the “Denkin Employment Agreement”). Pursuant to the Denkin Employment Agreement:

 

  The term of Mr. Denkin’s employment agreement is through June 21, 2019.
Mr. Denkin’s base salary is $192,000 per annum, and he receives a car allowance of $750 per month.
Commencing with the quarter ended December 31, 2017, Mr. Denkin is awarded quarterly compensation of $6,000, payable in cash or shares of our common stock at the Company’s discretion, on the fifth calendar day preceding each fiscal quarter.
In the event of the termination of Mr. Denkin’s employment by the Company other than for Cause, or by Mr. Denkin for Good Reason (as such terms are defined in the Denkin Employment Agreement), Mr. Denkin will be entitled to aggregate severance payments equal to 8-months of his base salary.
Mr. Denkin was awarded a stock option to purchase 2,500,000 shares of the Company’s common stock at an exercise price of $0.20 per share on June 21, 2016

 

We entered into an employment agreement with Todd Peterson on June 19, 2015 under which he serves as our Chief Financial Officer. The employment agreement provides for an initial term of three-months, which renews automatically for successive three-month periods unless either party provides written notice of non-renewal at least 10-days prior to the expiration of the then term. The employment agreement also has confidentiality and non-solicit provisions. Mr. Peterson received an initial salary of $7,500 per month and a $500 monthly stipend to cover health insurance costs, which may be increased from time to time. In addition, Mr. Peterson was issued an option to purchase 100,000 shares of common stock at an exercise price of $0.33 (the closing price of our common stock on the date of grant), vesting quarterly over the one-year period following the grant date. On December 22, 2017 the employment agreement was amended to provide for additional quarterly compensation of $15,000, payable in cash or shares of common stock at the Company’s discretion, on the fifth calendar day preceding each fiscal quarter.

 

23
 

 

Prior to his passing in July 2018, Mr. Bianco was a party to an employment agreement with us that provided for a base salary of $96,000 per annum and a car allowance of $1,250 per month, the award of quarterly compensation of $22,500, payable in cash or shares of our common stock at the Company’s discretion, on the fifth calendar day preceding each fiscal quarter.

 

Outstanding Equity Awards

 

The following table sets forth information with respect to unexercised stock options, stock that has not vested, and equity incentive plan awards held by our executive officers at September 30, 2018.

 

Outstanding Option Awards at Fiscal Year-End
Name  Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Option Exercise Price  

Option Expiration

Date

                
Todd Denkin, Chief Operating Officer   2,500,000(1)   -0-(1)  $0.20   June 21, 2026
    500,000(2)   -0-(2)  $0.27   December 21, 2027
                   
Todd Peterson, Chief Financial Officer   100,000(3)   -0-(3)  $0.33   June 19, 2025

 

(1) Options granted on June 21, 2016, vest immediately as to one-half of the shares, one year from the grant date as to one-quarter of the shares, and two years following the grant date as to the remaining one-quarter.

   

(2) Options granted on December 22, 2017, fully vested.

   

(3) Options granted on June 19, 2015, vest in four equal annual installments, commencing three months from the date of grant, and continuing on the next three quarters thereof until fully vested.

 

Option Exercises and Stock Vested

 

None of our executive officers exercised any stock options or acquired stock through vesting of an equity award during the year ended September 30, 2018.

 

24
 

 

Director Compensation

 

The following table summarizes the compensation paid or accrued by us to our directors that are not executive officers for the year ended September 30, 2018.

 

Name  Fees Earned or Paid in Cash   Stock Award   Option Awards   Non-Equity Incentive Compensation   Change in Pension Value and Nonqualified Deferred Compensation Earnings   All other Compensation   Total 
                             
Dr. Alfredo Axtmayer(1)  $-   $26,276(2)  $-   $          -   $           -   $           -   $26,276 
Dr. Cindy Orser  $-   $-   $24,905(3)  $-   $-   $-   $24,905 
Bruce Raben  $-   $31,020(4)  $-   $-   $-   $-   $1,458 

 

(1) Dr. Alfredo Axtmayer resigned on August 27, 2018.

   

(2) Effective December 22, 2017, we issued Dr. Axtmayer 100,000 shares of our common stock. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company’s common stock on the date of grant.

   

(3) Effective September 12, 2018, upon being appointed to the board, we granted Dr. Orser an option to purchase 200,000 shares of common stock at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. As of September 30, 2018, options to purchase all 200,000 shares remained unvested and a total of $23,735 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019. Dr. Orser is also separately compensated for her services to us as our Chief Science Officer for which she receives an annual salary of $150,000.

   

(4) Effective September 12, 2018, upon being named to the board, we issued Bruce Raben 200,000 shares of our common stock. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company’s common stock on the date of grant. As of September 30, 2018, a total of $29,562 of unamortized expense is expected to be expensed during the fiscal year ended September 30, 2019.

 

Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our board of directors.

 

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth, as of December 25, 2018, certain information with regard to the record and beneficial ownership of the Company’s common stock by (i) each person known to the Company to be the record or beneficial owner of 5% or more of the Company’s common stock, (ii) each director of the Company, (iii) each of the named executive officers, and (iv) all executive officers and directors of the Company as a group. The address of each of our directors and executive officers named in the table is c/o Digipath, Inc., 6450 Cameron Street, Suite 113, Las Vegas, Nevada 89118:

 

       Series A 
   Common Stock   Preferred Stock 
Name of Beneficial Owner(1)  Number of Shares   % of Class(2)   Number of
Shares
   % of Class 
Officers and Directors:                    
Todd Denkin, CEO and Chairman(3)   3,172,611    6.9%   -    - 
Todd A. Peterson, CFO(4)   1,156,528    2.7%   -    - 
Dr. Cindy Orser, Director(5)   400,000    0.9%   -    - 
Bruce Raben, Director   200,000    0.5%   -    - 
Directors and Officers as a Group (4 persons)   4,929,139    10.6%   -    - 
5% Holders                    
Estate of Joseph Bianco(6)   5,576,273    11.6%   -    - 

 

25
 

 

* less than 1%

 

(1)Except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of Common Stock or Series A Preferred Stock owned by such person.
  
(2)Percentage of beneficial ownership is based upon 43,257,277 shares of Common Stock outstanding as of December 25, 2018. For each named person, this percentage includes Common Stock that the person has the right to acquire either currently or within 60 days of December 25, 2018, including through the exercise of an option; however, such Common Stock is not deemed outstanding for the purpose of computing the percentage owned by any other person.
  
(3)Includes options to purchase 2,500,000 shares of common stock exercisable at $0.20 per share, and options to purchase 500,000 shares of common stock exercisable at $0.27 per share.
  
(4)Includes options to purchase 100,000 shares of common stock exercisable at $0.33 per share.
  
(5)Includes options to purchase 200,000 shares of common stock exercisable at $0.40 per share, options to purchase 100,000 shares of common stock exercisable at $0.27 per share, and options to purchase 50,000 shares of common stock exercisable at $0.16 per share.
  
(6)Includes options to purchase 4,750,000 shares of common stock exercisable at $0.20 per share.

 

ITEM 13. Certain Relationships and Related Transactions, and Director Independence

 

Director Independence

 

Our board of directors currently consists of Todd Denkin, our President and Chief Executive Officer, Dr. Cindy Orser, our Chief Science Officer, and Bruce Raben. As executive officers, neither Mr. Denkin nor Dr. Orser qualify as “independent” under standards of independence set forth by national securities exchanges, thus we do not have a majority of our board comprised of “independent directors”. Our Board of Directors has determined that Mr. Raben is “independent” in accordance with the NASDAQ Global Market’s requirements. As our common stock is currently quoted on the OTC Bulletin Board, we are not currently subject to corporate governance standards of listed companies.

 

ITEM 14. Principal AccountING Fees And Services

 

All audit work was performed by the full-time employees of M&K CPAS, PLLC (“M&K”) for the years ended September 30, 2018 and 2017, respectively. Our board of directors does not have an audit committee. The functions customarily delegated to an audit committee are performed by our full board of directors. Our board of directors approves in advance, all services performed by M&K. Our board of directors has considered whether the provision of non-audit services is compatible with maintaining the principal accountant’s independence, and has approved such services.

 

The following table sets forth fees billed by our auditors during the last two fiscal years for services rendered for the audit of our annual consolidated financial statements and the review of our quarterly financial statements, services by our auditors that are reasonably related to the performance of the audit or review of our consolidated financial statements and that are not reported as audit fees, services rendered in connection with tax compliance, tax advice and tax planning, and all other fees for services rendered.

 

   Years Ended September 30, 
   2018   2017 
Audit fees:(1)          
M&K CPAS, PLLC  $30,000   $15,000 
Anton & Chia, LLP   -    20,000 
Audit related fees   -    - 
Tax fees   -    - 
All other fees   -    - 
Total  $30,000   $35,000 

 

(1) Audit fees were principally for audit services and work performed in the review of the Company’s quarterly reports on Form 10-Q

 

26
 

 

PART IV

 

ITEM 15. Exhibits and Financial Statement Schedules

 

Exhibit   Description
3.1   Articles of Incorporation (incorporated by reference to Exhibit 3.1 of the Form 10 filed with the Securities and Exchange Commission by Digipath, Inc. on July 15, 2011)
3.2   Bylaws (incorporated by reference to Exhibit 3.2 of the Form 10 filed with the Securities and Exchange Commission by Digipath, Inc. on July 15, 2011)
3.3   Certificate of Amendment to Articles of Incorporation dated April 4, 2014 (incorporated by reference to Exhibit 3.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on April 10, 2014)
3.4   Certificate of Designations, Preferences, Limitations, Restrictions and Relative Rights of Series A Convertible Preferred Stock dated April 9, 2014 (incorporated by reference to Exhibit 3.2 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on April 10, 2014)
3.5   Certificate of Amendment to Articles of Incorporation dated May 22, 2015 (incorporated by reference to Exhibit 3.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on May 26, 2015)
4.1   Form of 8% Senior Secured Convertible Notes due December 31, 2020 (incorporated by reference to Exhibit 4.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on November 21, 2018)
10.1   2012 Stock Incentive Plan (incorporated by reference to Exhibit 4.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on March 9, 2012)
10.2   Digipath, Inc. Amended and Restated 2012 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on June 27, 2016)
10.3   Form of Stock Option Grant Notice for grants under the Amended and Restated 2012 Stock Incentive Plan (incorporated by reference to Exhibit 10.2 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on June 27, 2016)
10.4   Form of Option Agreement for grants under the Amended and Restated 2012 Stock Incentive Plan (incorporated by reference to Exhibit 10.3 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on June 27, 2016)
10.5   Employment Agreement between Digipath, Inc. and Joseph J. Bianco, dated as of June 21, 2016 (incorporated by reference to Exhibit 10.4 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on June 27, 2016)
10.6   Amended and Restated Employment Agreement between Digipath, Inc. and Todd Denkin, dated as of June 21, 2016 (incorporated by reference to Exhibit 10.5 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on June 27, 2016)
10.7   Employment Agreement, dated as of April 9, 2014, between Digipath, Inc. and Todd Denkin (incorporated by reference to Exhibit 10.2 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on April 10, 2014)
10.8   Employment, Confidentiality and Proprietary Rights Agreement, dated as of June 19, 2015, between Digipath, Inc. and Todd A. Peterson (incorporated by reference to Exhibit 10.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on June 23, 2015)
10.9   Omnibus Agreement and Amendment, dated as of October 1, 2015, among Digipath, Inc., Digipath Corp. and Steven D. Barbee (incorporated by reference to Exhibit 10.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on October 7, 2015)
10.10   Consulting Agreement, dated as of November 23, 2015, between Digipath, Inc. and Alliance Advisory Partners, LLC whose beneficial owner is Joseph Bianco (incorporated by reference to Exhibit 10.2 of the Report on Form 10-Q filed with the Securities and Exchange Commission by Digipath, Inc. on February 19, 2016)
10.11   Amendment to Employment Agreement between Digipath, Inc. and Joseph J. Bianco, dated as of December 22, 2017 (incorporated by reference to Exhibit 10.11 of the Form 10-K filed with the Securities and Exchange Commission by Digipath, Inc. on December 29, 2017)
10.12   Amendment to Employment Agreement between Digipath, Inc. and Todd Denkin, dated as of December 22, 2017 (incorporated by reference to Exhibit 10.12 of the Form 10-K filed with the Securities and Exchange Commission by Digipath, Inc. on December 29, 2017)
10.13   Amendment to Employment Agreement between Digipath, Inc. and Todd Peterson, dated as of December 22, 2017 (incorporated by reference to Exhibit 10.13 of the Form 10-K filed with the Securities and Exchange Commission by Digipath, Inc. on December 29, 2017)
10.14   Master Joint Venture Agreement, dated as of March 20, 2017, between Digipath, Inc. and OC Testing LLC (incorporated by reference to Exhibit 10.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on February 23, 2017)
10.15   Operating Agreement of Humboldt Botanical, LLC, dated as of August 31, 2017, between Digipath, Inc. and Don Ashley (incorporated by reference to Exhibit 10.15 of the Form 10-K filed with the Securities and Exchange Commission by Digipath, Inc. on December 29, 2017)

 

27
 

 

10.16   Security Agreement, between Digipath, Inc. Digipath Labs, Inc., and collateral agent for the holders of the 8% Senior Secured Convertible Notes due December 31, 2020 (incorporated by reference to Exhibit 4.1 of the Report on Form 8-K filed with the Securities and Exchange Commission by Digipath, Inc. on November 21, 2018)
21.1   Subsidiaries (incorporated by reference to Exhibit 21.1 of the Form 10-K filed with the Securities and Exchange Commission by Digipath, Inc. on December 29, 2017)
31.1*   Section 302 Certification of Principal Executive Officer
31.2*   Section 302 Certification of Principal Financial Officer
32.1*   Section 906 Certification of Principal Executive Officer
32.2*   Section 906 Certification of Principal Financial Officer
101.INS*   XBRL Instance Document
101.SCH*   XBRL Schema Document
101.CAL*   XBRL Calculation Linkbase Document
101.DEF*   XBRL Definition Linkbase Document
101.LAB*   XBRL Labels Linkbase Document
101.PRE*   XBRL Presentation Linkbase Document

 

* Filed herewith.

 

28
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  DIGIPATH, INC.
  (Registrant)
     
  By: /s/ Todd Denkin
    Todd Denkin
    Chief Executive Officer
     
  Dated: December 27, 2018

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant, and in the capacities and on the dates indicated:

 

Signature   Title   Date
         
/s/ Todd Denkin   Chief Executive Officer and Chairman   December 27, 2018
Todd Denkin   (Principal Executive Officer)  
       

/s/ Todd A. Peterson

 

Chief Financial Officer and Secretary

  December 27, 2018
Todd A. Peterson   (Principal Financial Officer and Principal Accounting Officer)  
         

/s/ Cindy Orser

  Chief Science Officer, Director   December 27, 2018
Cindy Orser        
         

/s/ Bruce Raben

  Director   December 27, 2018
Bruce Raben      

 

29
 

 

GRAPHIC 2 image_001.jpg begin 644 image_001.jpg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end GRAPHIC 3 image_002.jpg begin 644 image_002.jpg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end EX-31.1 4 ex31-1.htm

 

Exhibit 31.1

 

DIGIPATH, INC.

 

CERTIFICATIONS PURSUANT TO

RULE 13A-14(A) OR RULE 15D-14(A),

AS ADOPTED PURSUANT TO

RULE 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Todd Denkin, certify that:

 

1. I have reviewed this Form 10-K of Digipath, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Todd Denkin
  Todd Denkin
  Chief Executive Officer

 

Dated: December 27, 2018

 

 
 

 

EX-31.2 5 ex31-2.htm

 

Exhibit 31.2

 

DIGIPATH, INC.

 

CERTIFICATIONS PURSUANT TO

RULE 13A-14(A) OR RULE 15D-14(A),

AS ADOPTED PURSUANT TO

RULE 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Todd A. Peterson, certify that:

 

1. I have reviewed this Form 10-K of Digipath, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Todd A. Peterson
  Todd A. Peterson
  Principal Financial Officer

 

Dated: December 27, 2018

 

 
 

 

EX-32.1 6 ex32-1.htm

 

EXHIBIT 32.1

 

DIGIPATH, INC.

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Digipath, Inc. (the “Company”) on Form 10-K for the year ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd Denkin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Todd Denkin

  Todd Denkin
Date: December 27, 2018 Principal Executive Officer

 

 
 

 

EX-32.2 7 ex32-2.htm

 

EXHIBIT 32.2

 

DIGIPATH, INC.

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Digipath, Inc. (the “Company”) on Form 10-K for the year ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd A. Peterson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Todd A. Peterson

  Todd A. Peterson
Date: December 27, 2018 Principal Financial Officer

 

 
 

 

EX-101.INS 8 digp-20180930.xml XBRL INSTANCE FILE 0001502966 2017-10-01 2018-09-30 0001502966 2016-09-30 0001502966 DIGP:TwoThousandTwleveStockIncentivePlanMember 2016-06-20 2016-06-21 0001502966 2017-09-30 0001502966 us-gaap:FairValueInputsLevel1Member 2017-09-30 0001502966 us-gaap:FairValueInputsLevel2Member 2017-09-30 0001502966 us-gaap:FairValueInputsLevel3Member 2017-09-30 0001502966 2018-09-30 0001502966 2016-10-01 2017-09-30 0001502966 us-gaap:InterestIncomeMember 2017-10-01 2018-09-30 0001502966 us-gaap:DebtMember 2017-10-01 2018-09-30 0001502966 DIGP:EntitiesUnderCommonControlAndOwnershipOneMember 2017-10-01 2018-09-30 0001502966 DIGP:EntitiesUnderCommonControlAndOwnershipTwoMember 2017-10-01 2018-09-30 0001502966 DIGP:EntitiesUnderCommonControlAndOwnershipThreeMember 2017-10-01 2018-09-30 0001502966 DIGP:EntitiesUnderCommonControlAndOwnershipFourMember 2017-10-01 2018-09-30 0001502966 DIGP:ToddPetersonMember 2017-12-21 2017-12-22 0001502966 DIGP:DrAlfredoAxtmayerMember 2017-12-21 2017-12-22 0001502966 us-gaap:FairValueInputsLevel1Member 2018-09-30 0001502966 us-gaap:FairValueInputsLevel2Member 2018-09-30 0001502966 us-gaap:FairValueInputsLevel3Member 2018-09-30 0001502966 us-gaap:ConvertiblePreferredStockMember 2018-09-30 0001502966 us-gaap:SeriesAPreferredStockMember 2018-09-30 0001502966 2017-12-18 2017-12-20 0001502966 us-gaap:CommonStockMember 2017-12-18 2017-12-20 0001502966 us-gaap:CommonStockMember 2017-12-20 0001502966 2017-12-13 2017-12-14 0001502966 us-gaap:CommonStockMember 2017-12-13 2017-12-14 0001502966 us-gaap:CommonStockMember 2017-12-14 0001502966 DIGP:CommonStockUnitMember 2017-12-13 2017-12-14 0001502966 DIGP:CommonStockOneMember 2017-12-13 2017-12-14 0001502966 DIGP:CommonStockOneMember 2017-12-14 0001502966 DIGP:ChiefScientistMember 2017-11-28 2017-11-29 0001502966 DIGP:ChiefScientistMember 2017-10-01 2018-09-30 0001502966 DIGP:TenEmployeesMember 2017-11-28 2017-11-29 0001502966 DIGP:TenEmployeesMember 2017-10-01 2018-09-30 0001502966 DIGP:ThreeConsultantsMember 2017-11-28 2017-11-29 0001502966 DIGP:JosephBiancoMember 2018-03-25 2018-03-26 0001502966 DIGP:ToddPetersonMember 2018-03-25 2018-03-26 0001502966 DIGP:TwoOptionHolderMember 2018-01-01 2018-01-03 0001502966 2018-01-01 2018-01-02 0001502966 2018-01-01 2018-01-03 0001502966 2018-01-03 0001502966 DIGP:TwoOptionHolderMember 2018-01-01 2018-01-02 0001502966 2018-12-25 0001502966 DIGP:JosephBiancoMember 2018-06-24 2018-06-25 0001502966 DIGP:ToddPetersonMember 2018-06-24 2018-06-25 0001502966 2018-04-08 2018-04-13 0001502966 2018-04-09 2018-04-12 0001502966 2018-04-08 2018-04-10 0001502966 us-gaap:CommonStockMember 2018-04-08 2018-04-13 0001502966 us-gaap:CommonStockMember 2018-04-09 2018-04-12 0001502966 us-gaap:CommonStockMember 2018-04-08 2018-04-10 0001502966 us-gaap:CommonStockMember 2018-04-13 0001502966 us-gaap:CommonStockMember 2018-04-12 0001502966 us-gaap:CommonStockMember 2018-04-10 0001502966 DIGP:ConsultantOneMember 2018-06-24 2018-06-25 0001502966 DIGP:ConsultantTwoMember 2018-06-24 2018-06-25 0001502966 DIGP:ToddDenkinMember 2017-12-21 2017-12-22 0001502966 DIGP:ToddDenkinMember 2017-12-22 0001502966 DIGP:ToddDenkinMember 2017-10-01 2018-09-30 0001502966 DIGP:ToddDenkinMember 2018-06-24 2018-06-25 0001502966 DIGP:ToddDenkinMember 2018-03-25 2018-03-26 0001502966 2017-12-31 0001502966 2017-12-30 0001502966 2018-03-31 0001502966 us-gaap:PreferredStockMember 2016-09-30 0001502966 us-gaap:CommonStockMember 2016-09-30 0001502966 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0001502966 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-09-30 0001502966 us-gaap:RetainedEarningsMember 2016-09-30 0001502966 us-gaap:PreferredStockMember 2016-10-01 2017-09-30 0001502966 us-gaap:PreferredStockMember 2017-09-30 0001502966 us-gaap:CommonStockMember 2016-10-01 2017-09-30 0001502966 us-gaap:CommonStockMember 2017-09-30 0001502966 us-gaap:AdditionalPaidInCapitalMember 2016-10-01 2017-09-30 0001502966 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 0001502966 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-01 2017-09-30 0001502966 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0001502966 us-gaap:RetainedEarningsMember 2016-10-01 2017-09-30 0001502966 us-gaap:RetainedEarningsMember 2017-09-30 0001502966 us-gaap:PreferredStockMember 2017-10-01 2018-09-30 0001502966 us-gaap:PreferredStockMember 2018-09-30 0001502966 us-gaap:CommonStockMember 2017-10-01 2018-09-30 0001502966 us-gaap:CommonStockMember 2018-09-30 0001502966 us-gaap:AdditionalPaidInCapitalMember 2017-10-01 2018-09-30 0001502966 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001502966 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-01 2018-09-30 0001502966 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0001502966 us-gaap:RetainedEarningsMember 2017-10-01 2018-09-30 0001502966 us-gaap:RetainedEarningsMember 2018-09-30 0001502966 us-gaap:ComputerSoftwareIntangibleAssetMember 2017-10-01 2018-09-30 0001502966 us-gaap:OfficeEquipmentMember 2017-10-01 2018-09-30 0001502966 us-gaap:FurnitureAndFixturesMember 2017-10-01 2018-09-30 0001502966 DIGP:LabEquipmentMember 2017-10-01 2018-09-30 0001502966 us-gaap:LeaseholdImprovementsMember 2017-10-01 2018-09-30 0001502966 DIGP:ToddDenkinMember 2018-09-24 2018-09-25 0001502966 DIGP:ToddPetersonMember 2018-09-24 2018-09-25 0001502966 DIGP:BruceRabenMember 2018-09-11 2018-09-12 0001502966 DIGP:BruceRabenMember 2017-10-01 2018-09-30 0001502966 DIGP:BruceRabenMember 2018-09-30 0001502966 DIGP:ChiefScienceOfficerMember 2018-09-11 2018-09-12 0001502966 DIGP:ChiefScienceOfficerMember 2018-09-12 0001502966 DIGP:ChiefScienceOfficerMember 2017-10-01 2018-09-30 0001502966 DIGP:ChiefScienceOfficerMember 2018-09-30 0001502966 2016-10-02 0001502966 us-gaap:FurnitureAndFixturesMember 2016-10-02 0001502966 DIGP:SoftwareMember 2016-10-02 0001502966 us-gaap:SeriesAPreferredStockMember 2017-10-01 2018-09-30 0001502966 us-gaap:SeriesAPreferredStockMember 2016-10-01 2017-09-30 0001502966 us-gaap:SeriesAPreferredStockMember 2017-09-30 0001502966 2018-07-10 2018-07-11 0001502966 us-gaap:CommonStockMember 2018-07-10 2018-07-11 0001502966 us-gaap:CommonStockMember 2018-07-11 0001502966 us-gaap:CommonStockMember 2017-08-24 2017-08-25 0001502966 us-gaap:CommonStockMember 2017-08-25 0001502966 2017-08-24 2017-08-25 0001502966 DIGP:CommonStockUnitMember 2017-08-24 2017-08-25 0001502966 DIGP:CommonStockOneMember 2017-08-24 2017-08-25 0001502966 DIGP:CommonStockOneMember 2017-08-25 0001502966 us-gaap:CommonStockMember 2017-08-03 2017-08-04 0001502966 us-gaap:CommonStockMember 2017-08-04 0001502966 2017-08-03 2017-08-04 0001502966 2017-07-27 2017-07-28 0001502966 us-gaap:CommonStockMember 2017-07-27 2017-07-28 0001502966 us-gaap:CommonStockMember 2017-07-28 0001502966 2017-06-20 2017-06-21 0001502966 us-gaap:CommonStockMember 2017-06-20 2017-06-21 0001502966 us-gaap:CommonStockMember 2017-06-21 0001502966 2017-02-20 2017-02-21 0001502966 us-gaap:CommonStockMember 2017-02-20 2017-02-21 0001502966 us-gaap:CommonStockMember 2017-02-21 0001502966 DIGP:PresidentAndCEOMember 2018-09-24 2018-09-25 0001502966 DIGP:CFOMember 2018-09-24 2018-09-25 0001502966 DIGP:ChiefScienceOfficerMember 2018-09-11 2018-09-12 0001502966 DIGP:ChiefScienceOfficerMember 2018-09-12 0001502966 DIGP:ChiefScienceOfficerMember 2017-10-01 2018-09-30 0001502966 DIGP:PresidentAndChiefOperatingOfficerMember 2017-12-21 2017-12-22 0001502966 DIGP:PresidentAndChiefOperatingOfficerMember 2017-12-22 0001502966 DIGP:PresidentAndChiefOperatingOfficerMember 2017-10-01 2018-09-30 0001502966 DIGP:ChiefScientistMember 2017-11-29 0001502966 DIGP:TenEmployeesMember 2017-11-29 0001502966 DIGP:CommonStockOptionOneMember 2017-10-01 2018-09-30 0001502966 DIGP:CommonStockOptionTwoMember 2017-10-01 2018-09-30 0001502966 DIGP:CommonStockOptionsMember 2017-01-01 2017-01-02 0001502966 DIGP:AmortizationOfStockOptionsMember 2017-10-01 2018-09-30 0001502966 DIGP:AmortizationOfStockOptionsMember 2016-10-01 2017-09-30 0001502966 us-gaap:WarrantMember 2017-10-01 2018-09-30 0001502966 us-gaap:WarrantMember 2016-10-01 2017-09-30 0001502966 us-gaap:SubsequentEventMember DIGP:EightPercentageSeniorSecuredConvertibleNotesMember DIGP:TwoInstitutionalInvestorsMember 2018-11-07 2018-11-08 0001502966 us-gaap:SubsequentEventMember DIGP:EightPercentageSeniorSecuredConvertibleNotesMember DIGP:TwoInstitutionalInvestorsMember 2018-11-08 0001502966 us-gaap:SubsequentEventMember DIGP:PresidentAndCEOMember 2018-12-24 2018-12-25 0001502966 us-gaap:SubsequentEventMember us-gaap:ChiefFinancialOfficerMember 2018-12-24 2018-12-25 0001502966 us-gaap:SubsequentEventMember DIGP:ThreeConsultantsMember 2018-12-24 2018-12-25 0001502966 us-gaap:SubsequentEventMember DIGP:ThreeConsultantsMember 2018-11-24 2018-11-25 0001502966 us-gaap:SubsequentEventMember DIGP:ConsultantMember 2018-10-29 2018-10-30 0001502966 us-gaap:SubsequentEventMember DIGP:ThreeConsultantsMember 2018-10-24 2018-10-25 0001502966 us-gaap:SubsequentEventMember DIGP:TenEmployeesMember 2018-12-24 2018-12-25 0001502966 us-gaap:SubsequentEventMember DIGP:TenEmployeesMember 2018-12-25 0001502966 us-gaap:SubsequentEventMember 2018-12-21 0001502966 us-gaap:SubsequentEventMember 2018-11-23 0001502966 DIGP:ThreeConsultantsMember 2018-09-24 2018-09-25 0001502966 DIGP:AnotherConsultantMember 2018-09-11 2018-09-12 0001502966 DIGP:CEOMember 2018-06-24 2018-06-25 0001502966 DIGP:COOMember 2018-06-24 2018-06-25 0001502966 DIGP:CFOMember 2018-06-24 2018-06-25 0001502966 DIGP:CEOMember 2018-03-25 2018-03-26 0001502966 DIGP:PresidentAndCOOMember 2018-03-25 2018-03-26 0001502966 DIGP:CFOMember 2018-03-25 2018-03-26 0001502966 DIGP:CFOMember 2017-12-21 2017-12-22 0001502966 DIGP:ConsultantMember 2018-03-25 2018-03-26 0001502966 DIGP:DrJohnAbroonMember 2017-05-01 2017-05-02 0001502966 DIGP:ConsultantMember 2017-05-01 2017-05-02 0001502966 DIGP:CFOMember 2017-02-27 2017-03-01 0001502966 DIGP:ChiefScientistMember 2017-02-27 2017-03-01 0001502966 DIGP:ConsultantMember 2017-02-20 2017-02-23 0001502966 DIGP:DrAlfredoAxtmayerMember 2017-02-20 2017-02-22 0001502966 DIGP:ConsultantMember 2017-02-20 2017-02-22 0001502966 DIGP:SixConsultantsMember 2017-02-06 2017-02-07 0001502966 DIGP:BruceRabenMember DIGP:SeptemberThirtyTwoThousandAndNineteenMember 2018-09-30 0001502966 DIGP:HoldersMember 2018-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure DIGP:Segment false --09-30 1897942 1425942 1425942 1897942 1425942 1425942 0.001 0.001 90000000 90000000 35027118 42245364 35027118 42245364 0001502966 FY 0.001 0.001 10000000 10000000 452537 246380 368608 560500 18000 25000 100008 25200 50400 50000 100000 50000 10500 150000 50000 50000 250000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Going Concern</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses from operations resulting in an accumulated deficit of ($13,150,328), and as of September 30, 2018, the Company&#8217;s cash on hand may not be sufficient to sustain operations. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management is actively pursuing new customers to increase revenues. In addition, the Company is currently seeking additional sources of capital to fund short term operations. Management believes these factors will contribute toward achieving profitability. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company&#8217;s ability to continue as a going concern. These financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Related Party Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock Issued to Officers for Services</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 25, 2018, we issued 39,344 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 25, 2018, we issued 98,361 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, we issued 118,421 shares of common stock to our then Chief Executive Officer, Joseph Bianco, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $22,500 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, we issued 31,579 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, we issued 78,947 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, we issued 207,852 shares of common stock to our then Chief Executive Officer, Joseph Bianco, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $45,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, we issued 55,427 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $12,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, we issued 138,568 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $30,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, we issued 300,000 shares of common stock to our Chief Financial Officer, Todd Peterson, as a bonus for services rendered. The aggregate fair value of the common stock was $78,828 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock Issued to Directors for Services</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 12, 2018, we issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company&#8217;s common stock on the date of grant, and is to be expensed over the requisite service period through September 30, 2019. A total of $1,458 was expensed during the year ended September 30, 2018, and as of September 30, 2018, a total of $29,562 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, we issued 100,000 shares of common stock to Dr. Alfredo Axtmayer for his service on our Board of Directors. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Options Issued to Officers and Directors for Services</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 12, 2018, we granted options to purchase 200,000 shares of common stock as compensation for services to our Chief Science Officer pursuant to her appointment to the Company&#8217;s Board of Directors. The options vest over a one-year period and are exercisable for a ten-year period at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. The options are being expensed over the vesting period, resulting in $1,170 of stock-based compensation expense during the year ended September 30, 2018. As of September 30, 2018, options to purchase 200,000 shares of common stock remained unvested and a total of $23,735 of unamortized expense is expected to be expensed during the fiscal year ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, we granted fully vested options to purchase 500,000 shares of common stock as compensation for services to our Chief Executive Officer, Todd Denkin. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.2094, was $104,698, which was expensed on the grant date, resulting in $104,698 of stock-based compensation expense during the year ended September 30, 2018.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Fair Value of Financial Instruments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has certain financial instruments that must be measured under the new fair value standard. The Company&#8217;s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 30.6pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 30.6pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 30.6pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets as of September 30, 2018 and 2017, respectively:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair Value Measurements at September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 1</font></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 2</font></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 3</font></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-size: 10pt"><b>Assets</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 55%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Cash</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">176,027</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">176,027</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"><font style="font-size: 10pt"><b>Liabilities</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">None</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">176,027</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair Value Measurements at September 30, 2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 1</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 2</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 3</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-size: 10pt"><b>Assets</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 55%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Cash</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">178,177</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">178,177</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"><font style="font-size: 10pt"><b>Liabilities</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">None</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">178,177</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of our intellectual properties are deemed to approximate book value, and are considered Level 3 inputs as defined by ASC Topic 820-10-35.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the years ended September 30, 2018 or 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognized other than temporary impairment losses of $50,000 on our available-for-sale securities during the year ended September 30, 2017.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Accounts Receivable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable was $167,734 and $266,613 at September 30, 2018 and 2017, respectively, net of allowance for uncollectible accounts of $14,900 and $32,180 at September 30, 2018 and 2017, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#8211; Fixed Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets consist of the following at September 30, 2018 and 2017:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td colspan="6" style="text-align: center"><font style="font-size: 10pt">For the Years Ended</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 72%"><font style="font-size: 10pt">Software</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">123,492</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">121,617</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">54,877</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">36,080</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">Furniture and fixtures</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">28,486</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">14,285</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Lab equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,110,930</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">938,450</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">489,147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">489,147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,806,932</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,599,579</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: accumulated depreciation</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(849,824</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(572,530</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">957,108</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,027,049</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 1, 2016, we disposed of fixed assets with a net book value of $3,122 pursuant to the deconsolidation of Digipath Corp. The fixed assets consisted of furniture and fixtures with a historical cost basis of $48,779 and software with a historical cost basis of $10,019, and accumulated depreciation of $48,779 and $6,897, respectively. No gain or loss was recognized on the disposals.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation and amortization expense totaled $277,294 and $253,535 for the years ended September 30, 2018 and 2017, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Stockholders&#8217; Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Convertible Preferred Stock</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share, of which 6,000,000 have been designated as Series A Convertible Preferred Stock (&#8220;Series A Preferred&#8221;), with the remaining 4,000,000 shares available for designation from time to time by the Board as set forth below. As of September 30, 2018, there were 1,425,942 shares of Series A Preferred issued and outstanding. The Board of Directors is authorized to determine any number of series into which the undesignated shares of preferred stock may be divided and to determine the rights, preferences, privileges and restrictions granted to any series of the preferred stock. Each share of Series A Preferred is currently convertible into five shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The conversion price is adjustable in the event of stock splits and other adjustments in the Company&#8217;s capitalization, and in the event of certain negative actions undertaken by the Company. At the current conversion price, the 1,425,942 shares of Series A Preferred outstanding at September 30, 2018 are convertible into 7,129,710 shares of the common stock of the Company. No holder is permitted to convert its shares of Series A Preferred if such conversion would cause the holder to beneficially own more than 4.99% of the issued and outstanding common stock of the Company immediately after such conversion, unless waived by such holder by providing at least sixty-five days&#8217; notice.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additional terms of the Series A Preferred include the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 10px; text-align: justify">&#160;</td> <td style="width: 48px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">The shares of Series A Preferred are entitled to dividends when, as and if declared by the Board as to the shares of the common stock of the Company into which such Series A Preferred may then be converted, subject to the 4.99% beneficial ownership limitation described above.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Upon the liquidation or dissolution of the Company, or any merger or sale of all or substantially all of the assets, the shares of Series A Preferred are entitled to receive, prior to any distribution to the holders of common stock, 100% of the purchase price per share of Series A Preferred plus all accrued but unpaid dividends.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">The Series A Preferred plus all declared but unpaid dividends thereon automatically will be converted into common stock, at the then applicable conversion rate, upon the affirmative vote of the holders of a majority of the outstanding shares of Series A Preferred.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Each share of Series A Preferred will carry a number of votes equal to the number of shares of common stock into which such Series A Preferred may then be converted, subject to the 4.99% beneficial ownership limitation described above. The Series A Preferred generally will vote together with the common stock and not as a separate class, except as provided below.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Consent of the holders of the outstanding Series A Preferred is required in order for the Company to: (i) amend or change the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series A Preferred; (ii) authorize, create or issue shares of any class of stock having rights, preferences, privileges or powers superior to the Series A Preferred; (iii) reclassify any outstanding shares into shares having rights, preferences, privileges or powers superior to the Series A Preferred; or (iv) amend the Company&#8217;s Articles of Incorporation or Bylaws in a manner that adversely affects the rights of the Series A Preferred.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Pursuant to the Securities Purchase Agreements, holders of Series A Preferred are entitled to unlimited &#8220;piggyback&#8221; registration rights on registrations by the Company, subject to pro rata cutback at any underwriter&#8217;s discretion.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Preferred Stock Conversions for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended September 30, 2018, a total of 472,000 shares of Series A Preferred were converted into 2,360,000 shares of common stock at a value of $0.20 per share of common stock, or a total of $472,000. The stock was converted in accordance with the conversion terms; therefore no gain or loss has been recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Preferred Stock Conversions for the Year Ended September 30, 2017</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended September 30, 2017, a total of 1,622,500 shares of Series A Preferred were converted into 8,112,500 shares of common stock at a value of $0.20 per share of common stock, or a total of $1,622,500. The stock was converted in accordance with the conversion terms; therefore no gain or loss has been recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common stock consists of $0.001 par value, 90,000,000 shares authorized, of which 42,245,364 shares were issued and outstanding as of September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Sales for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 11, 2018, the Company sold 66.67 units, consisting of 666,667 shares of its common stock and warrants to purchase 333,334 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $100,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2018, the Company sold 14 units, consisting of an aggregate of 140,000 shares of its common stock and warrants to purchase 70,000 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $25,200. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 12, 2018, the Company sold 28 units, consisting of an aggregate of 280,000 shares of its common stock and warrants to purchase 140,000 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $50,400. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company sold 27.78 units, consisting of an aggregate of 277,778 shares of its common stock and warrants to purchase 138,889 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 20, 2017, the Company sold 10 units, consisting of an aggregate of 100,000 shares of its common stock and warrants to purchase 50,000 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $18,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 14, 2017, the Company sold 13.89 units, consisting of an aggregate of 138,889 shares of its common stock and warrants to purchase 69,445 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $25,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 14, 2017, the Company sold 55.56 units, consisting of an aggregate of 555,600 shares of its common stock and warrants to purchase 277,800 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $100,008. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Sales for the Year Ended September 30, 2017</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 25, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 25, 2017, the Company sold 7 units, consisting of 70,000 shares of its common stock and warrants to purchase 35,000 shares of common stock, exercisable at $0.30 per share over a sixty month period, in exchange for total proceeds of $10,500. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 4, 2017, the Company sold 100 units, consisting of 1,000,000 shares of its common stock and warrants to purchase 500,000 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $150,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 28, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 21, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 21, 2017, the Company sold 1,428,575 units, consisting of 1,428,575 shares of its common stock and warrants to purchase 714,285 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $250,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis. The warrants were assigned to two individuals by the purchaser at the time of the sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Exercise of Options for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2018, two option holders exercised options to purchase a total of 500,000 shares of common stock at $0.181 per share on a cashless basis, resulting in the issuance of 317,172 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 2, 2018, an option holder exercised options to purchase 37,500 shares of common stock at $0.22 per share on a cashless basis, resulting in the issuance of 21,000 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Exercise of Warrants for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2018, a warrant holder exercised warrants to purchase 71,428 shares of common stock at $0.26 per share on a cashless basis, resulting in the issuance of 34,285 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Additional Common Stock Issuances for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 25, 2018, the Company issued 39,344 shares of common stock to its President and CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 25, 2018, the Company issued 98,361 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $22,875 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 12, 2018, the Company issued 193,424 shares of common stock to another consultant for business development services. The fair value of the common stock was $30,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 12, 2018, the Company issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company&#8217;s common stock on the date of grant, and is to be expensed over the requisite service period through September 30, 2019. A total of $1,458 was expensed during the year ended September 30, 2018, and as of September 30, 2018, a total of $29,562 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 118,421 shares of common stock to its then CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $22,500 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 31,579 shares of common stock to its then President and COO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 78,947 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 131,579 shares of common stock to a consultant for business development services. The fair value of the common stock was $25,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 100,000 shares of common stock to another consultant for business development services. The fair value of the common stock was $19,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, the Company issued 207,852 shares of common stock to its then CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $45,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, the Company issued 55,427 shares of common stock to its then President and COO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $12,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, the Company issued 138,568 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $30,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2018, the Company issued 69,284 shares of common stock to a consultant for business development services. The fair value of the common stock was $15,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, the Company issued 300,000 shares of common stock to its CFO as a bonus for services rendered. The aggregate fair value of the common stock was $78,828 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, the Company issued 100,000 shares of common stock to Dr. Alfredo Axtmayer for his service on our Board of Directors. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 29, 2017, a total of 314,069 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $82,600 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Additional Common Stock Issuances for the Year Ended September 30, 2017</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 2, 2017, the Company issued 100,000 shares of common stock to Dr. John Abroon in connection with his appointment to our newly created Advisory Board. The aggregate fair value of the common stock was $20,900 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 2, 2017, the Company issued 140,000 shares of common stock to a consultant in consideration of services rendered from April 1, 2017 through May 31, 2017. The aggregate fair value of the common stock was $29,260 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 1, 2017, the Company issued 25,000 shares of common stock to its CFO as a bonus for services rendered. The aggregate fair value of the common stock was $6,623 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 1, 2017, the Company issued 50,000 shares of common stock to its Chief Scientist as a bonus for services rendered. The aggregate fair value of the common stock was $13,245 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 23, 2017, the Company issued 100,000 shares of common stock to a consultant for services to be rendered over a six month period. The aggregate fair value of the common stock was $29,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2017, the Company issued 100,000 shares of common stock to Dr. Alfredo Axtmayer in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $34,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2017, the Company issued 40,000 shares of common stock to a consultant for services rendered. The aggregate fair value of the common stock was $13,600 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 7, 2017, a total of 370,000 shares of common stock were issued to six consultants that were engaged to assist the Company with acquisition activities over a six month period. The aggregate fair value of the common stock was $82,251 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2017.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Common Stock Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock Incentive Plan</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 21, 2016, we amended and restated our 2012 Stock Incentive Plan (the &#8220;2012 Plan&#8221;), which was originally adopted on March 5, 2012 and previously amended on May 20, 2014. As amended, the 2012 Plan provides for the issuance of up to 11,500,000 shares of common stock pursuant to the grant of options or other awards, including stock grants, to employees, officers or directors of, and consultants to, the Company and its subsidiaries. Options granted under the 2012 Plan may either be intended to qualify as incentive stock options under the Internal Revenue Code of 1986, or may be non-qualified options, and are exercisable over periods not exceeding ten years from date of grant. Options to purchase a total of 8,537,500 shares of common stock were outstanding as of September 30, 2018</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Option Issuances for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 12, 2018, we granted options to purchase 200,000 shares of common stock as compensation for services to our Chief Science Officer pursuant to her appointment to the Company&#8217;s Board of Directors. The options vest over a one-year period, are exercisable over a ten-year period at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. The options are being expensed over the vesting period, resulting in $1,170 of stock-based compensation expense during the year ended September 30, 2018. As of September 30, 2018, options to purchase 200,000 shares of common stock remained unvested and a total of $23,735 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, we granted fully vested options to purchase 500,000 shares of common stock as compensation for services to our then President and COO. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.2094, was $104,698. The options were expensed over the vesting period, resulting in $104,698 of stock-based compensation expense during the year ended September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 29, 2017, we granted fully vested options to purchase 100,000 shares of common stock as compensation for services to our Chief Scientist. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.21, was $21,004. The options were expensed over the vesting period, resulting in $21,004 of stock-based compensation expense during the year ended September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 29, 2017, we granted fully vested options to purchase an aggregate of 205,000 shares of common stock as compensation for services to a total of ten of our employees. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.21, was $43,057. The options were expensed over the vesting period, resulting in $43,057 of stock-based compensation expense during the year ended September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Options Exercised for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2018, two option holders exercised options to purchase a total of 500,000 shares of common stock at $0.181 per share on a cashless basis, resulting in the issuance of 317,172 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 2, 2018, an option holder exercised options to purchase 37,500 shares of common stock at $0.22 per share on a cashless basis, resulting in the issuance of 21,000 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Options Cancelled or Expired for the Year Ended September 30, 2018</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, options to purchase an aggregate of 110,000 shares of common stock, exercisable over a ten-year period, at a weighted average exercise price of $0.25 per share expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, options to purchase an aggregate of 1,110,000 shares of common stock, exercisable over a three-year period, at a weighted average exercise price of $0.44 per share expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Options Cancelled or Expired for the Year Ended September 30, 2017</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2017, a total of 1,530 common stock options exercisable over a three-year period from the original grant date of January 1, 2014 with an exercise price of $3.30 per share expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of information about the stock options outstanding at September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Shares Underlying Options Outstanding</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Shares Underlying </font><br /> <font style="font-size: 10pt">Options Exercisable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 20%; text-align: center"><font style="font-size: 10pt">Range of</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Remaining</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Options</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Contractual</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Options</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Prices</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Exercisable</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">$0.16 &#8211; $0.40</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,537,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4.27 years</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.20</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,337,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.21</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%"><font style="font-size: 10pt">Average risk-free interest rates</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.36</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Average expected life (in years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.25</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">N/A</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">Volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">N/A</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Black-Scholes option pricing model was developed for use in estimating the fair value of short-term traded options that have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including expected stock price volatility. Because the Company&#8217;s common stock options have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&#8217;s opinion the existing models do not necessarily provide a reliable single measure of the fair value of its common stock options. During the years ended September 30, 2018 and September 30, 2017, there were no options granted with an exercise price below the fair value of the underlying stock at the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average fair value of options granted with exercise prices at the current fair value of the underlying stock during the year ended September 30, 2018 was approximately $0.25 per option.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of activity of outstanding common stock options:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Number</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">of Shares</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2016</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,291,530</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0.23</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,530</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3.30</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">9,290,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.23</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,005,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(537,500</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(0.18</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,220,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.42</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,537,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.20</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Exercisable, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,337,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.21</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Amortization of Stock Options</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A total of $439,853 and $389,736 of stock-based compensation expense was recognized from the amortization of options over their vesting period during the years ended September 30, 2018 and 2017, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2018, these options in the aggregate had no intrinsic value as the per share market price of $0.15 of the Company&#8217;s common stock as of such date was less than the weighted-average exercise price of these options of $0.20.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Common Stock Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We issued warrants in connection with private placements of our securities as set forth in Note 8 above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2018 a warrant holder exercised warrants to purchase 71,428 shares of common stock at $0.26 per share on a cashless basis, resulting in the issuance of 34,285 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2017, warrants to purchase 200,000 shares of common stock at $0.30 per share expired, and on December 30, 2017, warrants to purchase another 300,000 shares of common stock at $0.45 per share also expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of information about our warrants to purchase common stock outstanding at September 30, 2018 (including those issued to both investors and service providers).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="text-align: center"><font style="font-size: 10pt">Shares Underlying</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Shares Underlying Warrants Outstanding</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Warrants Exercisable</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 20%; text-align: center"><font style="font-size: 10pt">Range of</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Remaining</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Warrants</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Contractual</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Warrants</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Prices</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Exercisable</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">$0.1901 &#8211; $0.40</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1.65 years</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Average risk-free interest rates</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.56</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.11</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Average expected life (in years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.00</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.50</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">110</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">145</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average fair value of warrants granted with exercise prices at the current fair value of the underlying stock during the years ended September 30, 2018 and 2017 was approximately $0.29 and $0.26 per warrant, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of activity of outstanding common stock warrants:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Number</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">of Shares</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2016</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,193,136</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0.29</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants granted</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,749,286</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.26</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,942,422</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.28</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,079,468</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.29</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(71,428</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(0.26</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(500,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.36</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Exercisable, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 12 - Income Tax</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the years ended September 30, 2018 and 2017, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At September 30, 2018, the Company had approximately $7,982,500 of federal net operating losses. The net operating loss carry forwards, if not utilized, will begin to expire in 2031.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effective income tax rate for the years ended September 30, 2018 and 2017 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%"><font style="font-size: 10pt">Federal statutory income tax rate</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">21</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">35</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">State income taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(21</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(35</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net effective income tax rate</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of the Company&#8217;s deferred tax asset are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">Deferred tax assets:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Net operating loss carry forwards</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,676,325</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,531,725</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Net deferred tax assets before valuation allowance</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,676,325</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,531,725</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Less: Valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,676,325</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,531,725</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 20pt"><font style="font-size: 10pt">Net deferred tax assets</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the available objective evidence, including the Company&#8217;s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at September 30, 2018 and 2017, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 13 &#8211; Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Debt Financing</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 8, 2018, the Company sold 8% Senior Secured Convertible Notes in the aggregate principal amount of $500,000 to two institutional investors. The Notes mature on December 31, 2020, bear interest at a rate of 8% per annum, and are convertible into shares of the Company&#8217;s common stock at a fixed conversion price of $0.14 per share. The Company&#8217;s obligation under the Notes are secured by a lien on the assets of the Company and its wholly-owned subsidiary Digipath Labs, Inc., pursuant to a Security Agreement between the Company, Digipath Labs, Inc. and the collateral agent for the investors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Issued for Services</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 25, 2018, the Company issued 46,261 shares of common stock to its President and CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 25, 2018, the Company issued 115,652 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $19,455 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $19,260 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 30, 2018, the Company issued 400,000 shares of common stock to another consultant for business development services to be performed from November 1, 2018 through April 30, 2019. The fair value of the common stock was $54,120 based on the closing price of the Company&#8217;s common stock on the date of grant, and is being expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $23,250 based on the closing price of the Company&#8217;s common stock on the date of grant, and was expensed over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Option Issuances</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 25, 2018, we granted options to purchase an aggregate of 235,000 shares of common stock as compensation for services to a total of ten of our employees, vesting twelve months from the grant date. The options are exercisable over a ten-year period at an exercise price of $0.13 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1017, was $35,078. The options are to be expensed over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Warrants Expired</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 21, 2018, warrants to purchase 166,667 shares of common stock at $0.30 per share expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 23, 2018, warrants to purchase another 100,000 shares of common stock at $0.40 per share also expired.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets as of September 30, 2018 and 2017, respectively:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair Value Measurements at September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 1</font></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 2</font></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 3</font></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-size: 10pt"><b>Assets</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 55%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Cash</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">176,027</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">176,027</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"><font style="font-size: 10pt"><b>Liabilities</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">None</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">176,027</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Fair Value Measurements at September 30, 2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 1</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 2</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Level 3</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-size: 10pt"><b>Assets</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 55%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Cash</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">178,177</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">178,177</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"><font style="font-size: 10pt"><b>Liabilities</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">None</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">178,177</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets consist of the following at September 30, 2018 and 2017:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td colspan="6" style="text-align: center"><font style="font-size: 10pt">For the Years Ended</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 72%"><font style="font-size: 10pt">Software</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">123,492</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">121,617</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">54,877</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">36,080</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">Furniture and fixtures</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">28,486</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">14,285</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Lab equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,110,930</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">938,450</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">489,147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">489,147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,806,932</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,599,579</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: accumulated depreciation</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(849,824</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(572,530</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">957,108</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,027,049</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> -1653657 -1065140 -1065140 -1653657 163998 384627 163998 384627 42004 58238 121994 325864 1571236 1399206 1027049 957108 544187 442098 25647 25647 73750 72690 266613 167734 1898 1426 35027 42245 12866984 14121236 -11496671 -13150328 1571236 1399206 105112 232068 -1758769 -1297208 2528848 2291214 1094486 1001289 1451642 1257745 770079 994006 39079547 29321193 -0.04 -0.04 472000 1622500 135390 178177 176027 -2150 42787 368608 560500 -207353 -140836 207353 140836 -163405 -376877 16234 -12243 203870 -35672 -1060 49504 -116159 200352 439853 389736 277294 253535 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Accounting</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. All references to Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) are in accordance with The FASB Accounting Standards Codification (&#8220;ASC&#8221;) and the Hierarchy of Generally Accepted Accounting Principles.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 68%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center"><font style="font-size: 10pt">State of</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Name of Entity<sup>(1)</sup></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Incorporation</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Relationship</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Digipath, Inc.<sup>(2)</sup></font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Parent</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Digipath Labs, Inc.</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">TNM News, Inc.</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">GroSciences, Inc.<sup>(3)</sup></font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Colorado</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>&#160;</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(1) </sup>All entities are in the form of a corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(2) </sup>Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(3) </sup>Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company and subsidiaries will be collectively referred to herein as the &#8220;Company&#8221;, &#8220;Digipath&#8221; or &#8220;DIGP&#8221;. The Company&#8217;s headquarters are located in Las Vegas, Nevada and substantially all of its customers are within the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Reclassifications</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior period interest income in the amount of $10,000 has been reclassified to net against the related $10,000 of bad debt expense to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Segment Reporting</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 280, &#8220;Segment Reporting,&#8221; requires use of the &#8220;management approach&#8221; model for segment reporting. The management approach model is based on the way a company&#8217;s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">-</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font></td> <td style="width: 96px">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">-</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">-</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short term nature of the instruments.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective October 1, 2018, the Company adopted ASC 606 &#8212; Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 &#8212; Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There was no impact on the Company&#8217;s financial statements from ASC 606 for the years ended September 30, 2018 or 2017 since it was not adopted until October 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue is primarily generated through our subsidiary, Digipath Labs, Inc., which recognizes revenue from the analytical testing of cannabis products for licensed producers and cultivators within the state of Nevada on a determinable fixed fee per test, or panel of tests basis. Revenue from the performance of those services is recognized upon completion of the tests, at which time test results are delivered to the customer, provided collectability of the fee is reasonably assured. We typically require payment within thirty days of the delivery of results. Management estimates an allowance for doubtful accounts based on the aging of its receivables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also recognizes revenue through our subsidiary, TNM News Corp., which primarily recognizes revenue from advertisements through partnered merchants. Payment for ad revenues are received prior to the distribution of the ad campaign, and the revenues are recognized ratably over the campaign. The Company defers any revenue for which the term of the campaign has not yet been realized. To date, these revenues have not been materially significant. Deferred revenues on advertisement campaigns was $525 at September 30, 2018.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 505-50 (ASC 505-50). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty&#8217;s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-07, <i>Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</i>, which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2018, the FASB issued ASU No. 2018-05, <i>Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118</i>. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The calculation of accumulated foreign earnings requires an analysis of each foreign entity&#8217;s financial results going back to 1986. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2018, the FASB issued ASU No. 2018-02, <i>Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i>. The guidance permits entities to reclassify tax effects stranded in Accumulated Other Comprehensive Income as a result of tax reform to retained earnings. This new guidance is effective for annual and interim periods in fiscal years beginning after December 15, 2018. Early adoption is permitted in annual and interim periods and can be applied retrospectively or in the period of adoption. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2017, the FASB issued ASU 2017-09, <i>Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting</i>, which clarifies when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU No. 2014-09, <i>Revenue from Contracts with Customers</i>. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted the new standard to be effective with our first interim reporting period for the three months ended December 31, 2017. We use the modified retrospective method of adoption. We have completed an initial evaluation of the potential impact from adopting the new standard, including a detailed review of performance obligations for all material revenue streams. Based on this initial evaluation, adoption does not have a material impact on our financial position, results of operations, or cash flows. Related disclosures have been expanded in line with the requirements of the standard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 68%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center"><font style="font-size: 10pt">State of</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Name of Entity<sup>(1)</sup></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Incorporation</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Relationship</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Digipath, Inc.<sup>(2)</sup></font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Parent</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Digipath Labs, Inc.</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">TNM News, Inc.</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">GroSciences, Inc.<sup>(3)</sup></font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Colorado</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>&#160;</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(1) </sup>All entities are in the form of a corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(2) </sup>Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(3) </sup>Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 11 &#8211; Other Income</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other income for the years ended September 30, 2018 and 2017 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%"><font style="font-size: 10pt">Settlement income on license agreement</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Rental income on subleases</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">76,800</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,568</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Restitution income</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">28,312</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">11,500</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">105,112</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">282,068</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other income for the years ended September 30, 2018 and 2017 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%"><font style="font-size: 10pt">Settlement income on license agreement</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Rental income on subleases</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">76,800</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,568</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Restitution income</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">28,312</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">11,500</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">105,112</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">282,068</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 &#8211; Nature of Business and Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Nature of Business</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (&#8220;Digipath,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;) supports the cannabis industry&#8217;s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units are described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt; background-color: white"><u>Digipath Labs, Inc</u>. Digipath Labs&#8217; mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients&#8217; products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt; background-color: white"><u>The National Marijuana News Corp</u>. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving&#8212;and profoundly controversial&#8212;medicinal and recreational marijuana industry.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Accounting</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. All references to Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) are in accordance with The FASB Accounting Standards Codification (&#8220;ASC&#8221;) and the Hierarchy of Generally Accepted Accounting Principles.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 68%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center"><font style="font-size: 10pt">State of</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Name of Entity<sup>(1)</sup></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Incorporation</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Relationship</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Digipath, Inc.<sup>(2)</sup></font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Parent</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Digipath Labs, Inc.</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">TNM News, Inc.</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Nevada</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">GroSciences, Inc.<sup>(3)</sup></font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Colorado</font></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Subsidiary</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>&#160;</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(1) </sup>All entities are in the form of a corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(2) </sup>Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(3) </sup>Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company and subsidiaries will be collectively referred to herein as the &#8220;Company&#8221;, &#8220;Digipath&#8221; or &#8220;DIGP&#8221;. The Company&#8217;s headquarters are located in Las Vegas, Nevada and substantially all of its customers are within the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Reclassifications</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior period interest income in the amount of $10,000 has been reclassified to net against the related $10,000 of bad debt expense to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Segment Reporting</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 280, &#8220;Segment Reporting,&#8221; requires use of the &#8220;management approach&#8221; model for segment reporting. The management approach model is based on the way a company&#8217;s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">-</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font></td> <td style="width: 96px">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">-</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">-</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short term nature of the instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are carried at their estimated collectible amounts. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. The Company had an allowance for doubtful accounts of $14,900 and $32,180 as of September 30, 2018 and 2017, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fixed Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="width: 70%; text-align: justify"><font style="font-size: 10pt">Software</font></td> <td style="width: 30%; text-align: right"><font style="font-size: 10pt">3 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Office equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Lab equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">7 years</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 10pt">Term of lease</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our intellectual property is comprised of indefinite-lived brand names acquired and have been assigned an indefinite life as we currently anticipate that these brand names will contribute cash flows to the Company perpetually. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective October 1, 2018, the Company adopted ASC 606 &#8212; Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 &#8212; Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There was no impact on the Company&#8217;s financial statements from ASC 606 for the years ended September 30, 2018 or 2017 since it was not adopted until October 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue is primarily generated through our subsidiary, Digipath Labs, Inc., which recognizes revenue from the analytical testing of cannabis products for licensed producers and cultivators within the state of Nevada on a determinable fixed fee per test, or panel of tests basis. Revenue from the performance of those services is recognized upon completion of the tests, at which time test results are delivered to the customer, provided collectability of the fee is reasonably assured. We typically require payment within thirty days of the delivery of results. Management estimates an allowance for doubtful accounts based on the aging of its receivables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also recognizes revenue through our subsidiary, TNM News Corp., which primarily recognizes revenue from advertisements through partnered merchants. Payment for ad revenues are received prior to the distribution of the ad campaign, and the revenues are recognized ratably over the campaign. The Company defers any revenue for which the term of the campaign has not yet been realized. To date, these revenues have not been materially significant. Deferred revenues on advertisement campaigns was $525 at September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $108,295 and $138,026 for the years ended September 30, 2018 and 2017, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basic and Diluted Loss Per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an &#8220;as if converted&#8221; basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended September 30, 2018 and 2017, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 505-50 (ASC 505-50). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty&#8217;s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Uncertain Tax Positions</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Various taxing authorities periodically audit the Company&#8217;s income tax returns. These audits include questions regarding the Company&#8217;s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The assessment of the Company&#8217;s tax position relies on the judgment of management to estimate the exposures associated with the Company&#8217;s various filing positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Various taxing authorities periodically audit the Company&#8217;s income tax returns. These audits include questions regarding the Company&#8217;s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-07, <i>Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</i>, which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2018, the FASB issued ASU No. 2018-05, <i>Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118</i>. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The calculation of accumulated foreign earnings requires an analysis of each foreign entity&#8217;s financial results going back to 1986. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2018, the FASB issued ASU No. 2018-02, <i>Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i>. The guidance permits entities to reclassify tax effects stranded in Accumulated Other Comprehensive Income as a result of tax reform to retained earnings. This new guidance is effective for annual and interim periods in fiscal years beginning after December 15, 2018. Early adoption is permitted in annual and interim periods and can be applied retrospectively or in the period of adoption. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2017, the FASB issued ASU 2017-09, <i>Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting</i>, which clarifies when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU No. 2014-09, <i>Revenue from Contracts with Customers</i>. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted the new standard to be effective with our first interim reporting period for the three months ended December 31, 2017. We use the modified retrospective method of adoption. We have completed an initial evaluation of the potential impact from adopting the new standard, including a detailed review of performance obligations for all material revenue streams. Based on this initial evaluation, adoption does not have a material impact on our financial position, results of operations, or cash flows. Related disclosures have been expanded in line with the requirements of the standard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.</p> 10000 10000 1 Digipath, Inc. Digipath Labs, Inc. TNM News, Inc. GroSciences, Inc. Nevada Nevada Nevada Colorado Parent Subsidiary Subsidiary Subsidiary 300000 100000 314069 207852 138568 118421 78947 131579 100000 31579 55427 925000 2326855 39344 98361 200000 39344 98361 46261 115652 150000 150000 400000 150000 150000 193424 118421 31579 78947 207852 55427 138568 300000 69284 100000 140000 25000 50000 100000 100000 40000 370000 0.27 0.16 1.12 0.00 1.12 1.12 1.12 1.07 1.07 1.12 1.10 1.45 1.07 178177 176027 178177 176027 178177 176027 32180 14900 277294 253535 121617 123492 36080 54877 14285 28486 938450 1110930 489147 489147 1599579 1806932 572530 849824 6000000 4000000 472000 1622500 2360000 8112500 10 100000 13.89 138889 55.56 555600 14 28 27.78 140000 280000 277778 66.67 666667 333334 33.333 7 70000 1000000 100 33.333 333334 33.333 333334 1428575 1428575 50000 69445 277800 71428 70000 140000 138889 200000 300000 333334 166667 35000 500000 166667 166667 714285 166667 100000 452537 246380 78828 26276 82600 45000 30000 22500 15000 25000 19000 6000 12000 925 245455 2327 450210 6000 15000 31020 6000 15000 6000 15000 19455 19260 54120 23250 22875 30000 22500 6000 15000 45000 12000 30000 78828 15000 20900 29260 6623 13245 29000 34000 13600 82251 0.18 0.181 0.22 0.22 0.26 0.29 0.26 0.26 0.26 0.26 0.30 0.30 0.30 0.30 0.45 0.30 0.26 0.30 0.26 0.26 0.26 0.26 0.30 0.40 317172 21000 34285 21000 1234962 1407238 1014579 3520 22491 11681282 -40800 -10431531 1898 35027 12866984 -11496671 1426 42245 14121236 -13150328 43257277 537500 500000 37500 37500 21004 43057 104698 104698 1458 1170 1170 104698 525 14203 2018 -17280 32180 2018-09-30 10-K 2069837 904166 -17280 32180 The options are exercisable over a ten year period The options vest over a one-year period and are exercisable for a ten-year period 0.2094 0.1245 0.1245 0.2094 0.21 0.21 0.1017 No No Yes 8120756 false true false false 2839916 1898172 105112 282068 50000 3520442 22491041 1897942 35027118 1425942 42245364 368608 560500 3499 557001 2159 366449 3498577 2158934 439853 389736 389736 439853 -1622 8112 -6490 -472 2360 -1888 -1622500 8112500 -472000 2360000 40800 40800 372457 372 -372 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#8211; Commitments and Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Lease Commitment</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company leases space for its lab operations in Las Vegas, Nevada. Amounts of minimum future annual commitments on a calendar year basis, including common area maintenance fees, under non-cancelable operating leases are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 60%"><font style="font-size: 10pt">2018</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 28%; text-align: right"><font style="font-size: 10pt">48,872</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">2019</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">198,904</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">151,283</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2021</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,102</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">449,161</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense was $191,751 and $210,907 for the years ended September 30, 2018 and 2017, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Nature of Business</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (&#8220;Digipath,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;) supports the cannabis industry&#8217;s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units are described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt; background-color: white"><u>Digipath Labs, Inc</u>. Digipath Labs&#8217; mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients&#8217; products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt; background-color: white"><u>The National Marijuana News Corp</u>. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving&#8212;and profoundly controversial&#8212;medicinal and recreational marijuana industry.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are carried at their estimated collectible amounts. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. The Company had an allowance for doubtful accounts of $14,900 and $32,180 as of September 30, 2018 and 2017, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fixed Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="width: 70%; text-align: justify"><font style="font-size: 10pt">Software</font></td> <td style="width: 30%; text-align: right"><font style="font-size: 10pt">3 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Office equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Lab equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">7 years</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 10pt">Term of lease</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our intellectual property is comprised of indefinite-lived brand names acquired and have been assigned an indefinite life as we currently anticipate that these brand names will contribute cash flows to the Company perpetually. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Uncertain Tax Positions</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Various taxing authorities periodically audit the Company&#8217;s income tax returns. These audits include questions regarding the Company&#8217;s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The assessment of the Company&#8217;s tax position relies on the judgment of management to estimate the exposures associated with the Company&#8217;s various filing positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Various taxing authorities periodically audit the Company&#8217;s income tax returns. These audits include questions regarding the Company&#8217;s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basic and Diluted Loss Per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an &#8220;as if converted&#8221; basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended September 30, 2018 and 2017, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $108,295 and $138,026 for the years ended September 30, 2018 and 2017, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="width: 70%; text-align: justify"><font style="font-size: 10pt">Software</font></td> <td style="width: 30%; text-align: right"><font style="font-size: 10pt">3 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Office equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Lab equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">7 years</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 10pt">Term of lease</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of information about the stock options outstanding at September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Shares Underlying Options Outstanding</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Shares Underlying </font><br /> <font style="font-size: 10pt">Options Exercisable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 20%; text-align: center"><font style="font-size: 10pt">Range of</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Remaining</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Options</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Contractual</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Options</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Prices</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Exercisable</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">$0.16 &#8211; $0.40</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,537,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4.27 years</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.20</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,337,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.21</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%"><font style="font-size: 10pt">Average risk-free interest rates</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.36</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Average expected life (in years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.25</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">N/A</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">Volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">N/A</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of activity of outstanding common stock options:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Number</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">of Shares</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2016</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,291,530</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0.23</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,530</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3.30</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">9,290,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.23</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,005,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(537,500</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(0.18</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Options expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,220,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.42</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,537,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.20</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Exercisable, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,337,500</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.21</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of information about our warrants to purchase common stock outstanding at September 30, 2018 (including those issued to both investors and service providers).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="text-align: center"><font style="font-size: 10pt">Shares Underlying</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Shares Underlying Warrants Outstanding</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Warrants Exercisable</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Shares</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 20%; text-align: center"><font style="font-size: 10pt">Range of</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Remaining</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Underlying</font></td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 13%; text-align: center"><font style="font-size: 10pt">Average</font></td> <td style="width: 1%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Warrants</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Contractual</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Warrants</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Prices</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Exercisable</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">$0.1901 &#8211; $0.40</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1.65 years</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Average risk-free interest rates</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.56</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.11</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Average expected life (in years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.00</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.50</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify"><font style="font-size: 10pt">Volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">110</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">145</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of activity of outstanding common stock warrants:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Average</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Number</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Exercise</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">of Shares</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Price</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2016</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,193,136</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0.29</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants granted</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,749,286</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.26</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,942,422</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.28</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,079,468</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.29</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(71,428</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(0.26</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Warrants expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(500,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.36</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Exercisable, September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,450,462</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.28</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 60%"><font style="font-size: 10pt">2018</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 28%; text-align: right"><font style="font-size: 10pt">48,872</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">2019</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">198,904</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">151,283</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2021</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,102</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">449,161</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effective income tax rate for the years ended September 30, 2018 and 2017 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 62%"><font style="font-size: 10pt">Federal statutory income tax rate</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">21</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">35</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">State income taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(21</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(35</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">%)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net effective income tax rate</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of the Company&#8217;s deferred tax asset are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">September 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td><font style="font-size: 10pt">Deferred tax assets:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Net operating loss carry forwards</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,676,325</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,531,725</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Net deferred tax assets before valuation allowance</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,676,325</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,531,725</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Less: Valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,676,325</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,531,725</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 20pt"><font style="font-size: 10pt">Net deferred tax assets</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> 32180 14900 525 108295 138026 P3Y P5Y P5Y P7Y Term of lease 500000 200000 200000 31020 29562 23735 29562 Digipath, Inc. 50000 24905 3122 48779 10019 48779 6897 7129710 0.0499 1.00 0.20 0.20 0.14 472000 1622500 11500000 9291530 9290000 8537500 200000 200000 235000 P1Y P12M P10Y P10Y P10Y P10Y P10Y P10Y P3Y P3Y P10Y 0.25 0.27 0.27 0.16 0.27 0.13 21004 43057 24905 104698 35078 100000 205000 500000 110000 1110000 1530 0.25 0.44 3.30 0.15 0.20 0.16 0.40 8537500 P4Y3M8D 0.20 8337500 0.21 0.0136 0.00 0.0156 0.0111 P5Y2M30D P0Y P3Y P3Y6M 1220000 1530 1005000 8337500 0.23 0.23 0.20 0.42 3.30 0.21 0.1901 0.40 6450462 P1Y7M24D 0.28 6450462 0.28 4193136 5942422 6450462 1079468 1749286 71428 500000 6450462 0.29 0.28 0.28 0.29 0.26 -0.26 -0.36 0.28 191751 210907 48872 198904 151283 50102 449161 250000 76800 20568 28312 11500 105112 282068 7982500 2031 0.21 0.35 0.00 0.00 -0.21 -0.35 0.00 0.00 2531725 1676325 2531725 1676325 2531725 1676325 500000 2020-12-31 0.08 Non-accelerated Filer DIGP 439853 389736 23735 200000 -525 All entities are in the form of a corporation. Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company. Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period. EX-101.SCH 9 digp-20180930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Business and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Common Stock Options link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Common Stock Warrants link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Other Income link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Income Tax link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Nature of Business and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Nature of Business and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Common Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Common Stock Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Other Income (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Income Tax (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Nature of Business and Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Nature of Business and Significant Accounting Policies - Schedule of Entities Under Common Control and Ownership (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Nature of Business and Significant Accounting Policies - Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Fair Value of Financial Instruments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Fair Value of Financial Instruments - Summary of Financial Instruments at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Accounts Receivable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Fixed Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Fixed Assets - Schedule of Fixed Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Common Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Common Stock Options - Summary of Common Stock Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Common Stock Options - Schedule of Option Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Common Stock Options - Summary of Common Stock Options Activity Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Common Stock Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Common Stock Warrants - Summary of Common Stock Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Common Stock Warrants - Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Common Stock Warrants - Summary of Common Stock Warrants Activity Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payment Under Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Other Income - Schedule of Other Income (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Income Tax (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Income Tax - Schedule of Effective Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Income Tax - Schedule of Deferred Tax Asset (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 digp-20180930_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 digp-20180930_def.xml XBRL DEFINITION FILE EX-101.LAB 12 digp-20180930_lab.xml XBRL LABEL FILE Plan Name [Axis] 2012 Stock Incentive Plan [Member] Fair Value, Hierarchy [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Income Statement Location [Axis] Interest Income [Member] Financial Instrument [Axis] Bad Debt [Member] Legal Entity [Axis] Entities Under Common Control and Ownership [Member] Entities Under Common Control and Ownership [Member] Entities Under Common Control and Ownership [Member] Entities Under Common Control and Ownership [Member] Related Party [Axis] Todd Peterson [Member] Dr. Alfredo Axtmayer [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Series A Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Common Stock Unit [Member] Common Stock One [Member] Title of Individual [Axis] Chief Scientist [Member] Ten Employees [Member] Three Consultants [Member] Joseph Bianco [Member] Two Option Holder [Member] Consultant One [Member] Consultant Two [Member] Todd Denkin [Member] Series A Convertible Preferred Stock [Member] Additional Paid-in Capital [Member] Accumulated Other Comprehensive Loss [Member] Accumulated (Deficit) [Member] Property, Plant and Equipment, Type [Axis] Software [Member] Office Equipment [Member] Furniture and Fixtures [Member] Lab Equipment [Member] Leasehold Improvements [Member] Bruce Raben [Member] Chief Science Officer [Member] Software [Member] President and CEO [Member] CFO [Member] President and Chief Operating Officer [Member] Option Indexed to Issuer's Equity, Type [Axis] Common Stock Option One [Member] Common Stock Option Two [Member] Common Stock Options [Member] Amortization of Stock Options [Member] Warrants [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Debt Instrument [Axis] 8% Senior Secured Convertible Notes [Member] Two Institutional Investors Member Chief Financial Officer [Member] Consultant [Member] Another Consultants [Member] CEO [Member] COO [Member] President and COO [Member] Dr. John Abroon [Member] Six Consultants [Member] Report Date [Axis] September 30, 2019 [Member] Holders [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filer Entity Current Reporting Status Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash Accounts receivable Prepaid expenses Deposits Total current assets Fixed assets, net Total Assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued expenses Deferred revenues Total current liabilities Total Liabilities Stockholders' Equity: Series A convertible preferred stock, $0.001 par value, 10,000,000 shares authorized; 1,425,942 and 1,897,942 shares issued and outstanding at September 30, 2018 and 2017, respectively Common stock, $0.001 par value, 90,000,000 shares authorized; 42,245,364 and 35,027,118 shares issued and outstanding at September 30, 2018 and 2017, respectively Additional paid-in capital Accumulated (deficit) Total Stockholders' Equity Total Liabilities and Stockholders' Equity Series A convertible preferred stock, par value Series A convertible preferred stock, shares authorized Series A convertible preferred stock, shares issued Series A convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost of sales Gross profit Operating expenses: General and administrative Professional fees Bad debts expense (recoveries) Total operating expenses Operating loss Other income: Other income Loss on impairment of securities available-for-sale Total other income Net loss Weighted average number of common shares outstanding - basic and fully diluted Net loss per share - basic and fully diluted Statement [Table] Statement [Line Items] Balance Balance, shares Units of common stock and warrants sold for cash Units of common stock and warrants sold for cash, shares Common stock issued for services Common stock issued for services, shares Common stock options issued for services Conversion of preferred stock to common stock Conversion of preferred stock to common stock, shares Realized loss on available-for-sale securities Cashless exercise of options and warrants Cashless exercise of options and warrants, shares Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operating activities: Change in allowance for doubtful accounts Depreciation and amortization expense Stock issued for services Options and warrants granted for services Realized loss on available-for-sale securities Decrease (increase) in assets: Accounts receivable Prepaid expenses Deposits Increase (decrease) in liabilities: Accounts payable Accrued expenses Deferred revenues Net cash used in operating activities Cash flows from investing activities Purchase of fixed assets Net cash used in investing activities Cash flows from financing activities Proceeds from sale of common stock Net cash provided by financing activities Net increase (decrease) in cash Cash - beginning Cash - ending Supplemental disclosures: Interest paid Income taxes paid Non-cash investing and financing activities: Value of preferred stock converted to common stock Accounting Policies [Abstract] Nature of Business and Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements [Abstract] Going Concern Related Party Transactions [Abstract] Related Party Transactions Fair Value Disclosures [Abstract] Fair Value of Financial Instruments Receivables [Abstract] Accounts Receivable Property, Plant and Equipment [Abstract] Fixed Assets Equity [Abstract] Stockholders' Equity Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Common Stock Options Common Stock Warrants Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Other Income and Expenses [Abstract] Other Income Income Tax Disclosure [Abstract] Income Tax Subsequent Events [Abstract] Subsequent Events Nature of Business Basis of Accounting Principles of Consolidation Reclassifications Use of Estimates Segment Reporting Fair Value of Financial Instruments Accounts Receivable Fixed Assets Impairment of Long-Lived Assets Revenue Recognition Advertising Costs Basic and Diluted Loss Per Share Stock-Based Compensation Income Taxes Uncertain Tax Positions Recent Accounting Pronouncements Schedule of Entities Under Common Control and Ownership Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment Summary of Financial Instruments at Fair Value on Recurring Basis Schedule of Fixed Assets Summary of Common Stock Options Outstanding Schedule of Option Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan Summary of Common Stock Options Activity Outstanding Summary of Common Stock Warrants Outstanding Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan Summary of Common Stock Warrants Activity Outstanding Schedule of Future Minimum Rental Payment Under Operating Leases Schedule of Other Income Schedule of Effective Income Tax Rate Reconciliation Schedule of Deferred Tax Asset Prior period reclassification net value Number of reportable segment Allowance for doubtful accounts receivable Deferred revenues Advertising and promotions expense Name of Entity State of Incorporation Relationship Range [Axis] Property, Plant and Equipment, Useful Life Property, Plant and Equipment Estimated Useful Lives Accumulated deficit Number of common stock shares issued for services Number of common stock issued for services Number of common stock shares compensation issued for services Number of common stock shares compensation issued for services, value Stock based compensation expense Number of common stock remained unvested Unamortized expenses Options exercisable description Common stock exercise price Fair value measurements, volatility rate Call option value Stock option expenses Loss on impairment of securities available-for-sale Fair Value Hierarchy and NAV [Axis] Cash Total assets Total liabilities Total Allowance for uncollectible accounts Fixed assets book value Fixed assets historical cost basis Fixed assets accumulated depreciation and amortization Gain or loss recognized on disposals Depreciation and amortization expense Software Office equipment Furniture and fixtures Lab equipment Leasehold improvements Fixed assets, gross Less: accumulated depreciation Total Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares designated Preferred stock, shares designated remaining Preferred stock, shares issued Preferred stock, shares outstanding Preferred stock convertible into common stock shares Percentage of equity beneficial ownership Stock conversion, shares converted Stock conversion, shares issued Stock conversion price per shares Stock conversion value Common stock par value Common stock authorized Common Stock, shares outstanding Number of common stock sold Number of warrant to purchase of common stock shares Warrants exercise price per share Share issued in exercise stock option Stock option exercise price per share Common stock shares issued Number of common stock issued for services Number of shares issued under stock plan Options exercisable period Number of options outstanding Number granted options to purchase shares of common stock Options vesting term Options exercise price per share Volatility rate Fair value of stock options Unamortized expenses expected to be expensed Number of shares granted fully vested common stock option Common stock options exercised Exercised option price per share Common stock options cancelled or expired Weighted average exercise price per share expired Amortization of stock options Intrinsic value Intrinsic value, market price per share Intrinsic value weighted-average exercise price per share Range of Exercise Price, Minimum Range of Exercise Price, Maximum Number of Options Outstanding Weighted Average Remaining Contractual Life Weighted Average Exercise Price Number of Shares Exercisable Weighted Average Exercise Price Exercisable Average risk-free interest rates Average expected life (in years) Volatility Number of Shares Outstanding, Beginning balance Number of Shares Options expired Number of Shares Options issued Number of Shares Options exercised Number of Shares Outstanding, Ending balance Number of Shares Exercisable Weighted Average Exercise Price, Outstanding, Beginning Weighted Average Exercise Price, Options expired Weighted Average Exercise Price, Options issued Weighted Average Exercise Price, Options exercised Weighted Average Exercise Price, Outstanding, Ending Weighted Average Exercise Price, Exercisable Number issuance of common stock, shares Range of Exercise Price, Minimum Range of Exercise Price, Maximum Number of Warrants Outstanding Weighted Average Remaining Contractual Life Weighted Average Exercise Price Number of Shares Exercisable Weighted Average Exercise Price, Exercisable Number of Shares, Balance beginning Number of Shares, Warrants granted Number of Shares, Warrants exercised Number of Shares, Warrants expired Number of Shares, Balance ending Number of Shares, Exercisable Weighted Average Exercise Price, Balance, beginning Weighted Average Exercise Price, Warrants granted Weighted Average Exercise Price, Warrants exercised Weighted Average Exercise Price, Warrants expired Weighted Average Exercise Price, Balance, ending Weighted Average Exercise Price, Exercisable Rent expense 2018 2019 2020 2021 Total Settlement income on license agreement Rental income on subleases Restitution income Other income Net operating loss carry forwards Operating loss expiration year Federal statutory income tax rate State income taxes Change in valuation allowance Net effective income tax rate Net operating loss carry forwards Net deferred tax assets before valuation allowance Less: Valuation allowance Net deferred tax assets Debt sold principal amount Notes maturity date Notes bear interest rate Notes conversion price per share Value of common stock shares issued for services Chief Operating Officer and President [Member] Chief Scientist [Member] Common Stock One [Member] Common Stock Two [Member] Common Stock Unit [Member] Common Stock Warrant [Member] Common Stock Warrants [Text Block] Consultant [Member] Consultant One [Member] Consultant Two [Member] Dr. Alfredo Axtmayer [Member] Entities Under Common Control And Ownership Four [Member] Entities Under Common Control And Ownership One [Member] Entities Under Common Control And Ownership Three [Member] Entities Under Common Control and Ownership [Member] Entity Incorporation Relationship. Lab Equipment Gross. Options exercisable description. Preferred Stock Designated Preference Shares. Preferred stock, shares designated remaining. President and COO [Member] Schedule of Entities Under Common Control and Ownership [Table Text Block] Ten Employees [Member] Three Consultants [Member] Two Option Holder [Member] Two Thousand Twleve Stock Incentive Plan [Member] Bad debts expense (recoveries). Stock option issued for services. Cashless exercise of options and warrants. Cashless exercise of options and warrants, shares. Nature of Business [Policy Text Block] Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment [Table Text Block] Summary of Common Stock Option Outstanding [Table Text Block] Summary of Common Stock Warrants Outstanding [Table Text Block] Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grands Under Fixed Option Plan [Table Text Block] Lab Equipment [Member] Todd Denkin [Member] Todd Peterson [Member] Joseph Bianco [Member] Bruce Raben [Member] Chief Science Officer [Member] Stock option expenses. Software [Member] President and CEO [Member] CFO [Member] President and Chief Operating Officer [Member] Common Stock Option One [Member] Common Stock Option Two [Member] Common Stock Options [Member] Amortization of Stock Options [Member] Intrinsic value weighted-average exercise price per share. The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding non-options equity awards on all non-option equity plans and other required information pertaining to awards in the customized range. The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding non-options equity awards on all non-option equity plans and other required information pertaining to awards in the customized range. The number of shares reserved for issuance pertaining to the outstanding non-options equity as of the balance sheet date for all non-option equity plans in the customized range of exercise prices. Weighted average remaining contractual term of outstanding non-option equity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding non-option equity which are in the customized range of exercise prices. The number of shares reserved for issuance pertaining to the outstanding exercisable non-option equity as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. The number of shares into which fully or partially vested non-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option equity plan. Weighted average per share amount at which grantees can acquire shares of common stock by non-option equity. Weighted average price at which option holders acquired shares when converting their non-option equity into shares. Weighted average price at which grantees could have acquired the underlying shares with respect to non-option equity of the plan that expired. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. Settlement income on license agreement. Restitution income. Operating loss expiration year. 8% Senior Secured Convertible Notes [Member] Two Institutional Investors Member Another Consultants [Member] CEO [Member] COO [Member] Dr. John Abroon [Member] Six Consultants [Member] September 30, 2019 [Member] Unamortized expenses expected to be expensed. Holders [Member] EntitiesUnderCommonControlAndOwnershipTwoMember EntitiesUnderCommonControlAndOwnershipThreeMember EntitiesUnderCommonControlAndOwnershipFourMember Preferred Stock [Member] SoftwareMember Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Other Nonoperating Income (Expense) Shares, Outstanding Available-for-sale Securities, Gross Realized Losses Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deposits Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Fair Value of Financial Instruments, Policy [Policy Text Block] Receivables, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Deferred Revenue Cash and Cash Equivalents, Fair Value Disclosure Depreciation, Depletion and Amortization, Nonproduction Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisePriceRangeLowerRangeLimit ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisePriceRangeUpperRangeLimit ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisePriceRangeWeightedAverageRemainingContractualTerm2 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisePriceRangeWeightedAverageExercisePriceBeginningBalance1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisePriceRangeNumberOfExercisableShares Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice Operating Leases, Future Minimum Payments Due Other Income [Default Label] Deferred Tax Assets, Operating Loss Carryforwards Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance EX-101.PRE 13 digp-20180930_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - USD ($)
12 Months Ended
Sep. 30, 2018
Dec. 25, 2018
Mar. 31, 2018
Document And Entity Information      
Entity Registrant Name Digipath, Inc.    
Entity Central Index Key 0001502966    
Document Type 10-K    
Document Period End Date Sep. 30, 2018    
Amendment Flag false    
Current Fiscal Year End Date --09-30    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filer No    
Entity Current Reporting Status Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business Flag false    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 8,120,756
Entity Common Stock, Shares Outstanding   43,257,277  
Trading Symbol DIGP    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2018    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Current assets:    
Cash $ 176,027 $ 178,177
Accounts receivable 167,734 266,613
Prepaid expenses 72,690 73,750
Deposits 25,647 25,647
Total current assets 442,098 544,187
Fixed assets, net 957,108 1,027,049
Total Assets 1,399,206 1,571,236
Current liabilities:    
Accounts payable 325,864 121,994
Accrued expenses 58,238 42,004
Deferred revenues 525
Total current liabilities 384,627 163,998
Total Liabilities 384,627 163,998
Stockholders' Equity:    
Series A convertible preferred stock, $0.001 par value, 10,000,000 shares authorized; 1,425,942 and 1,897,942 shares issued and outstanding at September 30, 2018 and 2017, respectively 1,426 1,898
Common stock, $0.001 par value, 90,000,000 shares authorized; 42,245,364 and 35,027,118 shares issued and outstanding at September 30, 2018 and 2017, respectively 42,245 35,027
Additional paid-in capital 14,121,236 12,866,984
Accumulated (deficit) (13,150,328) (11,496,671)
Total Stockholders' Equity 1,014,579 1,407,238
Total Liabilities and Stockholders' Equity $ 1,399,206 $ 1,571,236
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2018
Sep. 30, 2017
Statement of Financial Position [Abstract]    
Series A convertible preferred stock, par value $ 0.001 $ 0.001
Series A convertible preferred stock, shares authorized 10,000,000 10,000,000
Series A convertible preferred stock, shares issued 1,425,942 1,897,942
Series A convertible preferred stock, shares outstanding 1,425,942 1,897,942
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 90,000,000 90,000,000
Common stock, shares issued 42,245,364 35,027,118
Common stock, shares outstanding 42,245,364 35,027,118
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]    
Revenues $ 2,839,916 $ 1,898,172
Cost of sales 2,069,837 904,166
Gross profit 770,079 994,006
Operating expenses:    
General and administrative 1,451,642 1,257,745
Professional fees 1,094,486 1,001,289
Bad debts expense (recoveries) (17,280) 32,180
Total operating expenses 2,528,848 2,291,214
Operating loss (1,758,769) (1,297,208)
Other income:    
Other income 105,112 282,068
Loss on impairment of securities available-for-sale (50,000)
Total other income 105,112 232,068
Net loss $ (1,653,657) $ (1,065,140)
Weighted average number of common shares outstanding - basic and fully diluted 39,079,547 29,321,193
Net loss per share - basic and fully diluted $ (0.04) $ (0.04)
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated (Deficit) [Member]
Total
Balance at Sep. 30, 2016 $ 3,520 $ 22,491 $ 11,681,282 $ (40,800) $ (10,431,531) $ 1,234,962
Balance, shares at Sep. 30, 2016 3,520,442 22,491,041        
Units of common stock and warrants sold for cash $ 3,499 557,001 560,500
Units of common stock and warrants sold for cash, shares 3,498,577        
Common stock issued for services $ 925 245,455 246,380
Common stock issued for services, shares 925,000        
Common stock options issued for services 389,736 389,736
Conversion of preferred stock to common stock $ (1,622) $ 8,112 (6,490)
Conversion of preferred stock to common stock, shares (1,622,500) 8,112,500        
Realized loss on available-for-sale securities 40,800 40,800
Net loss (1,065,140) (1,065,140)
Balance at Sep. 30, 2017 $ 1,898 $ 35,027 12,866,984 (11,496,671) 1,407,238
Balance, shares at Sep. 30, 2017 1,897,942 35,027,118        
Units of common stock and warrants sold for cash $ 2,159 366,449 368,608
Units of common stock and warrants sold for cash, shares 2,158,934        
Common stock issued for services $ 2,327 450,210 452,537
Common stock issued for services, shares 2,326,855        
Common stock options issued for services 439,853 439,853
Conversion of preferred stock to common stock $ (472) $ 2,360 (1,888)
Conversion of preferred stock to common stock, shares (472,000) 2,360,000        
Cashless exercise of options and warrants $ 372 (372)
Cashless exercise of options and warrants, shares 372,457        
Net loss (1,653,657) (1,653,657)
Balance at Sep. 30, 2018 $ 1,426 $ 42,245 $ 14,121,236 $ (13,150,328) $ 1,014,579
Balance, shares at Sep. 30, 2018 1,425,942 42,245,364        
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net loss $ (1,653,657) $ (1,065,140)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in allowance for doubtful accounts (17,280) 32,180
Depreciation and amortization expense 277,294 253,535
Stock issued for services 452,537 246,380
Options and warrants granted for services 439,853 389,736
Realized loss on available-for-sale securities 50,000
Decrease (increase) in assets:    
Accounts receivable 116,159 (200,352)
Prepaid expenses 1,060 (49,504)
Deposits 14,203
Increase (decrease) in liabilities:    
Accounts payable 203,870 (35,672)
Accrued expenses 16,234 (12,243)
Deferred revenues 525
Net cash used in operating activities (163,405) (376,877)
Cash flows from investing activities    
Purchase of fixed assets (207,353) (140,836)
Net cash used in investing activities (207,353) (140,836)
Cash flows from financing activities    
Proceeds from sale of common stock 368,608 560,500
Net cash provided by financing activities 368,608 560,500
Net increase (decrease) in cash (2,150) 42,787
Cash - beginning 178,177 135,390
Cash - ending 176,027 178,177
Supplemental disclosures:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Value of preferred stock converted to common stock $ 472,000 $ 1,622,500
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Business and Significant Accounting Policies
12 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Nature of Business and Significant Accounting Policies

Note 1 – Nature of Business and Significant Accounting Policies

 

Nature of Business

 

Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (“Digipath,” the “Company,” “we,” “our” or “us”) supports the cannabis industry’s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units are described below.

 

  Digipath Labs, Inc. Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.
     
  The National Marijuana News Corp. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving—and profoundly controversial—medicinal and recreational marijuana industry.

 

Basis of Accounting

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The FASB Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:

 

    State of    
Name of Entity(1)   Incorporation   Relationship
Digipath, Inc.(2)   Nevada   Parent
Digipath Labs, Inc.   Nevada   Subsidiary
TNM News, Inc.   Nevada   Subsidiary
GroSciences, Inc.(3)   Colorado   Subsidiary

 

(1) All entities are in the form of a corporation.

(2) Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.

(3) Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.

 

The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company and subsidiaries will be collectively referred to herein as the “Company”, “Digipath” or “DIGP”. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its customers are within the United States.

 

These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.

 

Reclassifications

 

Prior period interest income in the amount of $10,000 has been reclassified to net against the related $10,000 of bad debt expense to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.

 

Fair Value of Financial Instruments

 

The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

 

  - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.  
  - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.  
  - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.  

 

The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short term nature of the instruments.

 

Accounts Receivable

 

Accounts receivable are carried at their estimated collectible amounts. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. The Company had an allowance for doubtful accounts of $14,900 and $32,180 as of September 30, 2018 and 2017, respectively.

 

Fixed Assets

 

Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:

 

Software 3 years
Office equipment 5 years
Furniture and fixtures 5 years
Lab equipment 7 years
Leasehold improvements Term of lease

 

Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.

 

Impairment of Long-Lived Assets

 

Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.

 

Our intellectual property is comprised of indefinite-lived brand names acquired and have been assigned an indefinite life as we currently anticipate that these brand names will contribute cash flows to the Company perpetually. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.

 

Revenue Recognition

 

Effective October 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.

 

There was no impact on the Company’s financial statements from ASC 606 for the years ended September 30, 2018 or 2017 since it was not adopted until October 1, 2018.

 

Revenue is primarily generated through our subsidiary, Digipath Labs, Inc., which recognizes revenue from the analytical testing of cannabis products for licensed producers and cultivators within the state of Nevada on a determinable fixed fee per test, or panel of tests basis. Revenue from the performance of those services is recognized upon completion of the tests, at which time test results are delivered to the customer, provided collectability of the fee is reasonably assured. We typically require payment within thirty days of the delivery of results. Management estimates an allowance for doubtful accounts based on the aging of its receivables.

 

The Company also recognizes revenue through our subsidiary, TNM News Corp., which primarily recognizes revenue from advertisements through partnered merchants. Payment for ad revenues are received prior to the distribution of the ad campaign, and the revenues are recognized ratably over the campaign. The Company defers any revenue for which the term of the campaign has not yet been realized. To date, these revenues have not been materially significant. Deferred revenues on advertisement campaigns was $525 at September 30, 2018.

 

Advertising Costs

 

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $108,295 and $138,026 for the years ended September 30, 2018 and 2017, respectively.

 

Basic and Diluted Loss Per Share

 

The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended September 30, 2018 and 2017, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.

 

Stock-Based Compensation

 

The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 505-50 (ASC 505-50). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.

 

Income Taxes

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.

 

Uncertain Tax Positions

 

In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

Recent Accounting Pronouncements

 

In June 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the “Tax Act”) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The calculation of accumulated foreign earnings requires an analysis of each foreign entity’s financial results going back to 1986. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The guidance permits entities to reclassify tax effects stranded in Accumulated Other Comprehensive Income as a result of tax reform to retained earnings. This new guidance is effective for annual and interim periods in fiscal years beginning after December 15, 2018. Early adoption is permitted in annual and interim periods and can be applied retrospectively or in the period of adoption. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.

 

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted the new standard to be effective with our first interim reporting period for the three months ended December 31, 2017. We use the modified retrospective method of adoption. We have completed an initial evaluation of the potential impact from adopting the new standard, including a detailed review of performance obligations for all material revenue streams. Based on this initial evaluation, adoption does not have a material impact on our financial position, results of operations, or cash flows. Related disclosures have been expanded in line with the requirements of the standard.

 

There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Going Concern
12 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

Note 2 – Going Concern

 

As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses from operations resulting in an accumulated deficit of ($13,150,328), and as of September 30, 2018, the Company’s cash on hand may not be sufficient to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management is actively pursuing new customers to increase revenues. In addition, the Company is currently seeking additional sources of capital to fund short term operations. Management believes these factors will contribute toward achieving profitability. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. These financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions
12 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
Related Party Transactions

Note 3 – Related Party Transactions

 

Stock Issued to Officers for Services

 

On September 25, 2018, we issued 39,344 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On September 25, 2018, we issued 98,361 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On June 25, 2018, we issued 118,421 shares of common stock to our then Chief Executive Officer, Joseph Bianco, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $22,500 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On June 25, 2018, we issued 31,579 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On June 25, 2018, we issued 78,947 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On March 26, 2018, we issued 207,852 shares of common stock to our then Chief Executive Officer, Joseph Bianco, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $45,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On March 26, 2018, we issued 55,427 shares of common stock to our Chief Executive Officer, Todd Denkin, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $12,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On March 26, 2018, we issued 138,568 shares of common stock to our Chief Financial Officer, Todd Peterson, for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $30,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On December 22, 2017, we issued 300,000 shares of common stock to our Chief Financial Officer, Todd Peterson, as a bonus for services rendered. The aggregate fair value of the common stock was $78,828 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

Stock Issued to Directors for Services

 

On September 12, 2018, we issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company’s common stock on the date of grant, and is to be expensed over the requisite service period through September 30, 2019. A total of $1,458 was expensed during the year ended September 30, 2018, and as of September 30, 2018, a total of $29,562 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.

 

On December 22, 2017, we issued 100,000 shares of common stock to Dr. Alfredo Axtmayer for his service on our Board of Directors. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

Options Issued to Officers and Directors for Services

 

On September 12, 2018, we granted options to purchase 200,000 shares of common stock as compensation for services to our Chief Science Officer pursuant to her appointment to the Company’s Board of Directors. The options vest over a one-year period and are exercisable for a ten-year period at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. The options are being expensed over the vesting period, resulting in $1,170 of stock-based compensation expense during the year ended September 30, 2018. As of September 30, 2018, options to purchase 200,000 shares of common stock remained unvested and a total of $23,735 of unamortized expense is expected to be expensed during the fiscal year ended September 30, 2019.

 

On December 22, 2017, we granted fully vested options to purchase 500,000 shares of common stock as compensation for services to our Chief Executive Officer, Todd Denkin. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.2094, was $104,698, which was expensed on the grant date, resulting in $104,698 of stock-based compensation expense during the year ended September 30, 2018.

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments
12 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

Note 4 – Fair Value of Financial Instruments

 

Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value.

 

The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows:

 

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

 

Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).

 

Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.

 

The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets as of September 30, 2018 and 2017, respectively:

 

    Fair Value Measurements at September 30, 2018  
    Level 1     Level 2     Level 3  
Assets                        
Cash   $ 176,027     $ -     $ -  
Total assets     176,027       -       -  
Liabilities                        
None     -       -       -  
Total liabilities     -       -       -  
    $ 176,027     $ -     $ -  

 

    Fair Value Measurements at September 30, 2017  
    Level 1     Level 2     Level 3  
Assets                        
Cash   $ 178,177     $ -     $ -  
Total assets     178,177       -       -  
Liabilities                        
None     -       -       -  
Total liabilities     -       -       -  
    $ 178,177     $ -     $ -  

 

The fair value of our intellectual properties are deemed to approximate book value, and are considered Level 3 inputs as defined by ASC Topic 820-10-35.

 

There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the years ended September 30, 2018 or 2017.

 

We recognized other than temporary impairment losses of $50,000 on our available-for-sale securities during the year ended September 30, 2017.

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accounts Receivable
12 Months Ended
Sep. 30, 2018
Receivables [Abstract]  
Accounts Receivable

Note 5 – Accounts Receivable

 

Accounts receivable was $167,734 and $266,613 at September 30, 2018 and 2017, respectively, net of allowance for uncollectible accounts of $14,900 and $32,180 at September 30, 2018 and 2017, respectively.

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fixed Assets
12 Months Ended
Sep. 30, 2018
Property, Plant and Equipment [Abstract]  
Fixed Assets

Note 6 – Fixed Assets

 

Fixed assets consist of the following at September 30, 2018 and 2017:

 

    For the Years Ended  
    September 30,  
    2018     2017  
Software   $ 123,492     $ 121,617  
Office equipment     54,877       36,080  
Furniture and fixtures     28,486       14,285  
Lab equipment     1,110,930       938,450  
Leasehold improvements     489,147       489,147  
      1,806,932       1,599,579  
Less: accumulated depreciation     (849,824 )     (572,530 )
Total   $ 957,108     $ 1,027,049  

 

On October 1, 2016, we disposed of fixed assets with a net book value of $3,122 pursuant to the deconsolidation of Digipath Corp. The fixed assets consisted of furniture and fixtures with a historical cost basis of $48,779 and software with a historical cost basis of $10,019, and accumulated depreciation of $48,779 and $6,897, respectively. No gain or loss was recognized on the disposals.

 

Depreciation and amortization expense totaled $277,294 and $253,535 for the years ended September 30, 2018 and 2017, respectively.

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity
12 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Stockholders' Equity

Note 7 – Stockholders’ Equity

 

Convertible Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share, of which 6,000,000 have been designated as Series A Convertible Preferred Stock (“Series A Preferred”), with the remaining 4,000,000 shares available for designation from time to time by the Board as set forth below. As of September 30, 2018, there were 1,425,942 shares of Series A Preferred issued and outstanding. The Board of Directors is authorized to determine any number of series into which the undesignated shares of preferred stock may be divided and to determine the rights, preferences, privileges and restrictions granted to any series of the preferred stock. Each share of Series A Preferred is currently convertible into five shares of common stock.

 

The conversion price is adjustable in the event of stock splits and other adjustments in the Company’s capitalization, and in the event of certain negative actions undertaken by the Company. At the current conversion price, the 1,425,942 shares of Series A Preferred outstanding at September 30, 2018 are convertible into 7,129,710 shares of the common stock of the Company. No holder is permitted to convert its shares of Series A Preferred if such conversion would cause the holder to beneficially own more than 4.99% of the issued and outstanding common stock of the Company immediately after such conversion, unless waived by such holder by providing at least sixty-five days’ notice.

 

Additional terms of the Series A Preferred include the following:

 

  The shares of Series A Preferred are entitled to dividends when, as and if declared by the Board as to the shares of the common stock of the Company into which such Series A Preferred may then be converted, subject to the 4.99% beneficial ownership limitation described above.
     
  Upon the liquidation or dissolution of the Company, or any merger or sale of all or substantially all of the assets, the shares of Series A Preferred are entitled to receive, prior to any distribution to the holders of common stock, 100% of the purchase price per share of Series A Preferred plus all accrued but unpaid dividends.
     
  The Series A Preferred plus all declared but unpaid dividends thereon automatically will be converted into common stock, at the then applicable conversion rate, upon the affirmative vote of the holders of a majority of the outstanding shares of Series A Preferred.
     
  Each share of Series A Preferred will carry a number of votes equal to the number of shares of common stock into which such Series A Preferred may then be converted, subject to the 4.99% beneficial ownership limitation described above. The Series A Preferred generally will vote together with the common stock and not as a separate class, except as provided below.
     
  Consent of the holders of the outstanding Series A Preferred is required in order for the Company to: (i) amend or change the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series A Preferred; (ii) authorize, create or issue shares of any class of stock having rights, preferences, privileges or powers superior to the Series A Preferred; (iii) reclassify any outstanding shares into shares having rights, preferences, privileges or powers superior to the Series A Preferred; or (iv) amend the Company’s Articles of Incorporation or Bylaws in a manner that adversely affects the rights of the Series A Preferred.
     
  Pursuant to the Securities Purchase Agreements, holders of Series A Preferred are entitled to unlimited “piggyback” registration rights on registrations by the Company, subject to pro rata cutback at any underwriter’s discretion.

 

Preferred Stock Conversions for the Year Ended September 30, 2018

 

For the year ended September 30, 2018, a total of 472,000 shares of Series A Preferred were converted into 2,360,000 shares of common stock at a value of $0.20 per share of common stock, or a total of $472,000. The stock was converted in accordance with the conversion terms; therefore no gain or loss has been recognized.

 

Preferred Stock Conversions for the Year Ended September 30, 2017

 

For the year ended September 30, 2017, a total of 1,622,500 shares of Series A Preferred were converted into 8,112,500 shares of common stock at a value of $0.20 per share of common stock, or a total of $1,622,500. The stock was converted in accordance with the conversion terms; therefore no gain or loss has been recognized.

 

Common Stock

 

Common stock consists of $0.001 par value, 90,000,000 shares authorized, of which 42,245,364 shares were issued and outstanding as of September 30, 2018.

 

Common Stock Sales for the Year Ended September 30, 2018

 

On July 11, 2018, the Company sold 66.67 units, consisting of 666,667 shares of its common stock and warrants to purchase 333,334 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $100,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On April 13, 2018, the Company sold 14 units, consisting of an aggregate of 140,000 shares of its common stock and warrants to purchase 70,000 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $25,200. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On April 12, 2018, the Company sold 28 units, consisting of an aggregate of 280,000 shares of its common stock and warrants to purchase 140,000 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $50,400. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On April 10, 2018, the Company sold 27.78 units, consisting of an aggregate of 277,778 shares of its common stock and warrants to purchase 138,889 shares of common stock, exercisable at $0.30 per share over a thirty-six month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On December 20, 2017, the Company sold 10 units, consisting of an aggregate of 100,000 shares of its common stock and warrants to purchase 50,000 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $18,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On December 14, 2017, the Company sold 13.89 units, consisting of an aggregate of 138,889 shares of its common stock and warrants to purchase 69,445 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $25,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On December 14, 2017, the Company sold 55.56 units, consisting of an aggregate of 555,600 shares of its common stock and warrants to purchase 277,800 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $100,008. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

Common Stock Sales for the Year Ended September 30, 2017

 

On August 25, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On August 25, 2017, the Company sold 7 units, consisting of 70,000 shares of its common stock and warrants to purchase 35,000 shares of common stock, exercisable at $0.30 per share over a sixty month period, in exchange for total proceeds of $10,500. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On August 4, 2017, the Company sold 100 units, consisting of 1,000,000 shares of its common stock and warrants to purchase 500,000 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $150,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On July 28, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On June 21, 2017, the Company sold 33.333 units, consisting of 333,334 shares of its common stock and warrants to purchase 166,667 shares of common stock, exercisable at $0.26 per share over a sixty month period, in exchange for total proceeds of $50,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis.

 

On February 21, 2017, the Company sold 1,428,575 units, consisting of 1,428,575 shares of its common stock and warrants to purchase 714,285 shares of common stock, exercisable at $0.26 per share over a thirty-six month period, in exchange for total proceeds of $250,000. The proceeds received were allocated between the common stock and warrants on a relative fair value basis. The warrants were assigned to two individuals by the purchaser at the time of the sale.

 

Exercise of Options for the Year Ended September 30, 2018

 

On January 3, 2018, two option holders exercised options to purchase a total of 500,000 shares of common stock at $0.181 per share on a cashless basis, resulting in the issuance of 317,172 shares of common stock.

 

On January 2, 2018, an option holder exercised options to purchase 37,500 shares of common stock at $0.22 per share on a cashless basis, resulting in the issuance of 21,000 shares of common stock.

 

Exercise of Warrants for the Year Ended September 30, 2018

 

On January 3, 2018, a warrant holder exercised warrants to purchase 71,428 shares of common stock at $0.26 per share on a cashless basis, resulting in the issuance of 34,285 shares of common stock.

 

Additional Common Stock Issuances for the Year Ended September 30, 2018

 

On September 25, 2018, the Company issued 39,344 shares of common stock to its President and CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 25, 2018, the Company issued 98,361 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $22,875 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 12, 2018, the Company issued 193,424 shares of common stock to another consultant for business development services. The fair value of the common stock was $30,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On September 12, 2018, the Company issued 200,000 shares of common stock to Bruce Raben in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $31,020 based on the closing price of the Company’s common stock on the date of grant, and is to be expensed over the requisite service period through September 30, 2019. A total of $1,458 was expensed during the year ended September 30, 2018, and as of September 30, 2018, a total of $29,562 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.

 

On June 25, 2018, the Company issued 118,421 shares of common stock to its then CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $22,500 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 31,579 shares of common stock to its then President and COO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 78,947 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 131,579 shares of common stock to a consultant for business development services. The fair value of the common stock was $25,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On June 25, 2018, the Company issued 100,000 shares of common stock to another consultant for business development services. The fair value of the common stock was $19,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 207,852 shares of common stock to its then CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $45,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 55,427 shares of common stock to its then President and COO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $12,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 138,568 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $30,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On March 26, 2018, the Company issued 69,284 shares of common stock to a consultant for business development services. The fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

On December 22, 2017, the Company issued 300,000 shares of common stock to its CFO as a bonus for services rendered. The aggregate fair value of the common stock was $78,828 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On December 22, 2017, the Company issued 100,000 shares of common stock to Dr. Alfredo Axtmayer for his service on our Board of Directors. The aggregate fair value of the common stock was $26,276 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On November 29, 2017, a total of 314,069 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $82,600 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2018.

 

Additional Common Stock Issuances for the Year Ended September 30, 2017

 

On May 2, 2017, the Company issued 100,000 shares of common stock to Dr. John Abroon in connection with his appointment to our newly created Advisory Board. The aggregate fair value of the common stock was $20,900 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On May 2, 2017, the Company issued 140,000 shares of common stock to a consultant in consideration of services rendered from April 1, 2017 through May 31, 2017. The aggregate fair value of the common stock was $29,260 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On March 1, 2017, the Company issued 25,000 shares of common stock to its CFO as a bonus for services rendered. The aggregate fair value of the common stock was $6,623 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On March 1, 2017, the Company issued 50,000 shares of common stock to its Chief Scientist as a bonus for services rendered. The aggregate fair value of the common stock was $13,245 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On February 23, 2017, the Company issued 100,000 shares of common stock to a consultant for services to be rendered over a six month period. The aggregate fair value of the common stock was $29,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2017.

 

On February 22, 2017, the Company issued 100,000 shares of common stock to Dr. Alfredo Axtmayer in connection with his appointment to our Board of Directors. The aggregate fair value of the common stock was $34,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On February 22, 2017, the Company issued 40,000 shares of common stock to a consultant for services rendered. The aggregate fair value of the common stock was $13,600 based on the closing price of the Company’s common stock on the date of grant, and was expensed in full.

 

On February 7, 2017, a total of 370,000 shares of common stock were issued to six consultants that were engaged to assist the Company with acquisition activities over a six month period. The aggregate fair value of the common stock was $82,251 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period that ended on September 30, 2017.

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Options
12 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Common Stock Options

Note 8 – Common Stock Options

 

Stock Incentive Plan

 

On June 21, 2016, we amended and restated our 2012 Stock Incentive Plan (the “2012 Plan”), which was originally adopted on March 5, 2012 and previously amended on May 20, 2014. As amended, the 2012 Plan provides for the issuance of up to 11,500,000 shares of common stock pursuant to the grant of options or other awards, including stock grants, to employees, officers or directors of, and consultants to, the Company and its subsidiaries. Options granted under the 2012 Plan may either be intended to qualify as incentive stock options under the Internal Revenue Code of 1986, or may be non-qualified options, and are exercisable over periods not exceeding ten years from date of grant. Options to purchase a total of 8,537,500 shares of common stock were outstanding as of September 30, 2018

 

Common Stock Option Issuances for the Year Ended September 30, 2018

 

On September 12, 2018, we granted options to purchase 200,000 shares of common stock as compensation for services to our Chief Science Officer pursuant to her appointment to the Company’s Board of Directors. The options vest over a one-year period, are exercisable over a ten-year period at an exercise price of $0.16 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1245, was $24,905. The options are being expensed over the vesting period, resulting in $1,170 of stock-based compensation expense during the year ended September 30, 2018. As of September 30, 2018, options to purchase 200,000 shares of common stock remained unvested and a total of $23,735 of unamortized expenses are expected to be expensed during the fiscal year ended September 30, 2019.

 

On December 22, 2017, we granted fully vested options to purchase 500,000 shares of common stock as compensation for services to our then President and COO. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.2094, was $104,698. The options were expensed over the vesting period, resulting in $104,698 of stock-based compensation expense during the year ended September 30, 2018.

 

On November 29, 2017, we granted fully vested options to purchase 100,000 shares of common stock as compensation for services to our Chief Scientist. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.21, was $21,004. The options were expensed over the vesting period, resulting in $21,004 of stock-based compensation expense during the year ended September 30, 2018.

 

On November 29, 2017, we granted fully vested options to purchase an aggregate of 205,000 shares of common stock as compensation for services to a total of ten of our employees. The options are exercisable over a ten-year period at an exercise price of $0.27 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 112% and a call option value of $0.21, was $43,057. The options were expensed over the vesting period, resulting in $43,057 of stock-based compensation expense during the year ended September 30, 2018.

 

Common Stock Options Exercised for the Year Ended September 30, 2018

 

On January 3, 2018, two option holders exercised options to purchase a total of 500,000 shares of common stock at $0.181 per share on a cashless basis, resulting in the issuance of 317,172 shares of common stock.

 

On January 2, 2018, an option holder exercised options to purchase 37,500 shares of common stock at $0.22 per share on a cashless basis, resulting in the issuance of 21,000 shares of common stock.

 

Common Stock Options Cancelled or Expired for the Year Ended September 30, 2018

 

During the year ended September 30, 2018, options to purchase an aggregate of 110,000 shares of common stock, exercisable over a ten-year period, at a weighted average exercise price of $0.25 per share expired.

 

During the year ended September 30, 2018, options to purchase an aggregate of 1,110,000 shares of common stock, exercisable over a three-year period, at a weighted average exercise price of $0.44 per share expired.

 

Common Stock Options Cancelled or Expired for the Year Ended September 30, 2017

 

On January 1, 2017, a total of 1,530 common stock options exercisable over a three-year period from the original grant date of January 1, 2014 with an exercise price of $3.30 per share expired.

The following is a summary of information about the stock options outstanding at September 30, 2018.

 

Shares Underlying Options Outstanding     Shares Underlying
Options Exercisable
 
                                         
              Weighted                          
      Shares       Average       Weighted       Shares       Weighted  
Range of     Underlying       Remaining       Average       Underlying       Average  
Exercise     Options       Contractual       Exercise       Options       Exercise  
Prices     Outstanding       Life       Price       Exercisable       Price  
                                         
$0.16 – $0.40     8,537,500       4.27 years     $ 0.20       8,337,500     $ 0.21  

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

    September 30,     September 30,  
    2018     2017  
             
Average risk-free interest rates     1.36 %     N/A %
Average expected life (in years)     5.25       N/A  
Volatility     112 %     N/A %

 

The Black-Scholes option pricing model was developed for use in estimating the fair value of short-term traded options that have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including expected stock price volatility. Because the Company’s common stock options have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion the existing models do not necessarily provide a reliable single measure of the fair value of its common stock options. During the years ended September 30, 2018 and September 30, 2017, there were no options granted with an exercise price below the fair value of the underlying stock at the grant date.

 

The weighted average fair value of options granted with exercise prices at the current fair value of the underlying stock during the year ended September 30, 2018 was approximately $0.25 per option.

 

The following is a summary of activity of outstanding common stock options:

 

          Weighted  
          Average  
    Number     Exercise  
    of Shares     Price  
             
Balance, September 30, 2016     9,291,530     $ 0.23  
Options expired     (1,530 )     (3.30 )
                 
Balance, September 30, 2017     9,290,000       0.23  
Options issued     1,005,000       0.25  
Options exercised     (537,500 )     (0.18 )
Options expired     (1,220,000 )     (0.42 )
                 
Balance, September 30, 2018     8,537,500     $ 0.20  
                 
Exercisable, September 30, 2018     8,337,500     $ 0.21  

 

Amortization of Stock Options

 

A total of $439,853 and $389,736 of stock-based compensation expense was recognized from the amortization of options over their vesting period during the years ended September 30, 2018 and 2017, respectively.

 

As of September 30, 2018, these options in the aggregate had no intrinsic value as the per share market price of $0.15 of the Company’s common stock as of such date was less than the weighted-average exercise price of these options of $0.20.

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Warrants
12 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Common Stock Warrants

Note 9 – Common Stock Warrants

 

We issued warrants in connection with private placements of our securities as set forth in Note 8 above.

 

On January 3, 2018 a warrant holder exercised warrants to purchase 71,428 shares of common stock at $0.26 per share on a cashless basis, resulting in the issuance of 34,285 shares of common stock.

 

On December 31, 2017, warrants to purchase 200,000 shares of common stock at $0.30 per share expired, and on December 30, 2017, warrants to purchase another 300,000 shares of common stock at $0.45 per share also expired.

 

The following is a summary of information about our warrants to purchase common stock outstanding at September 30, 2018 (including those issued to both investors and service providers).

 

    Shares Underlying  
Shares Underlying Warrants Outstanding       Warrants Exercisable  
                                         
              Weighted                          
      Shares       Average       Weighted       Shares       Weighted  
Range of     Underlying       Remaining       Average       Underlying       Average  
Exercise     Warrants       Contractual       Exercise       Warrants       Exercise  
Prices     Outstanding       Life       Price       Exercisable       Price  
                                         
$0.1901 – $0.40     6,450,462       1.65 years     $ 0.28       6,450,462     $ 0.28  

 

The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

    September 30,     September 30,  
    2018     2017  
             
Average risk-free interest rates     1.56 %     1.11 %
Average expected life (in years)     3.00       3.50  
Volatility     110 %     145 %

 

The weighted average fair value of warrants granted with exercise prices at the current fair value of the underlying stock during the years ended September 30, 2018 and 2017 was approximately $0.29 and $0.26 per warrant, respectively.

 

The following is a summary of activity of outstanding common stock warrants:

 

          Weighted  
          Average  
    Number     Exercise  
    of Shares     Price  
             
Balance, September 30, 2016     4,193,136     $ 0.29  
Warrants granted     1,749,286       0.26  
                 
Balance, September 30, 2017     5,942,422       0.28  
Warrants granted     1,079,468       0.29  
Warrants exercised     (71,428 )     (0.26 )
Warrants expired     (500,000 )     (0.36 )
                 
Balance, September 30, 2018     6,450,462     $ 0.28  
                 
Exercisable, September 30, 2018     6,450,462     $ 0.28  

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
12 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 10 – Commitments and Contingencies

 

Lease Commitment

 

The Company leases space for its lab operations in Las Vegas, Nevada. Amounts of minimum future annual commitments on a calendar year basis, including common area maintenance fees, under non-cancelable operating leases are as follows:

 

2018   $ 48,872  
2019     198,904  
2020     151,283  
2021     50,102  
Total   $ 449,161  

 

Rent expense was $191,751 and $210,907 for the years ended September 30, 2018 and 2017, respectively.

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Income
12 Months Ended
Sep. 30, 2018
Other Income and Expenses [Abstract]  
Other Income

Note 11 – Other Income

 

Other income for the years ended September 30, 2018 and 2017 consisted of the following:

 

    September 30,  
    2018     2017  
Settlement income on license agreement   $ -     $ 250,000  
Rental income on subleases     76,800       20,568  
Restitution income     28,312       11,500  
    $ 105,112     $ 282,068  

XML 31 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Tax
12 Months Ended
Sep. 30, 2018
Income Tax Disclosure [Abstract]  
Income Tax

Note 12 - Income Tax

 

The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences.

 

For the years ended September 30, 2018 and 2017, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At September 30, 2018, the Company had approximately $7,982,500 of federal net operating losses. The net operating loss carry forwards, if not utilized, will begin to expire in 2031.

 

The effective income tax rate for the years ended September 30, 2018 and 2017 consisted of the following:

 

    September 30,  
    2018     2017  
Federal statutory income tax rate     21 %     35 %
State income taxes          - %     - %
Change in valuation allowance     (21 %)     (35 %)
Net effective income tax rate     -       -  

 

The components of the Company’s deferred tax asset are as follows:

 

    September 30,  
    2018     2017  
Deferred tax assets:                
Net operating loss carry forwards   $ 1,676,325     $ 2,531,725  
                 
Net deferred tax assets before valuation allowance   $ 1,676,325     $ 2,531,725  
Less: Valuation allowance     (1,676,325 )     (2,531,725 )
Net deferred tax assets   $ -     $ -  

 

Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at September 30, 2018 and 2017, respectively.

 

In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
12 Months Ended
Sep. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events

Note 13 – Subsequent Events

 

Debt Financing

 

On November 8, 2018, the Company sold 8% Senior Secured Convertible Notes in the aggregate principal amount of $500,000 to two institutional investors. The Notes mature on December 31, 2020, bear interest at a rate of 8% per annum, and are convertible into shares of the Company’s common stock at a fixed conversion price of $0.14 per share. The Company’s obligation under the Notes are secured by a lien on the assets of the Company and its wholly-owned subsidiary Digipath Labs, Inc., pursuant to a Security Agreement between the Company, Digipath Labs, Inc. and the collateral agent for the investors.

 

Common Stock Issued for Services

 

On December 25, 2018, the Company issued 46,261 shares of common stock to its President and CEO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $6,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On December 25, 2018, the Company issued 115,652 shares of common stock to its CFO for services rendered pursuant to his employment agreement. The aggregate fair value of the common stock was $15,000 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On December 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $19,455 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On November 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $19,260 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

On October 30, 2018, the Company issued 400,000 shares of common stock to another consultant for business development services to be performed from November 1, 2018 through April 30, 2019. The fair value of the common stock was $54,120 based on the closing price of the Company’s common stock on the date of grant, and is being expensed over the requisite service period.

 

On October 25, 2018, a total of 150,000 shares of common stock were issued to three consultants that were engaged to assist the Company with acquisition activities. The aggregate fair value of the common stock was $23,250 based on the closing price of the Company’s common stock on the date of grant, and was expensed over the requisite service period.

 

Common Stock Option Issuances

 

On December 25, 2018, we granted options to purchase an aggregate of 235,000 shares of common stock as compensation for services to a total of ten of our employees, vesting twelve months from the grant date. The options are exercisable over a ten-year period at an exercise price of $0.13 per share. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 107% and a call option value of $0.1017, was $35,078. The options are to be expensed over the vesting period.

 

Common Stock Warrants Expired

 

On December 21, 2018, warrants to purchase 166,667 shares of common stock at $0.30 per share expired.

 

On November 23, 2018, warrants to purchase another 100,000 shares of common stock at $0.40 per share also expired.

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Business and Significant Accounting Policies (Policies)
12 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Nature of Business

Nature of Business

 

Digipath, Inc. was incorporated in Nevada on October 5, 2010. Digipath, Inc. and its subsidiaries (“Digipath,” the “Company,” “we,” “our” or “us”) supports the cannabis industry’s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Our business units are described below.

 

  Digipath Labs, Inc. Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and standardization. Digipath has been operating a cannabis-testing lab in Nevada since 2015 and has plans to open labs in other states and countries that have legalized the sale of cannabis, beginning with California.
     
  The National Marijuana News Corp. provides a balanced and unbiased approach to cannabis news, interviews and education with a news/talk podcast, national marijuana news website and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of the rapidly evolving—and profoundly controversial—medicinal and recreational marijuana industry.

Basis of Accounting

Basis of Accounting

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The FASB Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles.

Principles of Consolidation

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:

 

    State of    
Name of Entity(1)   Incorporation   Relationship
Digipath, Inc.(2)   Nevada   Parent
Digipath Labs, Inc.   Nevada   Subsidiary
TNM News, Inc.   Nevada   Subsidiary
GroSciences, Inc.(3)   Colorado   Subsidiary

 

(1) All entities are in the form of a corporation.

(2) Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.

(3) Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.

 

The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company and subsidiaries will be collectively referred to herein as the “Company”, “Digipath” or “DIGP”. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its customers are within the United States.

 

These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.

Reclassifications

Reclassifications

 

Prior period interest income in the amount of $10,000 has been reclassified to net against the related $10,000 of bad debt expense to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

Use of Estimates

Use of Estimates

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

Segment Reporting

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Company adopted ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

 

  - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.  
  - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.  
  - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.  

 

The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short term nature of the instruments.

Accounts Receivable

Accounts Receivable

 

Accounts receivable are carried at their estimated collectible amounts. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. The Company had an allowance for doubtful accounts of $14,900 and $32,180 as of September 30, 2018 and 2017, respectively.

Fixed Assets

Fixed Assets

 

Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:

 

Software 3 years
Office equipment 5 years
Furniture and fixtures 5 years
Lab equipment 7 years
Leasehold improvements Term of lease

 

Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.

 

Our intellectual property is comprised of indefinite-lived brand names acquired and have been assigned an indefinite life as we currently anticipate that these brand names will contribute cash flows to the Company perpetually. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.

Revenue Recognition

Revenue Recognition

 

Effective October 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.

 

There was no impact on the Company’s financial statements from ASC 606 for the years ended September 30, 2018 or 2017 since it was not adopted until October 1, 2018.

 

Revenue is primarily generated through our subsidiary, Digipath Labs, Inc., which recognizes revenue from the analytical testing of cannabis products for licensed producers and cultivators within the state of Nevada on a determinable fixed fee per test, or panel of tests basis. Revenue from the performance of those services is recognized upon completion of the tests, at which time test results are delivered to the customer, provided collectability of the fee is reasonably assured. We typically require payment within thirty days of the delivery of results. Management estimates an allowance for doubtful accounts based on the aging of its receivables.

 

The Company also recognizes revenue through our subsidiary, TNM News Corp., which primarily recognizes revenue from advertisements through partnered merchants. Payment for ad revenues are received prior to the distribution of the ad campaign, and the revenues are recognized ratably over the campaign. The Company defers any revenue for which the term of the campaign has not yet been realized. To date, these revenues have not been materially significant. Deferred revenues on advertisement campaigns was $525 at September 30, 2018.

Advertising Costs

Advertising Costs

 

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $108,295 and $138,026 for the years ended September 30, 2018 and 2017, respectively.

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share

 

The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended September 30, 2018 and 2017, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 505-50 (ASC 505-50). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.

Income Taxes

Income Taxes

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.

Uncertain Tax Positions

Uncertain Tax Positions

 

In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

 

The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.

 

Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In June 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the “Tax Act”) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The calculation of accumulated foreign earnings requires an analysis of each foreign entity’s financial results going back to 1986. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The guidance permits entities to reclassify tax effects stranded in Accumulated Other Comprehensive Income as a result of tax reform to retained earnings. This new guidance is effective for annual and interim periods in fiscal years beginning after December 15, 2018. Early adoption is permitted in annual and interim periods and can be applied retrospectively or in the period of adoption. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.

 

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted the new standard to be effective with our first interim reporting period for the three months ended December 31, 2017. We use the modified retrospective method of adoption. We have completed an initial evaluation of the potential impact from adopting the new standard, including a detailed review of performance obligations for all material revenue streams. Based on this initial evaluation, adoption does not have a material impact on our financial position, results of operations, or cash flows. Related disclosures have been expanded in line with the requirements of the standard.

 

There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

XML 34 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Business and Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of Entities Under Common Control and Ownership

The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2018:

 

    State of    
Name of Entity(1)   Incorporation   Relationship
Digipath, Inc.(2)   Nevada   Parent
Digipath Labs, Inc.   Nevada   Subsidiary
TNM News, Inc.   Nevada   Subsidiary
GroSciences, Inc.(3)   Colorado   Subsidiary

 

(1) All entities are in the form of a corporation.

(2) Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.

(3) Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.

Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment

The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy:

 

Software 3 years
Office equipment 5 years
Furniture and fixtures 5 years
Lab equipment 7 years
Leasehold improvements Term of lease

XML 35 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments at Fair Value on Recurring Basis

The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets as of September 30, 2018 and 2017, respectively:

 

    Fair Value Measurements at September 30, 2018  
    Level 1     Level 2     Level 3  
Assets                        
Cash   $ 176,027     $ -     $ -  
Total assets     176,027       -       -  
Liabilities                        
None     -       -       -  
Total liabilities     -       -       -  
    $ 176,027     $ -     $ -  

 

    Fair Value Measurements at September 30, 2017  
    Level 1     Level 2     Level 3  
Assets                        
Cash   $ 178,177     $ -     $ -  
Total assets     178,177       -       -  
Liabilities                        
None     -       -       -  
Total liabilities     -       -       -  
    $ 178,177     $ -     $ -  

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fixed Assets (Tables)
12 Months Ended
Sep. 30, 2018
Property, Plant and Equipment [Abstract]  
Schedule of Fixed Assets

Fixed assets consist of the following at September 30, 2018 and 2017:

 

    For the Years Ended  
    September 30,  
    2018     2017  
Software   $ 123,492     $ 121,617  
Office equipment     54,877       36,080  
Furniture and fixtures     28,486       14,285  
Lab equipment     1,110,930       938,450  
Leasehold improvements     489,147       489,147  
      1,806,932       1,599,579  
Less: accumulated depreciation     (849,824 )     (572,530 )
Total   $ 957,108     $ 1,027,049  

XML 37 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Options (Tables)
12 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Common Stock Options Outstanding

The following is a summary of information about the stock options outstanding at September 30, 2018.

 

Shares Underlying Options Outstanding     Shares Underlying
Options Exercisable
 
                                         
              Weighted                          
      Shares       Average       Weighted       Shares       Weighted  
Range of     Underlying       Remaining       Average       Underlying       Average  
Exercise     Options       Contractual       Exercise       Options       Exercise  
Prices     Outstanding       Life       Price       Exercisable       Price  
                                         
$0.16 – $0.40     8,537,500       4.27 years     $ 0.20       8,337,500     $ 0.21  

Schedule of Option Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

    September 30,     September 30,  
    2018     2017  
             
Average risk-free interest rates     1.36 %     N/A %
Average expected life (in years)     5.25       N/A  
Volatility     112 %     N/A %

Summary of Common Stock Options Activity Outstanding

The following is a summary of activity of outstanding common stock options:

 

          Weighted  
          Average  
    Number     Exercise  
    of Shares     Price  
             
Balance, September 30, 2016     9,291,530     $ 0.23  
Options expired     (1,530 )     (3.30 )
                 
Balance, September 30, 2017     9,290,000       0.23  
Options issued     1,005,000       0.25  
Options exercised     (537,500 )     (0.18 )
Options expired     (1,220,000 )     (0.42 )
                 
Balance, September 30, 2018     8,537,500     $ 0.20  
                 
Exercisable, September 30, 2018     8,337,500     $ 0.21  

XML 38 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Warrants (Tables)
12 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Summary of Common Stock Warrants Outstanding

The following is a summary of information about our warrants to purchase common stock outstanding at September 30, 2018 (including those issued to both investors and service providers).

 

    Shares Underlying  
Shares Underlying Warrants Outstanding       Warrants Exercisable  
                                         
              Weighted                          
      Shares       Average       Weighted       Shares       Weighted  
Range of     Underlying       Remaining       Average       Underlying       Average  
Exercise     Warrants       Contractual       Exercise       Warrants       Exercise  
Prices     Outstanding       Life       Price       Exercisable       Price  
                                         
$0.1901 – $0.40     6,450,462       1.65 years     $ 0.28       6,450,462     $ 0.28  

Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan

The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

    September 30,     September 30,  
    2018     2017  
             
Average risk-free interest rates     1.56 %     1.11 %
Average expected life (in years)     3.00       3.50  
Volatility     110 %     145 %

Summary of Common Stock Warrants Activity Outstanding

The following is a summary of activity of outstanding common stock warrants:

 

          Weighted  
          Average  
    Number     Exercise  
    of Shares     Price  
             
Balance, September 30, 2016     4,193,136     $ 0.29  
Warrants granted     1,749,286       0.26  
                 
Balance, September 30, 2017     5,942,422       0.28  
Warrants granted     1,079,468       0.29  
Warrants exercised     (71,428 )     (0.26 )
Warrants expired     (500,000 )     (0.36 )
                 
Balance, September 30, 2018     6,450,462     $ 0.28  
                 
Exercisable, September 30, 2018     6,450,462     $ 0.28  

XML 39 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Tables)
12 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Rental Payment Under Operating Leases

2018   $ 48,872  
2019     198,904  
2020     151,283  
2021     50,102  
Total   $ 449,161  

XML 40 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Income (Tables)
12 Months Ended
Sep. 30, 2018
Other Income and Expenses [Abstract]  
Schedule of Other Income

Other income for the years ended September 30, 2018 and 2017 consisted of the following:

 

    September 30,  
    2018     2017  
Settlement income on license agreement   $ -     $ 250,000  
Rental income on subleases     76,800       20,568  
Restitution income     28,312       11,500  
    $ 105,112     $ 282,068  

XML 41 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Tax (Tables)
12 Months Ended
Sep. 30, 2018
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation

The effective income tax rate for the years ended September 30, 2018 and 2017 consisted of the following:

 

    September 30,  
    2018     2017  
Federal statutory income tax rate     21 %     35 %
State income taxes          - %     - %
Change in valuation allowance     (21 %)     (35 %)
Net effective income tax rate     -       -  

Schedule of Deferred Tax Asset

The components of the Company’s deferred tax asset are as follows:

 

    September 30,  
    2018     2017  
Deferred tax assets:                
Net operating loss carry forwards   $ 1,676,325     $ 2,531,725  
                 
Net deferred tax assets before valuation allowance   $ 1,676,325     $ 2,531,725  
Less: Valuation allowance     (1,676,325 )     (2,531,725 )
Net deferred tax assets   $ -     $ -  

XML 42 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Business and Significant Accounting Policies (Details Narrative)
12 Months Ended
Sep. 30, 2018
USD ($)
Segment
Sep. 30, 2017
USD ($)
Number of reportable segment | Segment 1  
Allowance for doubtful accounts receivable $ 14,900 $ 32,180
Deferred revenues 525  
Advertising and promotions expense 108,295 $ 138,026
Bad Debt [Member]    
Prior period reclassification net value 10,000  
Interest Income [Member]    
Prior period reclassification net value $ 10,000  
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Business and Significant Accounting Policies - Schedule of Entities Under Common Control and Ownership (Details) - Entities Under Common Control and Ownership [Member]
12 Months Ended
Sep. 30, 2018
Name of Entity Digipath, Inc. [1],[2]
State of Incorporation Nevada [2]
Relationship Parent [2]
Name of Entity Digipath Labs, Inc. [1]
State of Incorporation Nevada
Relationship Subsidiary
Name of Entity TNM News, Inc. [1]
State of Incorporation Nevada
Relationship Subsidiary
Name of Entity GroSciences, Inc. [1],[3]
State of Incorporation Colorado [3]
Relationship Subsidiary [3]
[1] All entities are in the form of a corporation.
[2] Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above were wholly-owned by Digipath, Inc., the parent company.
[3] Entity formed for prospective purposes, but has not incurred any income or expenses as of the end of the period.
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Business and Significant Accounting Policies - Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment (Details)
12 Months Ended
Sep. 30, 2018
Software [Member]  
Property, Plant and Equipment, Useful Life 3 years
Office Equipment [Member]  
Property, Plant and Equipment, Useful Life 5 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment, Useful Life 5 years
Lab Equipment [Member]  
Property, Plant and Equipment, Useful Life 7 years
Leasehold Improvements [Member]  
Property, Plant and Equipment Estimated Useful Lives Term of lease
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Going Concern (Details Narrative) - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ (13,150,328) $ (11,496,671)
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details Narrative) - USD ($)
12 Months Ended
Sep. 25, 2018
Sep. 12, 2018
Jun. 25, 2018
Mar. 26, 2018
Dec. 22, 2017
Feb. 22, 2017
Sep. 30, 2018
Sep. 30, 2017
Number of common stock issued for services             $ 452,537 $ 246,380
Fair value measurements, volatility rate             112.00% 0.00%
Todd Denkin [Member]                
Number of common stock shares issued for services 39,344   31,579 55,427        
Number of common stock issued for services $ 6,000   $ 6,000 $ 12,000        
Number of common stock shares compensation issued for services         500,000      
Stock based compensation expense         $ 104,698   $ 104,698  
Options exercisable description         The options are exercisable over a ten year period      
Common stock exercise price         $ 0.27      
Fair value measurements, volatility rate         112.00%      
Call option value         $ 0.2094      
Todd Peterson [Member]                
Number of common stock shares issued for services 98,361   78,947 138,568 300,000      
Number of common stock issued for services $ 15,000   $ 15,000 $ 30,000 $ 78,828      
Joseph Bianco [Member]                
Number of common stock shares issued for services     118,421 207,852        
Number of common stock issued for services     $ 22,500 $ 45,000        
Bruce Raben [Member]                
Number of common stock shares issued for services   200,000            
Number of common stock issued for services   $ 31,020            
Number of common stock shares compensation issued for services   200,000            
Number of common stock shares compensation issued for services, value   $ 31,020            
Stock based compensation expense             1,458  
Unamortized expenses             29,562  
Dr. Alfredo Axtmayer [Member]                
Number of common stock shares issued for services         100,000 100,000    
Number of common stock issued for services         $ 26,276 $ 34,000    
Chief Science Officer [Member]                
Number of common stock shares compensation issued for services   200,000            
Stock based compensation expense             $ 1,170  
Number of common stock remained unvested             200,000  
Unamortized expenses             $ 23,735  
Options exercisable description   The options vest over a one-year period and are exercisable for a ten-year period            
Common stock exercise price   $ 0.16            
Fair value measurements, volatility rate   107.00%            
Call option value   $ 0.1245            
Stock option expenses   $ 24,905            
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Fair Value Disclosures [Abstract]    
Loss on impairment of securities available-for-sale $ 50,000
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments - Summary of Financial Instruments at Fair Value on Recurring Basis (Details) - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Level 1 [Member]    
Cash $ 176,027 $ 178,177
Total assets 176,027 178,177
Total liabilities
Total 176,027 178,177
Level 2 [Member]    
Cash
Total assets
Total liabilities
Total
Level 3 [Member]    
Cash
Total assets
Total liabilities
Total
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accounts Receivable (Details Narrative) - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Receivables [Abstract]    
Accounts receivable $ 167,734 $ 266,613
Allowance for uncollectible accounts $ 14,900 $ 32,180
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fixed Assets (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Oct. 02, 2016
Fixed assets book value     $ 3,122
Gain or loss recognized on disposals  
Depreciation and amortization expense $ 277,294 $ 253,535  
Furniture and Fixtures [Member]      
Fixed assets historical cost basis     48,779
Fixed assets accumulated depreciation and amortization     48,779
Software [Member]      
Fixed assets historical cost basis     10,019
Fixed assets accumulated depreciation and amortization     $ 6,897
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fixed Assets - Schedule of Fixed Assets (Details) - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Property, Plant and Equipment [Abstract]    
Software $ 123,492 $ 121,617
Office equipment 54,877 36,080
Furniture and fixtures 28,486 14,285
Lab equipment 1,110,930 938,450
Leasehold improvements 489,147 489,147
Fixed assets, gross 1,806,932 1,599,579
Less: accumulated depreciation (849,824) (572,530)
Total $ 957,108 $ 1,027,049
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
12 Months Ended
Sep. 25, 2018
Sep. 12, 2018
Jul. 11, 2018
Jun. 25, 2018
Apr. 13, 2018
Apr. 12, 2018
Apr. 10, 2018
Mar. 26, 2018
Jan. 03, 2018
Jan. 02, 2018
Dec. 22, 2017
Dec. 20, 2017
Dec. 14, 2017
Nov. 29, 2017
Aug. 25, 2017
Aug. 04, 2017
Jul. 28, 2017
Jun. 21, 2017
May 02, 2017
Mar. 01, 2017
Feb. 23, 2017
Feb. 22, 2017
Feb. 21, 2017
Feb. 07, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Dec. 30, 2017
Preferred stock, shares authorized                                                 10,000,000 10,000,000    
Preferred stock, par value                                                 $ 0.001 $ 0.001    
Preferred stock, shares issued                                                 1,425,942 1,897,942    
Preferred stock, shares outstanding                                                 1,425,942 1,897,942    
Common stock par value                                                 $ 0.001 $ 0.001    
Common stock authorized                                                 90,000,000 90,000,000    
Common stock, shares issued                                                 42,245,364 35,027,118    
Common Stock, shares outstanding                                                 42,245,364 35,027,118    
Number of common stock sold     66.67   14 28 27.78         10 13.89   33.333 100 33.333 33.333         1,428,575          
Number of warrant to purchase of common stock shares                 71,428                                   200,000 300,000
Warrants exercise price per share                 $ 0.26                               $ 0.29 $ 0.26 $ 0.30 $ 0.45
Proceeds from sale of common stock                                                 $ 368,608 $ 560,500    
Share issued in exercise stock option                   37,500                             537,500      
Stock option exercise price per share                   $ 0.22                             $ 0.18      
Common stock shares issued                 34,285 21,000                                    
Common stock issued for services                                                 $ 452,537 $ 246,380    
Consultant One [Member]                                                        
Number of common stock issued for services       131,579                                                
Common stock issued for services       $ 25,000                                                
Consultant Two [Member]                                                        
Number of common stock issued for services       100,000                                                
Common stock issued for services       $ 19,000                                                
Holders [Member]                                                        
Percentage of equity beneficial ownership                                                 100.00%      
President and CEO [Member]                                                        
Number of common stock issued for services 39,344                                                      
Common stock issued for services $ 6,000                                                      
CFO [Member]                                                        
Number of common stock issued for services 98,361     78,947       138,568     300,000                 25,000                
Common stock issued for services $ 15,000     $ 15,000       $ 30,000     $ 78,828                 $ 6,623                
Three Consultants [Member]                                                        
Number of common stock issued for services 150,000                         314,069                            
Common stock issued for services $ 22,875                         $ 82,600                            
Another Consultants [Member]                                                        
Number of common stock issued for services   193,424                                                    
Common stock issued for services   $ 30,000                                                    
Bruce Raben [Member]                                                        
Number of common stock issued for services   200,000                                                    
Common stock issued for services   $ 31,020                                                    
Stock based compensation expense                                                 $ 1,458      
Unamortized expenses                                                 29,562      
Bruce Raben [Member] | September 30, 2019 [Member]                                                        
Unamortized expenses                                                 $ 29,562      
CEO [Member]                                                        
Number of common stock issued for services       118,421       207,852                                        
Common stock issued for services       $ 22,500       $ 45,000                                        
COO [Member]                                                        
Number of common stock issued for services       31,579                                                
Common stock issued for services       $ 6,000                                                
President and COO [Member]                                                        
Number of common stock issued for services               55,427                                        
Common stock issued for services               $ 12,000                                        
Consultant [Member]                                                        
Number of common stock issued for services               69,284                     140,000   100,000 40,000            
Common stock issued for services               $ 15,000                     $ 29,260   $ 29,000 $ 13,600            
Dr. Alfredo Axtmayer [Member]                                                        
Number of common stock issued for services                     100,000                     100,000            
Common stock issued for services                     $ 26,276                     $ 34,000            
Dr. John Abroon [Member]                                                        
Number of common stock issued for services                                     100,000                  
Common stock issued for services                                     $ 20,900                  
Chief Scientist [Member]                                                        
Number of common stock issued for services                                       50,000                
Common stock issued for services                                       $ 13,245                
Six Consultants [Member]                                                        
Number of common stock issued for services                                               370,000        
Common stock issued for services                                               $ 82,251        
Common Stock [Member]                                                        
Number of common stock sold     666,667   140,000 280,000 277,778         100,000 138,889   333,334 1,000,000 333,334 333,334         1,428,575          
Number of warrant to purchase of common stock shares     333,334   70,000 140,000 138,889         50,000 69,445   166,667 500,000 166,667 166,667         714,285          
Warrants exercise price per share     $ 0.30   $ 0.30 $ 0.30 $ 0.30         $ 0.26 $ 0.26   $ 0.26 $ 0.26 $ 0.26 $ 0.26         $ 0.26          
Proceeds from sale of common stock     $ 100,000   $ 25,200 $ 50,400 $ 50,000         $ 18,000 $ 25,000   $ 50,000 $ 150,000 $ 50,000 $ 50,000         $ 250,000          
Number of common stock issued for services                                                 2,326,855 925,000    
Common stock issued for services                                                 $ 2,327 $ 925    
Common Stock Unit [Member]                                                        
Number of common stock sold                         55.56   7                          
Common Stock One [Member]                                                        
Number of common stock sold                         555,600   70,000                          
Number of warrant to purchase of common stock shares                         277,800   35,000                          
Warrants exercise price per share                         $ 0.26   $ 0.30                          
Proceeds from sale of common stock                         $ 100,008   $ 10,500                          
Two Option Holder [Member]                                                        
Share issued in exercise stock option                 500,000 37,500                                    
Stock option exercise price per share                 $ 0.181 $ 0.22                                    
Common stock shares issued                 317,172 21,000                                    
Series A Convertible Preferred Stock [Member]                                                        
Preferred stock, shares designated                                                 6,000,000      
Preferred stock, shares designated remaining                                                 4,000,000      
Series A Preferred Stock [Member]                                                        
Preferred stock, shares issued                                                 1,425,942      
Preferred stock, shares outstanding                                                 1,425,942      
Preferred stock convertible into common stock shares                                                 7,129,710      
Percentage of equity beneficial ownership                                                 4.99%      
Stock conversion, shares converted                                                 472,000 1,622,500    
Stock conversion, shares issued                                                 2,360,000 8,112,500    
Stock conversion price per shares                                                 $ 0.20 $ 0.20    
Stock conversion value                                                 $ 472,000 $ 1,622,500    
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Options (Details Narrative) - USD ($)
12 Months Ended
Sep. 12, 2018
Jan. 03, 2018
Jan. 02, 2018
Dec. 22, 2017
Nov. 29, 2017
Jan. 02, 2017
Jun. 21, 2016
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Number of options outstanding               8,537,500 9,290,000 9,291,530
Options exercise price per share               $ 0.25    
Volatility rate               112.00% 0.00%  
Common stock options exercised     37,500         537,500    
Exercised option price per share     $ 0.22         $ 0.18    
Common stock shares issued   34,285 21,000              
Intrinsic value                  
Intrinsic value, market price per share               $ 0.15    
Intrinsic value weighted-average exercise price per share               $ 0.20    
Common Stock Option One [Member]                    
Options exercisable period               10 years    
Common stock options cancelled or expired               110,000    
Weighted average exercise price per share expired               $ 0.25    
Common Stock Option Two [Member]                    
Options exercisable period               3 years    
Common stock options cancelled or expired               1,110,000    
Weighted average exercise price per share expired               $ 0.44    
Common Stock Options [Member]                    
Options exercisable period           3 years        
Common stock options cancelled or expired           1,530        
Weighted average exercise price per share expired           $ 3.30        
Amortization of Stock Options [Member]                    
Amortization of stock options               $ 439,853 $ 389,736  
Two Option Holder [Member]                    
Common stock options exercised   500,000 37,500              
Exercised option price per share   $ 0.181 $ 0.22              
Common stock shares issued   317,172 21,000              
Ten Employees [Member]                    
Options exercisable period         10 years          
Options exercise price per share         $ 0.27          
Volatility rate         112.00%          
Call option value         $ 0.21          
Fair value of stock options         $ 43,057          
Stock based compensation expense               $ 43,057    
Number of shares granted fully vested common stock option         205,000          
Chief Science Officer [Member]                    
Options exercisable period 10 years                  
Number granted options to purchase shares of common stock 200,000             200,000    
Options vesting term 1 year                  
Options exercise price per share $ 0.16                  
Volatility rate 107.00%                  
Call option value $ 0.1245                  
Fair value of stock options $ 24,905                  
Stock based compensation expense               $ 1,170    
Unamortized expenses expected to be expensed               23,735    
President and Chief Operating Officer [Member]                    
Options exercisable period       10 years            
Options exercise price per share       $ 0.27            
Volatility rate       112.00%            
Call option value       $ 0.2094            
Fair value of stock options       $ 104,698            
Stock based compensation expense               104,698    
Number of shares granted fully vested common stock option       500,000            
Chief Scientist [Member]                    
Options exercisable period         10 years          
Options exercise price per share         $ 0.27          
Volatility rate         112.00%          
Call option value         $ 0.21          
Fair value of stock options         $ 21,004          
Stock based compensation expense               $ 21,004    
Number of shares granted fully vested common stock option         100,000          
2012 Stock Incentive Plan [Member]                    
Number of shares issued under stock plan             11,500,000      
Options exercisable period             10 years      
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Options - Summary of Common Stock Options Outstanding (Details)
12 Months Ended
Sep. 30, 2018
$ / shares
shares
Equity [Abstract]  
Range of Exercise Price, Minimum $ 0.16
Range of Exercise Price, Maximum $ 0.40
Number of Options Outstanding | shares 8,537,500
Weighted Average Remaining Contractual Life 4 years 3 months 8 days
Weighted Average Exercise Price $ 0.20
Number of Shares Exercisable | shares 8,337,500
Weighted Average Exercise Price Exercisable $ 0.21
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Options - Schedule of Option Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Equity [Abstract]    
Average risk-free interest rates 1.36% 0.00%
Average expected life (in years) 5 years 2 months 30 days 0 years
Volatility 112.00% 0.00%
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Options - Summary of Common Stock Options Activity Outstanding (Details) - $ / shares
12 Months Ended
Jan. 02, 2018
Sep. 30, 2018
Sep. 30, 2017
Equity [Abstract]      
Number of Shares Outstanding, Beginning balance   9,290,000 9,291,530
Number of Shares Options expired   (1,220,000) (1,530)
Number of Shares Options issued   1,005,000  
Number of Shares Options exercised (37,500) (537,500)  
Number of Shares Outstanding, Ending balance   8,537,500 9,290,000
Number of Shares Exercisable   8,337,500  
Weighted Average Exercise Price, Outstanding, Beginning   $ 0.23 $ 0.23
Weighted Average Exercise Price, Options expired   (0.42) (3.30)
Weighted Average Exercise Price, Options issued   0.25  
Weighted Average Exercise Price, Options exercised $ (0.22) (0.18)  
Weighted Average Exercise Price, Outstanding, Ending   0.20 $ 0.23
Weighted Average Exercise Price, Exercisable   $ 0.21  
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Warrants (Details Narrative) - $ / shares
Jan. 03, 2018
Jan. 02, 2018
Sep. 30, 2018
Dec. 31, 2017
Dec. 30, 2017
Sep. 30, 2017
Equity [Abstract]            
Number of warrant to purchase of common stock shares 71,428     200,000 300,000  
Warrants exercise price per share $ 0.26   $ 0.29 $ 0.30 $ 0.45 $ 0.26
Number issuance of common stock, shares 34,285 21,000        
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Warrants - Summary of Common Stock Warrants Outstanding (Details)
12 Months Ended
Sep. 30, 2018
$ / shares
shares
Equity [Abstract]  
Range of Exercise Price, Minimum $ 0.1901
Range of Exercise Price, Maximum $ 0.40
Number of Warrants Outstanding | shares 6,450,462
Weighted Average Remaining Contractual Life 1 year 7 months 24 days
Weighted Average Exercise Price $ 0.28
Number of Shares Exercisable | shares 6,450,462
Weighted Average Exercise Price, Exercisable $ 0.28
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Warrants - Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Average risk-free interest rates 1.36% 0.00%
Average expected life (in years) 5 years 2 months 30 days 0 years
Volatility 112.00% 0.00%
Warrants [Member]    
Average risk-free interest rates 1.56% 1.11%
Average expected life (in years) 3 years 3 years 6 months
Volatility 110.00% 145.00%
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Warrants - Summary of Common Stock Warrants Activity Outstanding (Details) - $ / shares
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Equity [Abstract]    
Number of Shares, Balance beginning 5,942,422 4,193,136
Number of Shares, Warrants granted 1,079,468 1,749,286
Number of Shares, Warrants exercised (71,428)  
Number of Shares, Warrants expired (500,000)  
Number of Shares, Balance ending 6,450,462 5,942,422
Number of Shares, Exercisable 6,450,462  
Weighted Average Exercise Price, Balance, beginning $ 0.28 $ 0.29
Weighted Average Exercise Price, Warrants granted 0.29 0.26
Weighted Average Exercise Price, Warrants exercised (0.26)  
Weighted Average Exercise Price, Warrants expired (0.36)  
Weighted Average Exercise Price, Balance, ending 0.28 $ 0.28
Weighted Average Exercise Price, Exercisable $ 0.28  
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]    
Rent expense $ 191,751 $ 210,907
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - Schedule of Future Minimum Rental Payment Under Operating Leases (Details)
Sep. 30, 2018
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2018 $ 48,872
2019 198,904
2020 151,283
2021 50,102
Total $ 449,161
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Income - Schedule of Other Income (Details) - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Other Income and Expenses [Abstract]    
Settlement income on license agreement $ 250,000
Rental income on subleases 76,800 20,568
Restitution income 28,312 11,500
Other income $ 105,112 $ 282,068
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Tax (Details Narrative)
12 Months Ended
Sep. 30, 2018
USD ($)
Income Tax Disclosure [Abstract]  
Net operating loss carry forwards $ 7,982,500
Operating loss expiration year 2031
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Tax - Schedule of Effective Income Tax Rate Reconciliation (Details)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Income Tax Disclosure [Abstract]    
Federal statutory income tax rate 21.00% 35.00%
State income taxes 0.00% 0.00%
Change in valuation allowance (21.00%) (35.00%)
Net effective income tax rate 0.00% 0.00%
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Tax - Schedule of Deferred Tax Asset (Details) - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 1,676,325 $ 2,531,725
Net deferred tax assets before valuation allowance 1,676,325 2,531,725
Less: Valuation allowance (1,676,325) (2,531,725)
Net deferred tax assets
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details Narrative) - USD ($)
12 Months Ended
Dec. 25, 2018
Nov. 25, 2018
Nov. 08, 2018
Oct. 30, 2018
Oct. 25, 2018
Nov. 29, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 21, 2018
Nov. 23, 2018
Jan. 03, 2018
Dec. 31, 2017
Dec. 30, 2017
Value of common stock shares issued for services             $ 452,537 $ 246,380          
Options exercise price per share             $ 0.25            
Volatility rate             112.00% 0.00%          
Number of warrant to purchase of common stock shares                     71,428 200,000 300,000
Warrants exercise price per share             $ 0.29 $ 0.26     $ 0.26 $ 0.30 $ 0.45
Ten Employees [Member]                          
Options exercisable period           10 years              
Options exercise price per share           $ 0.27              
Volatility rate           112.00%              
Call option value           $ 0.21              
Fair value of stock options           $ 43,057              
Subsequent Event [Member]                          
Number of warrant to purchase of common stock shares                 166,667 100,000      
Warrants exercise price per share                 $ 0.30 $ 0.40      
Subsequent Event [Member] | Ten Employees [Member]                          
Number granted options to purchase shares of common stock 235,000                        
Options vesting term 12 months                        
Options exercisable period 10 years                        
Options exercise price per share $ 0.13                        
Volatility rate 107.00%                        
Call option value $ 0.1017                        
Fair value of stock options $ 35,078                        
Subsequent Event [Member] | President and CEO [Member]                          
Number of common stock shares issued for services 46,261                        
Value of common stock shares issued for services $ 6,000                        
Subsequent Event [Member] | Chief Financial Officer [Member]                          
Number of common stock shares issued for services 115,652                        
Value of common stock shares issued for services $ 15,000                        
Subsequent Event [Member] | Three Consultants [Member]                          
Number of common stock shares issued for services 150,000 150,000     150,000                
Value of common stock shares issued for services $ 19,455 $ 19,260     $ 23,250                
Subsequent Event [Member] | Consultant [Member]                          
Number of common stock shares issued for services       400,000                  
Value of common stock shares issued for services       $ 54,120                  
Subsequent Event [Member] | 8% Senior Secured Convertible Notes [Member] | Two Institutional Investors Member                          
Debt sold principal amount     $ 500,000                    
Notes maturity date     Dec. 31, 2020                    
Notes bear interest rate     8.00%                    
Notes conversion price per share     $ 0.14                    
EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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˹'$E\K"L-.(-@YZT=?*@HS42 F6A1[ M$(!B4GF&5V V"9=-Q"([D'OD:OHF\@R4P)@0"!.^$SS&A+@"$RL!,,%<]GW[ M7#=."6-"7(&)E0"8B$0R1(I<2@F)2GDB8$H0HH>V-3=JZ-M4=2F<JH;G-[OS_P!02P,$% @ 6HN; M3:H%2RG; 0 8@0 !D !X;"]W;W)K&UL?53; M;MLP#/T5P1]0^9:T"&P#38IB S8@Z+#U6;'I"ZJ+)REQ]_?3K:Z7&,M#)%+G M')(2Z6(2\DWU !J],\I5&?5:CSN,5=T#(^I.C,#-22LD(]J8LL-JE$ :1V(4 MIW&\Q8P,/*H*YSO*JA!G30<.1XG4F3$B_^R!BJF,DNC#\3)TO;8.7!4CZ> ' MZ)_C41H+SRK-P("K07 DH2VCQV1WR"W> 7X-,*G%'ME*3D*\6>-K4T:Q30@H MU-HJ$+-XVL<_,E?I$-*D**28D_6.-Q/9$LLO,9=;6Z>[.G9EJ ME?%>JBS)"GRQ0@&S]YAT@4EF!#;J-G MRP3SS;I OBJ0.X%\(?!P?0FWD$U\58:';!V$!XCY726"%T_#0':NBQ6JQ9EK M>PD+[SPHCZE]VBO_W@R0[_=/&3]]WXGL!J[026C3..YY6R$TF"3C.]/2O1GX MV:#0:KN]-WOIV]X;6HQAHO'\6:G^ E!+ P04 " !:BYM-"*$!?VL" !* M"@ &0 'AL+W=O,ED2\L)I6ZLF)\9)(->1G)&I.R=$$E07R/2]")JS'/.25B)GEU^PJ];'.D 0_S.:2/N[AU=RIZQ=SWX=ER[GC:B!3U( MG8*HRY5N:5'H3,KC;Y?4[=^I ^_O;]F_F.)5,7LBZ)85?_*CS-;NTG6.]$0N MA7QCS5?:%12Z3E?]=WJEA<*UB7K'@17"_#J'BY"L[+(HE9)\M->\,M>FRW\+ M@P/\+L#O _!B,B#H H)1 &K-3*F?B21IPEGC\/;?JHG>%/@U4(MYT)-F["FAN=T-0"R52:9H0K&PO=V]R:W-H965T0/J &[ M)(L :4U5;=(F19W6/3MP":@V9K83NK^?;0AB@/82^UZ?^= M5)[*J^%-"R<5Z*L03/UY B[[#$7HWGAM+K5Q#9RG';O #S _NY.R%9Y4RD9 MJQO9!@JJ#'V.#D?J\![PUD"O9_/ )3E+^>Z*KV6&0F<(.!3&*3 [W. (G#LA M:^/WJ(FF+1UQ/K^KO_CL-LN9:3A*_JLI39VA/0I*J-B5FU?9?X$QSR,*QO#? MX ;*=M$^*1$$^$B/Z70$8" M61#PX,Q'?6:&Y:F2?:"&P^J8NQ/1@=B/6;BF_W9^S:;5MGO+21RF^.:$1LS3 M@(EGF/A?Q'&-(+L)@JV!R46\Z2+V?#+C1W2_+4 V!8@7H#,!NDPQ0!(/:8<] MDMV.T$64-2Q.DB0BVV[HIANZS%\<=;26G *H8/]DK7]L%/!8?*N.G.SM5P[8?"R&Y\T7CZ6\G_ M E!+ P04 " !:BYM-^&=7&%T" "-!P &0 'AL+W=OUNFS 4?17$ ]38?"4106H239NT256G=;\=X@14@YGM MA.[M9QN7$G"B3I&"?3GGGG,OX)MUC+^*DA#IO=6T$6N_E+)= 2"*DM18/+"6 M-.K.D?$:2[7E)R!:3O#!D&H*4! DH,95X^>9B3WQ/&-G2:N&/'%/G.L:\[\; M0EFW]J'_'GBN3J74 9!G+3Z1GT3^:I^XVH$ARZ&J22,JUGB<'-?^(USMH"$8 MQ$M%.C%:>[J4/6.O>O/ML/8#[8A04DB= JO+A6P)I3J3\O'')O4'34TK_TXNA"JX=J(T"D:% M^?>*LY"LMEF4E1J_]=>J,=>NOQ/'EN8F($M P$F=PFA)80?A.@N(;*$:$( M?2FF-SLL<9YQUGF\?[PMUF\17$6J^X4.FF:;>ZH]0D4O>8A0!BXZD<5L>@P: M8>" "K[((%<$ALTHT\$MG-$F%Y#=@X("MTN0F>AH4D0726()B(])C&8IL? M43>N5"*G2N10B2?MG&/B8-*0NY K&['31CSC0SBU$<^*16F*EI.>;!VP.%0_ MMYW$:2>9V4'IC02I,T'J:&LR>7@])AX9C19ING3++)PR"X?,]$5<_(_,TBFS M=+3CQN.%@?NK#3[1$ L:6X5! &]8A3?.!_B)GEC0^"5)%LMT(@1&9U)-^,F< M]\(KV+F1^M,>18>9\HCTF3:);^!JVT^&CS3]H/J!^:EJA+=G4IV8YEP[,B:) M,AD\J$:4:C8.&TJ.4B]3M>;]@.@WDK5V^(%A N?_ %!+ P04 " !:BYM- M4#N]=FT" #%!P &0 'AL+W=O<\Y MSWL<[-55Z1=SDM(FKTW=FG5ZLK:[SS*S.\E&F#O5R=:].2C=".NF^IB93DNQ M[X.:.D, Y%DCJC;=K/JU![U9J;.MJU8^Z,2G;PF-U/%F_ MD&U6G3C*'](^=0_:S;(IR[YJ9&LJU29:'M;I1WA?0N #>L7/2E[-;)QX*\]* MO?C)U_TZ!9Y(UG)G?0KA'A=9RKKVF1S'[S%I.M7T@?/Q6_;/O7EGYED86:KZ M5[6WIW7*TF0O#^)O?.;?&K5XV&+%5=O&)1LUVT*"9!KU7E$L%+B9)Y@ F"A2E M0'T\GL5#"N,)<#0![A.0=S9X8&/0Y+VF'8H@3'CH)2:#.;SAAT1QR!('@P!G MT-!9'4I8400T2Q7. 0-Q&!J%H1$8&,#011G$",L#F*4*$L1H'":/PN01F& ' MMOFR#(2 AQTLESJ.&:$WFE-$>8H(#PYXBD4=PC@DX5;]5_8.AT5Q6 2'!#AL MV1X&TX'$@'@7B$2 : /%%H0^,<(8"\#*BHP6B^,:&N=LA>F*! M!1(/6S1JYA^Q,PX!"\^MI0X"5 2]BB;G:?^@OLN]+%J3?*LK#N:^P/TH)25 M+BFX&ULE5QK M5QK+$OTK+GZ 3+^[L]2UB(]H8CP^8F+X1N(870?$"R2>\^_O#,QXF:I=T)3T:)Z._O5G[_,RM']LM%DW-=%X?N3T=-S[V!O^=GE[&!O^GLQ?GHN M+V<[\]^3R6CV[_MR/'W=[ZE>^\'UTZ_'1?U!_V#O9?2KO"D7MR^7L^I=_ZV7 M^Z=)^3Q_FC[OS,J'_=Y O1LF]&ZX?KO;>\GRZ>OGN;':%X>3L?? MGNX7C_N]V-NY+Q]&O\>+Z^GK:=D\D>OM-(]_7OXIQQ6\]J2R\7,ZGB__W?GY M>[Z83II>*EES]?5W]QIFF&&^BF@7YKH.S&!J9I8'(;V*:!S6W@ MF@8NMX%O&OC4JFW/5DJZR65SKEGV=S;YNV=?9[.N6?9W-OF[9U]GLZY9]G!HM!@=[,VFKSNS54)[&=5Y4[VK6E6=UY\NT\ORCU5"F%>?_CDP MQN_U_]0]-9CW*XQ>P^AHNYA#A'%=S!''&!.ZF&/4#_'G!/43NY@/").ZF%. ML447J' FESQVR0.7"!U#GT?:-EC'G8#="< =\N3# MP!X\"1,[ ]EQ*F*G(G/*TWD=F26KM77&6^H31U8"JH-2$?N4L$\)#!31O6'* M=HHC-SM5KUU@)5, MXBUHP94_W@SY_VN)P)VTN"ZH4!+#([1A)M39$^'W<#2 M.K!'IM0%ZDN979J6+EN<6A]2LVL,X>@*&B56KW-[N\D%WL&QK:K%X 3"I=)5 M <))POO8@-:-A=H:2YX/OJ",C@ 0.<+)Q(CI&X%5 MAT^*YV03')TL0P!S75S7)2%U*Y2[(W7)(7II_H(H46F%O*U0XDYT[GH^1):M M"3\!F%9R- FI6_'@" VGH3)9^$S*UXZC9!ZD/(M(JG M6IW(+#M6/(,JHUQ(V)86\J?F^9..X7&#Z0R-$]G2@G!K(-Q!J-6TM KA^LE' M1DNK"\&6H%.:ZQ0?&:X^*LF6!/'10'R"4%1K02TT4(M RS,(LH(A008TD $I MAVLA<#4/7$;C>\UK:9/6MS2ZIH1XU#P>*8OO&\PZBUXF40A:#>KC(*RQC1", MA@"'E&$'N#)<[3J[E*4?'X*A''!:U%V>;H)T&R:)0'1E!%@V7 M13;0AX:7/:J2-"UHFA'DTVRO>PX-+V>,G .-H)X&5#.%Y*T@C":CFCDTO)K1 M&W*V%034;J]F#BVO9HPJM&1)4"C+%4HGNB%J@?98)\PL*\B !3)0T-6@Y36/ M3LX+1805U,*"#56IH+32)B@H9KB[(+PWN"O$K05Q*]7K5HA;FQ&WQQ;$K8I6 MDYQ[!G"Z"-%)SR7$M]T>W\<6+% 9B5T[$59, "&8C2WK@@ S9G46/! MMJ"\IG&""KB,-8WC*B#7?$X0 0>6-%':H!?"VV4L:$M]N^ MHCES8$6CY8$11, !$8A"^>.DHPL>W6!@^)F$3^R<^@N 584+JW"^(ARH5 MATV"<\=/.#!K6W%=GP0E2YY= "_-)C. !9)M"0HG@<%310V*[R@99YK&1N9 M6P_V?#<,C"!YGDL>'9C;!M.-32UMPGOI$!;LXD1AM\(+\>TS=G&^>["+$S:, MC* #?OLVSG?/MW%B51,)=8H7HMN#Z!:<#4(\AIPSR< W2GS]HF>2 (=2UP> MTY'C3A$N5"]Z-HGL E&]0#@3(SN?!#A3O\BX7(EVZ1%E9HH2+Z2UD'&X>Q0R#EI/A MG-MU3(9XV2FY(U2< >UY"5NW0:@E [HSQQZ)[WDYYSP/-H[;4$A'H3:-J#8E ML_0BPAHQ,I< SLAS.0H%4T0%$\T^#6A+]H$H8=\I"FD\\C3.1/XB\N7I4N0C M=0CAQ*M 4<@[$2UCA4W1*.A8S+CA]#$*RUA"_"> VW##*0HB%C-N.'UL0-U+ MOBK2;UK$+1>AN@X),A9SKCA%<,5)!14T]>C_NN,4!56,7!5%YJ7+Q$#)6 :+ M?&_,;[RX+$A>!)*7Z/7N".X);S*6!#%+0,R2P'D2U"- M"=J2T!*!4I' _:6-Q@352$ U$KNQS<_T@](I*(D*05X2NL/$C %0$C8JDR : M"8A&HM='$]B?#YKIV& @,IW#]*Z7@G*D8!R)'KJF8 B&(^^1@"04:D-;@GJ MD4!-Q4ZI&Q"13N;29E37'4&)$E(B^L6&Q+?Q!.XX$'/77_M>9/U=_L^CV:^G MY_G.C^EB,9TLOP?Y,)TNRJK78K<:\\=R=/_V9EP^+.I?ZS)YMOH*_>K-8OJR MO_K_ ?IO_TG!P7\!4$L#!!0 ( %J+FTU^M(K#H@4 &,@ 9 >&PO M=V]R:W-H965T2W;,:&6D!$DLWF[2.),4$]?8C^F-OIZ99FSJ<>R9-C4?ZHUL[5HY^[ M[;ZZ':_K^O EBJJ7M=OEU4UQBW.5U\[%\BZI#Z?)5%[3;1C*.;;3+ M-_OQ=-)]]U1.)\5[O=WLW5,YJMYWN[S\9^:VQ?%V+,:?7WS?O*WK]HMH.CGD M;^YW5_]Q>"J;3]%YE-5FY_;5IMB/2O=Z._Y%?'FTI@WH%']NW+&Z>#]J#^6Y M*'ZT'Y:KVW'<5N2V[J5NA\B;EP\W=]MM.U)3Q]]^T/$Y9QMX^?YS]$5W\,W! M/.>5FQ?;OS:K>GT[3L>CE7O-W[?U]^+XX/P!F?'('_VO[L-M&WE;29/CI=A6 MW=_1RWM5%SL_2E/*+O]Y>MWLN]?CZ1>3^C ^0/H >0X0^FJ \@%J:(#V 7IH M@/$!9FB ]0%V:$#B Y*A :D/2(<&9#X@&QH@XL^9BP>'G"=;D)#HM$JZ97>7 MU_ET4A;'47ERSB%O#2J^-%'-X.VWW4+N?FR67M5\^S%563:)/MJ1O&9VTL@+ MC4Q-7S,/-4J+ON:.T\B^YI[+E?8U"VX<4L_74*/CN*]YX#2DYB533U_QC:DF MZ4L>N43_#1,U,W2>)LE/D^Q&T+T1%"GUI#&=9M]I4J,20P_[6ZC+9!;'5/?( MZH11,5^YXBM73.6:5'[2I!>9XAMI^#2:3Z.9-&1-+$.-S.AL\S+@S"Y9_>XU@.1Z' MB01=4%Y$)AHD0A<,P2028 Q ,\'@3-#UQHJ %06 CV#H(RA]O.AR,0D1P]4D M ($$@R!!$>1%PU G &$$@QAAP1@ "X+A0C@%H4@F:+T SXO0],P4A'X65^< M6%HPG@[G(&7F0&N0"?A:,,86"3^&!)Z5G&?)''QE1' .)/"LY#RK:2(1S@&\ MV$O4IW"FI;V9%UU.@+H!SI; V9)S-K@:2>!8R3F6PMF+[$6Q6F5-9T6[JE"G MTBQ1P)<2>%N&WFZ& 6, ;TONFD]:D+D7];J+..P"[QC=E29$ @I(A@*T#9E[ M44):#+J-\#+8KO0+ J20(2G"7L2+>L")#3I[@")$Q@9Z M10&>*&8K$0/\*X Q34+I-X9*T)> <96G+$5390Q)R;D\?+_=?WM,@"%9A@@ MB7]GK CMRP$H] !0S#0'"M32:@ */0 4,T:DT/9% U#H :"8>5'6/R2IT>E# M]S4&H&*F0U1(G<4H%4"%'H(*':)"B 0M/D *S9'"TDP,*52BT$$!4&BF\4!7 M( U H0> XIX5 5!H K-W2W0-!%WNP =D@'V-XRSJ5?N&1&\J!I@?Q/:/_#* MO1?UO2+C#.S)# " 80! O7+O1;T%'&N;@8N' 0PP(0-"LQCFSL*U7( !AF, M77]>=*6?[^="=R^Y_0?PG 'V-@/N+2Q8$;K3"LQMN%T%;4(-NUU ?@$(,-S- M0MJ$,B+L%X $R(@;$(-BP!P%;, 9:[N--,7M2[LC0[&V!,"R!@0PB$9O&B MH:D RS' +KV;/AH0USQB@4,L,P]" F\;8&W+>=ML@]]L*&WA;CF;@O<;;D[ MAY)FXT34F='%$\;V\?MO>?FVV5>CYZ*NBUWW1/&U*&K7#!C?- .N7;XZ?]BZ MU[I]FS3OR]-C[].'NCCX1_K1^?\*IO\"4$L#!!0 ( %J+FTW5H*CW'P( M $ & 9 >&PO=V]R:W-H965T2&JDT!/+H@S$@7!FG#: MM'Y9.-M!EH6X:M:T<)">NG).Y9\],-'O_-!_,SPWEUI; RF+CE[@.^@?W4&: M$YE43@V'5C6B]22<=_Y#N-V'@0UP'C\;Z-5L[]E2CD*\V,.7T\X/;$; H-)6 M@IKE!H_ F%4R>?P>1?V):0/G^S?U3ZYX4\R1*G@4[%=STO7.SWWO!&=Z9?I9 M])]A+"CUO;'ZKW #9MQM)H91":;1Z4UEC:X5[LXDKXSU5B9Q4)"; M%1I]]H-/-/,))P]BU"=$A"'VT;OP)+XC$*,YQDX@GO/3!!=(4('$"23_91 M MBAQ\F5=Y1:#-& MW&,_"Z'!)!.L3,FU&>?3@<%9VVUF]G*8:<-!BVZ&BM3&U3=C^?6U#*$NL MOF![..?,F<%,-G'Q*EL Y;TQVLO<;Y4:#@C)L@5&Y ,?H-=O:BX84?HH&B0' M :2R)$81#H(4,=+U?I'9V%D4&1\5[7HX"T^.C!'QYPB43[D?^K? 2]>TR@10 MD0VD@>^@?@QGH4]H5:DZ!KWL>.\)J'/_.3R<4H.W@)\=3'*S]TPE%\Y?S>%+ ME?N!,0042F44B%ZN< )*C9"V\7O1]->4AKC=W]0_V=IU+1Y_ M\+T*:C)2]<*GS[#4D_C>4OQ7N +5<.-$YR@YE?;IE:-4G"TJV@HC;_/:]7:= M%OT;S4W "P&O!)S\EQ MA&@EA+$M?G9F2_U(%"DRP2=/S!]K(.9.A(=(-[,T M0=L[^TY7*W7T6L1QD*&K$5HPQQF#-YAP12"MOJ; KA1'?$?'[Q.<[A'1HSM# MY"PBLOQH:S")W0*Q4R"V O&[+H2[+K@P^T+N,?@I&ULE99OKYHP%,:_"N']A)96T*C)KF39 MDBTQ=]GVNFI5O55FK M97C2NIE'D=J=>,741#2\-K\J8O+7$R_%=1FB\#;Q7!Q/VDY$JT7#COPKU]^:C32CZ)YE M7U2\5H6H \D/R_ ]FN>(V "G^%[PJ^K=![:4K1 O=O!IOPQC2\1+OM,V!3.7 M"U_SLK29#,?/+FEX][2!_?M;]@^N>%/,EBF^%N6/8J]/RS +@ST_L'.IG\7U M(^\*HF'05?^97WAIY);$>.Q$J=QWL#LK+:HNBT&IV&M[+6IWO7;Y;V%P .X" M\#V@79R' 4D7D/QK .D"B!<0M:6XM929O:P(21?1Q2;J-$^M!O?X.G(Z., D#Y6.?OH %0!@)E %#B 65CH.0/E<] HQE@1#RC5I/U MC.()]FCROX@&*"B&6U$,P%"_S[0B>WE[XO'$[T-$<$$$U](C1V M,K73!TYPV2^NVR$_FU^\\B^9_- M ?=*!#1+ZC?+3N09(<\HZKT;[>GF"Y/'HE;!5FCSFG4OPX,0FIN,\<3\OT[F M0'4?E/R@[6UJ[F5[JF@'6C3=B2FZ']M6OP%02P,$% @ 6HN;3?(> 1,P M @ U@8 !D !X;"]W;W)K&ULC95MKYL@&(;_ MBO$'%%] NQ/;9&UWNB5;TIQEVV?:TFH.B@-:S_[] #E&D6SMA\K+==\\SP-H MT3'^*DI"9/!6TT:LPE+*]@D <2I)C<6"M:11,Q?&:RQ5EU^!:#G!9R.J*4BB M* ,UKIIP79BQ U\7["9IU9 ##\2MKC'_LR&4=:LP#M\'7JIK*?4 6!75?@Q?MHCS1O@9T4Z,6H'.I,C8Z^Z\^6\"B,= M$*'D)+4#5H\[V1)*M9$*X[?U#(68[6 MB1:) ^V\T &ULE97;CILP$(9?!?$ ,>= 1) V6U6MU$K1 M5FVO'3():&U,;2=LW[X^L)001VIOXM,__S=CY$DY,/XJ&@#IO5'2B:W?2-EO M$!)U Q2+%>NA4ROT93 M?V+JP/G\W?VC*5X5<\ "GAGYV1YEL_5SWSO""5^(?&'#)Q@+2GUOK/X+7($H MN$@"S*9?\ 2 M5R5G@\?MY?=8?^-P$ZF[J?6FN0ISII(7:O=:)5E4HJLV&C4[JXEFFG!2(.4^ M(2(78A?=A2?Q X/8F6-L#.(Y/TWDBTA5I/.(%F2!O,O>P-:.T%K1S7I N309 ^J MR9V0W %9+R"YX\JBW$TIG)3"0[4X=\BDP/^"NW[?4KYN>V$]Z!2=5)S'L_,29!)1.L5,F- MZNC3@L!)ZNE:S;EM:W8A63^V;#3];U1_ %!+ P04 " !:BYM-CZFY4RX" M /!P &0 'AL+W=OV.FS 0?!7$ M QS!?(6((%U25:W42M%5O?YVR":@,YC:3KB^?6U#*(5ME3_87F9G9VQ89QT7 M;[($4,Y[S1JY=4NEVHWGR:*$FLHGWD*CWYRYJ*G22W'Q9"N GFQ2S3RR6L5> M3:O&S3,;.X@\XU?%J@8.PI'7NJ;BUPX8[[:N[]X#+]6E5";@Y5E++_ -U/?V M(/3*&UE.50V-K'CC"#AOW6=_LT\-W@)>*^CD9.X8)T?.W\SB\VGKKHP@8% H MPT#U<(,],&:(M(R? Z<[EC2)T_F=_:/UKKT M>/<)!C^1ZPSFO\ -F(8;);I&P9FT3Z>X2L7K@45+J>E[/U:-';N!_YZ&)Y A M@8P))/IO0C D!&."GUCSO3)K]0-5-,\$[QS1'U9+S3?A;P*]F84)VKVS[[1; MJ:.W/(RCS+L9H@&SZS%D@O%'A*?9QQ($*[$CBW3R=X']$A$D>(4 -1'8_'!J M(O1G)C#,7,<20]( %Q*B0D*D2# 3@F'"F1 ,$^%"(E1(A!#$,R%+#$GG.X)A M_K$C,2HD7@J)8YP@00F2!\X6P<3)S F&6>-"UJB0]0-GN\209+ZE"$^:/G43'KOY,3!^:Q7>ZV_?- M^0]-?U5\I>)2-=(Y&ULC59M;]L@$/XKEK^W-AB_54FD)M.T29M4=>KV MF20DL6H;#TC2_?L!=ET'+MGR(8;S<_<\!_BXV9F+5WE@3 5O3=W*>7A0JGN( M(KDYL(;*>]ZQ5K_9<=%0I:=B'\E.,+JU3DT=X3C.HH96;;B86=N36,SX4=55 MRYY$((]-0\6?):OY>1ZB\-WP7.T/RABBQ:RC>_:#J9?N2>A9-$;95@UK9<7; M0+#=/'Q$#RN4&@>+^%FQLYR, Y/*FO-7,_FZG8>Q4<1JME$F!-6/$UNQNC:1 MM([?0]!PY#2.T_%[],\V>9W,FDJVXO6O:JL.\[ (@RW;T6.MGOGY"QL22L-@ MR/X;.[%:PXT2S;'AM;3_P>8H%6^&*%I*0]_Z9]7:YWF(_^X&.^#! 8\.*+OI MD P.R8<#L'*?)XW-#R8J0*("(,H= MHL(CRD@:D\S==M.;A^.2SUPB4- C4N]4YC^#U$T MN>T:)O:V,9#!AA];9>Z5B75L/AZQN2T=^](T)?86_0C3=S3?J=A7K0S67.F[ MV-Z8.\X5TR+C>RWRH)NH<5*SG3+#7(]%WTGT$\6[H4N*QE9M\1=02P,$% M @ 6HN;3=?DKV7@ 0 : 0 !D !X;"]W;W)K&UL?519;MLP$+V*P .$VBPGABP@=E&T0 L8*=I^T])H0;BH)&6EMR\765%L MH3\B.7SOS<(9Y:.0KZH%T,$;HUSM4:MUO\-8E2TPHAY$#]SP JQCV*T-7PTC6MM@9< MY#UIX ?HG_U)FA.>5:J. 5>=X(&$>H^>H]TQM7@'^-7!J!;[P&9R%N+5'KY6 M>Q3:@(!"J:T",S2$I?[J_IGE[O)Y4P4' 7]W56ZW:-' M%%10DX'J%S%^@2F?#0JFY+_!!:B!VTB,CU)0Y;Y!.2@MV*1B0F'DS:\==^OH M;[(K;9T03X1X)D39?PG)1$C>":Z:V$?F4OU$-"ER*<9 ^L?JB>V):)>88I;6 MZ&KG[DRVRE@O1?J8YOABA2;,P6/B!2::$=BHSR[B-1>'^(X>?W1PO$,GRP"S>%T@715(G4#ZH0J;FRIX3.8PW#MYBK:;Z":7>U@^^?U!BWZ::SS_7(I_4$L#!!0 ( %J+ MFTWLW2&OZ@$ /X$ 9 >&PO=V]R:W-H965T+W(;.XDBYU?%VAY.PI/7KJ/B[Q$8'P\^]N^!E_;2*!- 13[0 M"_P$]6LX";U"BTO5=M#+EO>>@/K@?\+[8V+T5O#:PBA7<\]T^V4LW!3WVO M@II>F7KAXU>8^XE\;V[^.]R :;FI1#-*SJ1]>N55*M[-+KJ4CKY/8]O;<9S] M[VGN!#(GD"6!3+U,(%OY9ZIHD0L^>F+:^X&:(\9[HO>F-$&[%?:=+E[JZ*T( MTSA'-V,T:XZ3AORG218-TOX+A#@AQ!KL5@8X)FZ#G=-@9PTB:]!; Q+@=%/F M)(I7HC!-DP\XH9,3NCC9AO,HPEF:!:$;%#E!D0-$@@WH480C3-*=&Q0[0;$+ MA#>@1U$4X."#G4N&UL?57;CILP$/T5Q &\$]W_FM$,,V"'C3 D'\@0[0RYTS900)N627 M@ \,T$D[$1S$89@%!'6]7Y7:=F!52:\"=STOA"#VIP9,QYT?^7?#T]!N>=_Q1M][G":\!+!R-?S#V5R9'2 M5[7X>MKYH1($&!JA&) <;K 'C!61E/%[XO3GD,IQ.;^S?]:YRUR.B,.>XE_= M2;0[O_"]$YS1%8MG.GZ!*9_4]Z;DO\$-L(0K)3)&0S'7;Z^Y'.+9(9#%1Y75; Q:;C*PT R#>E-IFDH'[>4 MU"DEM:4\KN+4!I,NXN19$:[5V*@X3+/"+29SBLD<8J*5F,P.4R31^HAM5!2E M_ZI,[A236V**590ZMPX@"M/($F/#XB(.K=($BTM$@%UTO^%>0Z^]4)_KPCJW MM*=87<*5O9:MSG2F=QK3)[\C=NEZ[AVID%=<7\0SI0*DRO!!5JN5K7E>8#@+ M-8?0/474$L#!!0 ( %J+FTW6+QJ3U $ #X$ 9 M >&PO=V]R:W-H965T,SY\R,/>235*^Z S#HC3.A MBZ@S9CAAK*L..-4/<@!A3QJI.#765"W6@P):^R#.,(GC/>:T%U&9>]]%E;D< M#>L%7!32(^=4_3X#DU,1[:)WQTO?=L8Y<)D/M(5O8+X/%V4MO+#4/0>A>RF0 M@J:(GG:G<^;P'O"CATFO]LA5K((S<5_@1LP M"W>96(U*,NV_J!JUD7QFL:EP^A;67OAU"B=).H=M!Y Y@"P!)-02A'SF'ZBA M9:[DA%3H_4#=%>].Q/:FRO31Y+CFR.:,>> (2O,;D%@R[Y( MD"V),_DO/#T>M@F2S1P33Y"L]??';8)TDR#U!.D_129W10;,WF.$QQP>CR2+ MXVVA;%,HVQ!*[X0")EL)D3BY;RA>W1\'U?J7JU$E1^&G9N5=AN.)^/O_"P^3 M]96JMA<:7:6QK\C?=2.E 9M+_Z.PP+P:#QKCMP>Y5>-+!,'*8IQ4OOXSR M#U!+ P04 " !:BYM-8HW1<@X" #]!0 &0 'AL+W=O '[7T(O9 MW-&5'!E[U8MOI]SUM"$@4$JM@-5PA3T0HH64C;=1TYU2:N)\_J'^;&I7M1RQ M@#TC?^J3K'+WT75.<,8=D2^L_PIC/;'KC,5_ARL0!==.5(Z2$6&^3MD)R>BH MHJQ0_#Z,=6/&?MA)DY%F)P0C(9@(_GU".!+"3T)DBA^X<-E MM5C_$_XV5(=9ZJ Y.[.GJA4J>BVB39RAJQ8:,;L!$\PP_H1 2GU*$=A2[((5 M/;A-L%\CPM2>(;06$1I^.#>8/-H%(JM 9 2BFU-(%J=@PZ2+0FR8_QB)K49B MB\!F862-"3;APLA]S(V1Q&HD60G$GKS44^,4T&.&4K&ND_C]GT:F'/07ZU2WB.]7;AE;T*3,TQA^87^I& M.$.-"PD:\=FBZ:.7_P#4$L# M!!0 ( %J+FTU"UH@J\0$ (,% 9 >&PO=V]R:W-H965T? M;5Q$P8E_[G./?)>!\9/Q%- #2>^UH+_:HD7+882S*!CHB'M@ O=JI&>^( M5"6_8#%P()4Q=12'OI_BCK0]*G*S=N)%SJZ2MCVN74?XWP-0-NY1@-X6 MGMI+(_4"+O*!7. GR.?AQ%6%YY2J[: 7+>L]#O4>?0IVQU3KC>!7"Z-8S#W= MR9FQ%UU\J_;(UT! H90Z@:CA!D>@5 CD3 4=& M?[>5;/;H$7D5U.1*Y1,;OX+M)T&>;?X[W( JN2919Y2,"O/KE5Q[**)LE6 ',%*&3(C3^ M:.$/TD=W0.0,B$Q O B(/T:K-B9-:C2]/21+HS!9-;/5A4D49 O=.Z#8"11O M@!)_==!ATB3_!=KJ[@(E3J#$ 92N@)+-01_<1 [A7:34B90ZD+(5DDNS@KDK MF3#PXG/0U],/PB]M+[PSD^K+,N]_S9@$%><_J+8:=2/.!85:ZFFFYGRZ%Z9" MLL%>>7B^=XM_4$L#!!0 ( %J+FTT6Z&*GCP0 +L7 9 >&PO=V]R M:W-H965T7Z9G^S\!X5U:_ZI4QS>AWD6_J2;!J MFNUE&-9O*U-D]46Y-1O[GV59%5EC+ZOWL-Y6)EMT1D4>\BC289&M-\%TW-U[ MJ:;C\J/)UQOS4HWJCZ+(JO]F)B]WDX %AQO?U^^KIKT13L?;[-W\;9I_MB^5 MO0J/7A;KPFSJ=;D9568Y"?YBE\\R:@TZXL?:[.J3WZ-V**]E^:N]N%],@JC- MR.3FK6E=9/;KT\Q-GK>>;![_.J?!,69K>/K[X/VF&[P=S&M6FWF9_UPOFM4D M2(+1PBRSC[SY7N[NC!N0"D9N](_FT^06;S.Q,=[*O.[^CMX^ZJ8LG!>;2I'] MWG^O-]WWSOD_F.$&W!GPHP&39PV$,Q!##:0SD'\,]%D#Y0S4T C:&>BA!K$S MB(<:),X@&6J0.H-TJ &+#C,7#38Y3C8;;'*8;C9XOMEAPMG@&6>'*6?2,PGW MR[?KAZNLR:;CJMR-JGU+;[-6.=BE1:WS]F[78=T_;4_4]N[G5$7)./QL/3EF MMF?X"2/ZQ!P2*DK[S!7"L*C/7&,,ZS,W&,/[S"V2L51]Y@XRGI=[Q$O<1[YA MR7C%>< 8V6<>L82]@3\AC/(&]8PQ^LB$=BT<%P3'%P3O/,A>MG[I]HSNF$W' M2,657YQ[B'&I11+A^0@\'P'RD9%7O;L]DYP$BBZXPL-(/(Q$POC#A@Q/_36# M,0+/1.&9*.!!:"^3QSVC3@8<,\F]OGV"E#T$V(^W9B F^E@O:XUGK9&LM5<_ MC4V3)Q/W*.1Y>AP"/6&0UYO/&".)E1/C(X_ARN%$[1+<0P(] $7#&&)=I7B4 M].M&NDVQNL9XF'8;17>4Z.M6ND6@TU[J!Z*V+@;77,3\0 P;$B,B$9K(H"A* M#B(AJB@B156/D#L&]4XQ0L$9H64,BA"0D&\..FU[INW'$_$'C#LC#XQ0-8;) MFO9S4E^W[ ,*22(;0JT8E"O%J)DB^IYAC>\E.W-03X.%HJM'* 1#VI]+/Q:$ M%$N(0(1(,$0E?"V:H1 A1IQ0"8ZIA#\B!_6GFHQ$R 2',@'T:(9 @A$JP:F3 M$U0)H$Q9I# )E&"F MM"+V2T[T-H=MBU0F!95AM%X)HKL%[&Y%;;J"Z%L!6Q*6QD'*3]<[X\X'&%@J_4>Z.8IQ#3)'GK8$5U3BU-,6>98(0AA$5!80*&O'71:&F5W-2H4(2P"$19.[$6"D R!28:WZUTY MJ)?NN=(0TB*0XP!7?BP,(HZ;@M 5@>@*C_U &$3L1))0%8FIBO^:2:)G!O]\ M&)Z\(&M?:S]EU?MZ4X]>RZ8IB^Z%V+(L&V,]1A=V^:Q,MCA>Y&;9M#]C^[O: MOT[>7S3EUKTJ#X_OZZ?_ U!+ P04 " !:BYM-M%]UZWU7 !"F0$ % M 'AL+W-H87)E9%-T&UL[7UI<]M6ENCGP:] ];AGI"J(X2J23D]7 MR5O&_>*E+">IJ:[W 20A"@D$,%@L<^K]^'>VNP"X("%9MI,9UTQ7+ *XR[GG MGGWY6U&4_L>;)"W^XR_79;E[_-UWQ?HZN@F+0;:+4GARE>4W80E_YMOOBET> MA9OB.HK*F^2[\7!X_MU-&*=_\:LT_KV*GF956O['7V:3X5_^_KG?[MN_+O?_L./^(/1V/_ M59:6UP5\M8DVS<>7T6[@3X:!/QZ.%LV'SZ+UP!_/W ]?A3E\.>KX4BWWPKG< MYNORQKMH&Q=E'L)WK\.;J#5HO(UW87D=P%#K0<<83V'6/$S@E4WTT?\_T;YS M:>_WN]84H^'9_^G\X&V4QQEN9^,_"\O6MPJ4WK_\BPLD%S#&AL9YD83;YM.K M,"E:(SZM\IP^B(LU;.F_HC#OG/WL;+@\FPP[H/)+E"1GOZ79;>I?1F&1I='& M?UD4590W/WB==0SQS"M#5YF5 M5JLD7L.2L[#L@G1V=B*^X)_@_POXN75X+_[KV->$O];[VX5[U^;@.6#WH"KX\CX:#X7 $D,G]#V%218$_&@;#(?W/+_AFA55YG>7Q?T>;[_U1 M, 6NN)R.B1N/@L5R3G_)JS$2U@T]R\Q]],,2:.^NC&Y60-\4RZ6W$(4# &RQ MB]9E_"%*6F1!+GOG>I<'USL=!^/I+)B<3VFZR2P8CN?!"&;_?"N^V&R(%L(A MXJ4YBU-_'>YB.%0'YE4W54*W_V037<7KN&Q==T8'UYD?11Q:<)\O#]&AD[
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end XML 69 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 180 255 1 true 63 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://digipath.biz/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://digipath.biz/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://digipath.biz/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://digipath.biz/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://digipath.biz/role/StatementOfStockholdersEquity Consolidated Statement of Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://digipath.biz/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Business and Significant Accounting Policies Sheet http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPolicies Nature of Business and Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://digipath.biz/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Related Party Transactions Sheet http://digipath.biz/role/RelatedPartyTransactions Related Party Transactions Notes 9 false false R10.htm 00000010 - Disclosure - Fair Value of Financial Instruments Sheet http://digipath.biz/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Receivable Sheet http://digipath.biz/role/AccountsReceivable Accounts Receivable Notes 11 false false R12.htm 00000012 - Disclosure - Fixed Assets Sheet http://digipath.biz/role/FixedAssets Fixed Assets Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders' Equity Sheet http://digipath.biz/role/StockholdersEquity Stockholders' Equity Notes 13 false false R14.htm 00000014 - Disclosure - Common Stock Options Sheet http://digipath.biz/role/CommonStockOptions Common Stock Options Notes 14 false false R15.htm 00000015 - Disclosure - Common Stock Warrants Sheet http://digipath.biz/role/CommonStockWarrants Common Stock Warrants Notes 15 false false R16.htm 00000016 - Disclosure - Commitments and Contingencies Sheet http://digipath.biz/role/CommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 00000017 - Disclosure - Other Income Sheet http://digipath.biz/role/OtherIncome Other Income Notes 17 false false R18.htm 00000018 - Disclosure - Income Tax Sheet http://digipath.biz/role/IncomeTax Income Tax Notes 18 false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://digipath.biz/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - Nature of Business and Significant Accounting Policies (Policies) Sheet http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPoliciesPolicies Nature of Business and Significant Accounting Policies (Policies) Policies http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Nature of Business and Significant Accounting Policies (Tables) Sheet http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPoliciesTables Nature of Business and Significant Accounting Policies (Tables) Tables http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://digipath.biz/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://digipath.biz/role/FairValueOfFinancialInstruments 22 false false R23.htm 00000023 - Disclosure - Fixed Assets (Tables) Sheet http://digipath.biz/role/FixedAssetsTables Fixed Assets (Tables) Tables http://digipath.biz/role/FixedAssets 23 false false R24.htm 00000024 - Disclosure - Common Stock Options (Tables) Sheet http://digipath.biz/role/CommonStockOptionsTables Common Stock Options (Tables) Tables http://digipath.biz/role/CommonStockOptions 24 false false R25.htm 00000025 - Disclosure - Common Stock Warrants (Tables) Sheet http://digipath.biz/role/CommonStockWarrantsTables Common Stock Warrants (Tables) Tables http://digipath.biz/role/CommonStockWarrants 25 false false R26.htm 00000026 - Disclosure - Commitments and Contingencies (Tables) Sheet http://digipath.biz/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://digipath.biz/role/CommitmentsAndContingencies 26 false false R27.htm 00000027 - Disclosure - Other Income (Tables) Sheet http://digipath.biz/role/OtherIncomeTables Other Income (Tables) Tables http://digipath.biz/role/OtherIncome 27 false false R28.htm 00000028 - Disclosure - Income Tax (Tables) Sheet http://digipath.biz/role/IncomeTaxTables Income Tax (Tables) Tables http://digipath.biz/role/IncomeTax 28 false false R29.htm 00000029 - Disclosure - Nature of Business and Significant Accounting Policies (Details Narrative) Sheet http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPoliciesDetailsNarrative Nature of Business and Significant Accounting Policies (Details Narrative) Details http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPoliciesTables 29 false false R30.htm 00000030 - Disclosure - Nature of Business and Significant Accounting Policies - Schedule of Entities Under Common Control and Ownership (Details) Sheet http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPolicies-ScheduleOfEntitiesUnderCommonControlAndOwnershipDetails Nature of Business and Significant Accounting Policies - Schedule of Entities Under Common Control and Ownership (Details) Details 30 false false R31.htm 00000031 - Disclosure - Nature of Business and Significant Accounting Policies - Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment (Details) Sheet http://digipath.biz/role/NatureOfBusinessAndSignificantAccountingPolicies-ScheduleOfEstimatedUsefulLivesOfFixedAssetsPropertyPlantAndEquipmentDetails Nature of Business and Significant Accounting Policies - Schedule of Estimated Useful Lives of Fixed Assets Property, Plant and Equipment (Details) Details 31 false false R32.htm 00000032 - Disclosure - Going Concern (Details Narrative) Sheet http://digipath.biz/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://digipath.biz/role/GoingConcern 32 false false R33.htm 00000033 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://digipath.biz/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://digipath.biz/role/RelatedPartyTransactions 33 false false R34.htm 00000034 - Disclosure - Fair Value of Financial Instruments (Details Narrative) Sheet http://digipath.biz/role/FairValueOfFinancialInstrumentsDetailsNarrative Fair Value of Financial Instruments (Details Narrative) Details http://digipath.biz/role/FairValueOfFinancialInstrumentsTables 34 false false R35.htm 00000035 - Disclosure - Fair Value of Financial Instruments - Summary of Financial Instruments at Fair Value on Recurring Basis (Details) Sheet http://digipath.biz/role/FairValueOfFinancialInstruments-SummaryOfFinancialInstrumentsAtFairValueOnRecurringBasisDetails Fair Value of Financial Instruments - Summary of Financial Instruments at Fair Value on Recurring Basis (Details) Details 35 false false R36.htm 00000036 - Disclosure - Accounts Receivable (Details Narrative) Sheet http://digipath.biz/role/AccountsReceivableDetailsNarrative Accounts Receivable (Details Narrative) Details http://digipath.biz/role/AccountsReceivable 36 false false R37.htm 00000037 - Disclosure - Fixed Assets (Details Narrative) Sheet http://digipath.biz/role/FixedAssetsDetailsNarrative Fixed Assets (Details Narrative) Details http://digipath.biz/role/FixedAssetsTables 37 false false R38.htm 00000038 - Disclosure - Fixed Assets - Schedule of Fixed Assets (Details) Sheet http://digipath.biz/role/FixedAssets-ScheduleOfFixedAssetsDetails Fixed Assets - Schedule of Fixed Assets (Details) Details 38 false false R39.htm 00000039 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://digipath.biz/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://digipath.biz/role/StockholdersEquity 39 false false R40.htm 00000040 - Disclosure - Common Stock Options (Details Narrative) Sheet http://digipath.biz/role/CommonStockOptionsDetailsNarrative Common Stock Options (Details Narrative) Details http://digipath.biz/role/CommonStockOptionsTables 40 false false R41.htm 00000041 - Disclosure - Common Stock Options - Summary of Common Stock Options Outstanding (Details) Sheet http://digipath.biz/role/CommonStockOptions-SummaryOfCommonStockOptionsOutstandingDetails Common Stock Options - Summary of Common Stock Options Outstanding (Details) Details 41 false false R42.htm 00000042 - Disclosure - Common Stock Options - Schedule of Option Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details) Sheet http://digipath.biz/role/CommonStockOptions-ScheduleOfOptionPricingModelWeighted-averageAssumptionsUsedForGrantUnderFixedOptionPlanDetails Common Stock Options - Schedule of Option Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details) Details 42 false false R43.htm 00000043 - Disclosure - Common Stock Options - Summary of Common Stock Options Activity Outstanding (Details) Sheet http://digipath.biz/role/CommonStockOptions-SummaryOfCommonStockOptionsActivityOutstandingDetails Common Stock Options - Summary of Common Stock Options Activity Outstanding (Details) Details 43 false false R44.htm 00000044 - Disclosure - Common Stock Warrants (Details Narrative) Sheet http://digipath.biz/role/CommonStockWarrantsDetailsNarrative Common Stock Warrants (Details Narrative) Details http://digipath.biz/role/CommonStockWarrantsTables 44 false false R45.htm 00000045 - Disclosure - Common Stock Warrants - Summary of Common Stock Warrants Outstanding (Details) Sheet http://digipath.biz/role/CommonStockWarrants-SummaryOfCommonStockWarrantsOutstandingDetails Common Stock Warrants - Summary of Common Stock Warrants Outstanding (Details) Details 45 false false R46.htm 00000046 - Disclosure - Common Stock Warrants - Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details) Sheet http://digipath.biz/role/CommonStockWarrants-ScheduleOfWarrantPricingModelWeighted-averageAssumptionsUsedForGrantUnderFixedOptionPlanDetails Common Stock Warrants - Schedule of Warrant Pricing Model Weighted-average Assumptions Used for Grant Under Fixed Option Plan (Details) Details 46 false false R47.htm 00000047 - Disclosure - Common Stock Warrants - Summary of Common Stock Warrants Activity Outstanding (Details) Sheet http://digipath.biz/role/CommonStockWarrants-SummaryOfCommonStockWarrantsActivityOutstandingDetails Common Stock Warrants - Summary of Common Stock Warrants Activity Outstanding (Details) Details 47 false false R48.htm 00000048 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://digipath.biz/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://digipath.biz/role/CommitmentsAndContingenciesTables 48 false false R49.htm 00000049 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payment Under Operating Leases (Details) Sheet http://digipath.biz/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentUnderOperatingLeasesDetails Commitments and Contingencies - Schedule of Future Minimum Rental Payment Under Operating Leases (Details) Details 49 false false R50.htm 00000050 - Disclosure - Other Income - Schedule of Other Income (Details) Sheet http://digipath.biz/role/OtherIncome-ScheduleOfOtherIncomeDetails Other Income - Schedule of Other Income (Details) Details 50 false false R51.htm 00000051 - Disclosure - Income Tax (Details Narrative) Sheet http://digipath.biz/role/IncomeTaxDetailsNarrative Income Tax (Details Narrative) Details http://digipath.biz/role/IncomeTaxTables 51 false false R52.htm 00000052 - Disclosure - Income Tax - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://digipath.biz/role/IncomeTax-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Tax - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 52 false false R53.htm 00000053 - Disclosure - Income Tax - Schedule of Deferred Tax Asset (Details) Sheet http://digipath.biz/role/IncomeTax-ScheduleOfDeferredTaxAssetDetails Income Tax - Schedule of Deferred Tax Asset (Details) Details 53 false false R54.htm 00000054 - Disclosure - Subsequent Events (Details Narrative) Sheet http://digipath.biz/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://digipath.biz/role/SubsequentEvents 54 false false All Reports Book All Reports digp-20180930.xml digp-20180930.xsd digp-20180930_cal.xml digp-20180930_def.xml digp-20180930_lab.xml digp-20180930_pre.xml http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 74 0001493152-18-018010-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-18-018010-xbrl.zip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end